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The epidermis is vitally important in protecting the organism from environmental insults. 
Consisting of dynamic outer strata of keratinocytes that terminally differentiate from basal 
keratinocytes stem cells (KSC), the epidermis is maintained by constant spatial and temporal 
control. In psoriasis, a dysregulated and intensifying crosstalk between keratinocytes and 
immune cells disturbs epidermal homeostasis resulting in hyperproliferation and loss of 
differentiation. Recently, short (~22 nt) genetic molecules called microRNAs (miRNA) that 
regulate gene expression by repressing messenger RNA (mRNA) have gained attention as 
robust regulators of keratinocyte biology and key players in psoriasis. A specific miRNA 
elevated in psoriasis, miR-184, modulates the expression of Argonaute 2 (AGO2), an 
established effector of miRNA function. However, there is a paucity of research investigating 
miR-184 and the miR-184:AGO2 axis in epidermal keratinocyte biology. As such, the aim of 
this thesis was to delineate miR-184 expression and function during keratinocyte proliferation, 
differentiation and migration.  
Firstly, it was revealed that miR-184 was induced during keratinocyte differentiation in 
a process that relies exclusively on Ca2+ and the major keratinocyte Ca2+ entry pathway called 
store-operated calcium entry (SOCE). Furthermore, miR-184 was upregulated in a cohort of 
eight psoriasis patient samples. By modulating miR-184 expression it was elucidated that miR-
184 promotes early keratinocyte differentiation through concomitant induction of factors 
related to DNA damage, growth arrest and terminal differentiation.  
In addition, this thesis reports the discovery of SOCE-dependent induction of miR-184 
during keratinocyte migration as well as a long non-coding RNA, UCA1 that has been 
implicated in the regulation of miR-184. Importantly, ectopic miR-184 stimulated keratinocyte 
migration in scratched monolayers while inhibition of miR-184 reduced migration. 
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 Studies on AGO1-4 transcripts identified that AGO4 mRNA was the most abundant 
AGO in human epidermal keratinocytes and revealed no reduction of AGO2 expression in 
response to enhanced miR-184 levels during differentiation. Furthermore, both AGO1 and 
AGO4 were downregulated in psoriatic patients. Finally, it was established that AGO2 localises 
to the nucleus of terminally differentiated keratinocytes in a Ca2+-dependent mechanism, 
pointing to an apparent nuclear role for AGO2 during keratinocyte differentiation.  
 In summary, the results reported in this thesis highlight an important role for miR-184 
in the regulation of epidermal keratinocyte biology, reveal SOCE as a regulator of miRNA 
pathways in keratinocytes and show for the first time a role for miR-184 in epidermal 
keratinocyte migration. Together, these studies may facilitate the development of miRNA-
based dermaceuticals for cutaneous diseases. 
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In 1993, whilst studying the temporal control of development in Caenorhabditis elegans (C. 
elegans) two groups came across a non-protein coding gene called lin-4, which produced a 
single stranded, 22-nucleotide (nt) ribonucleic acid (RNA) molecule. Their work demonstrated 
that lin-4 directly supressed translation of lin-14 messenger RNA (mRNA) by partially binding 
to the 3’ untranslated region (3’UTR) in an antisense manner, which ultimately led to a 
reduction in protein level (Lee, Feinbaum and Ambros, 1993; Wightman, Ha and Ruvkun, 
1993). Seven years later, further work identified another regulatory non-protein coding gene 
called let-7, which they showed directly regulated a cascade of developmental genes including 
lin-14, confirming these short RNAs as a distinct class of biological regulators (Reinhart et al., 
2000). At the time, these non-coding regulatory genes were thought to be specific to C.elegans 
however, shortly after its identification let-7 was proven to be conserved across most of the 
bilateral phylogeny including humans (Pasquinelli et al., 2000).  
More than two decades since the initial work on lin-4, a plethora of regulatory RNAs 
with similar mechanisms of biogenesis and action have been discovered. In order to distinguish 
these RNAs from the other classes of regulatory RNAs like short interfering RNA (siRNA) 
and P-element Induced Wimpy testes (PIWI) interacting RNA (piRNA) they were termed 
microRNAs (miRNAs) (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001). 
MiRNAs are short, typically 18-25 nucleotides, non-coding RNA molecules found to be 
evolutionarily conserved across animals, insects and plants. These single stranded RNA 
molecules function to disrupt the translation of target mRNAs in a process known as post-
transcriptional gene silencing (PTGS) and are thought to significantly influence almost every 
aspect of cellular biology (Bartel, 2004). In humans, over 1000 miRNA species have been 
identified making up ~1% of the genome with over 60% of protein coding genes conserved 
targets of miRNAs (Friedman et al., 2009; Friedlander et al., 2014). Interestingly, translational 
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disruption of mRNA can occur in a competitive and synergistic nature whereby individual 
miRNAs can have multiple target mRNAs in one cell type often repressing the same biological 
pathway at various points. Equally, several miRNAs can target and bind to the same mRNA 
dependent on the length and specificity of its 3’ UTR (Baek et al., 2008; Selbach et al., 2008; 
Friedman et al., 2009).  
 
 
 
A large majority of all known miRNAs are found within introns of protein coding genes or 
noncoding transcription units. However, dependent on alternative splice site variations, around 
10% of miRNAs can also be derived from exonic transcripts (Rodriguez et al., 2004). Intronic 
miRNAs in the same orientation of protein-coding genes are usually transcribed under the same 
promoter as part of the pre-mRNA transcript (Fig. 1.1) (Baskerville and Bartel, 2005). It has 
also been revealed that some miRNAs are under control of their own distinct promoter. For 
instance, miR-21 is transcribed largely through binding of the transcription factor activator 
protein 1 (AP-1) to either the protein coding gene where it is located or to its own putative 
promoter (Cai, Hagedorn and Cullen, 2004; Fujita et al., 2008; Ribas et al., 2012). Many more 
miRNAs are located far from protein coding genes in intergenic regions but have the same 
transcription response elements and are most commonly generated as part of a cluster. 
Clustered miRNAs are usually under control of an individual promoter and often possess highly 
conserved sequences typically regulating the same transcripts or biological pathway (Fig. 1.1) 
(Bartel, 2004; Loffler et al., 2007; Friedman et al., 2009).  
RNA polymerase III (pol III) transcribes most small RNAs with miRNAs originally 
thought to follow the same process. However, newly transcribed primary miRNAs (pri-
miRNAs) are in some cases several kilobases in length and contain several stretches of uracil 
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(U) tandem repeats that would most likely terminate pol III transcription. It is now known, in 
part due to the presence of a 5′ 7-methylguanosine cap and a 3′ polyadenylated tail, that RNA 
polymerase II (pol II) transcribes most miRNAs (Fig. 1.2) (Cai, Hagedorn and Cullen, 2004; 
Lee et al., 2004). 
 
 
 
Figure 1.1. Genomic Location of miRNA. Intergenic miRNAs are found in regions distinct from transcription 
units. They can be transcribed by their own promoter (A; monocistronic) or as part of a cluster where multiple 
miRNAs are concomitantly transcribed (B; polycistronic). Intronic miRNAs are found in the introns of both 
protein-coding and non-coding genes and can be individual or clustered  (C, D). miRtrons are miRNAs that skip 
nuclear processing and arise through very short introns (E). Exonic miRNAs overlap between exons and introns, 
resulting in less common miRNA transcripts.  
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Following transcription, initial processing of the pri-miRNAs containing important stem loop 
hairpins is performed in the nucleus (Fig. 1.2) (Auyeung et al., 2013). Processing is catalysed 
by the RNase III endonuclease Drosha as part of the larger microprocessor complex with the 
double stranded RNA binding protein DiGeorge Critical Region 8 (DGCR8), in addition to 
accessory proteins such as the DEAD box RNA helicases such as p68 (DDX5), p72 (DDX17) 
or the transcription factors nuclear factor (NF) 45 and NF90 (Lee et al., 2003). DCGR8 acts as 
a molecular anchor, binding to the stem loop hairpins of pri-miRNA around 11 bp away from 
the dsRNA-ssRNA junction. It acts to orientate the pri-miRNA and stabilise Drosha allowing 
for cleavage and releasing precursor miRNA (pre-miRNA). These pre-miRNA molecules are 
60-100 nucleotides in length bearing a 5′ phosphate and a 2-nt 3′ overhang (Han et al., 2006; 
Nguyen et al., 2015). Some unique pre-miRNA molecules, termed mirtrons, derived from short 
introns with hairpin potential undergo splicing and debranching, evading Drosha processing 
before export into the cytoplasm (Berezikov et al., 2007). The output of pre-miRNA can be 
controlled post-transcriptionally with interactions between Drosha/DGCR8 and pri-miRNA 
stabilised by p68 and p72, increasing processing efficiency (Gregory et al., 2004; Davis et al., 
2008). Conversely, the NF45/NF90 complex associated with the microprocessor has been 
shown to act as a negative regulator, impairing access of the pri-miRNA to the catalytic core 
of the microprocessor and dampening pre-miRNA conversion (Sakamoto et al., 2009).  
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Figure 1.2. miRNA Biogenesis. Primary transcripts of miRNA (pri-miRNA) are transcribed by RNA polymerase 
II (PolII). The microprocessor complex consisting of Drosha along with its cofactor DGCR8 cleaves pri-miRNA 
forming precursor miRNA (pre-miRNA). Pre-miRNAs are exported from the nucleus by Exportin 5 under the 
influence of RanGTP. In the cytoplasm, Dicer in complex with TRBP cleaves pre-miRNA leaving a miRNA 
duplex. Mature miRNA, either 5p or 3p, is loaded into an AGO protein to form the miRISC. Mirtrons and m7G-
pre-miRNA differ in nuclear processing or nucleocytoplasmic export but ultimately form a functional miRISC 
complex. Typically, the miRISC binds mRNA targets and represses translation but mRNA degradation can occur 
through recruitment of poly(A)-deadenylases such as CCR4-NOT by the GW182 (TNRC6) family of scaffold 
proteins. Adapted from O’Brien et al., 2018. 
 Dicer 
TRBP 
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Further processing of the imperfect pre-miRNA is required within the cytoplasm. To facilitate 
this the small hairpin needs to be exported from the nucleus to the cytoplasm. Transportation 
across the nuclear membrane is mediated in large by the nucleocytoplasmic transporter 
Exportin-5. Although, recent evidence has suggested a role for Exportin-1 in transport of 
quiescent related miRNAs with abnormal trimethylguanosine 5′ caps (Yi et al., 2003; Xie et 
al., 2013; Martinez et al., 2017). The binding of pre-miRNA to Exportin not only enables 
nuclear export but also protects it from exonucleolytic digestion (Zeng and Cullen, 2004). Pre-
miRNAs bind to Exportin-5 by recognition of the 2-nt 3′ overhang, which via a conformational 
flip widens the minor groove of the miRNA stem allowing for additional interactions to occur 
between Exportin-5 residues and pre-miRNA nucleotides (Wang et al., 2011). Exportin-5 can 
bind to pre-miRNA, but only in the presence of the guanosine triphosphate (GTP)-binding 
nuclear protein Ran-GTP, which when together are known as the nuclear transport receptor. 
Nuclear pore complexes such as nucleoporin recognise nuclear transport receptors and allow 
translocation into the cytoplasm were hydrolysis of Ran-GTP to Ran-GDP by RanGAP induces 
a disassociation of the pre-miRNA cargo (Fig. 1.2) (Yi et al., 2003; Kim, 2004; Lund et al., 
2004).  
25 
 
 
The cytosolic portion of miRNA biogenesis relies on another RNase III endonuclease called 
Dicer (Hutvagner et al., 2001). Dicer is a multi-domain protein with PAZ 
(PIWI/Argonaute/Zwilli) domain, two RNaseIII nuclease domains and a dsRNA binding 
domain, major domains involved in processing of both miRNA and siRNA (Lau et al., 2012). 
During miRNA maturation, Dicer forms a processing complex with the human 
immunodeficiency virus transactivating response RNA-binding protein (TRBP) and protein 
activator of the interferon-induced protein kinase (PACT), which cleaves pre-miRNA close to 
the terminal loop, creating an additional 2-nt 3′ overhang and releasing a small RNA duplex 
(Fig. 1.2) (Chendrimada et al., 2005; Lee et al., 2006; MacRae, Zhou and Doudna, 2007). The 
cleavage process is initiated when Dicer recognizes the terminal 5’ phosphate and 2-nt 3’ 
overhang of the pre-miRNA, with the distance between Dicers PAZ binding domain and the 
two RNase III domains determining the site of cleavage upon the pre-miRNA (Macrae et al., 
2006; MacRae, Zhou and Doudna, 2007; Park et al., 2011; Fukunaga et al., 2014). Both PACT 
and TRBP act to stabilise Dicer, with depletion of either co-factors impacting pre-miRNA 
processing (Lee et al., 2013). The imperfect RNA duplex with adjacent 3′ overhangs is 19-25-
nt long and was initially termed miRNA:miRNA* consisting of the functional guide strand 
involved in mRNA disruption and the passenger strand once thought to be degraded. However, 
recent evidence suggests that both strands can be biologically active (Chang et al., 2013; Bang 
et al., 2014) and therefore a newer nomenclature was presented using the suffixes 5p and 3p to 
term each strand direction, e.g. 5p is forward (5′-3′) (Ambros et al., 2003; Fromm et al., 2015). 
The miRNA duplex is unwound following Dicer cleavage and subsequently loaded onto an 
Argonaute (AGO) protein with the guide strand selected dependent on the thermodynamic 
stability of 5’ end base pairs and the passenger strand ejected to be either loaded onto another 
AGO or degraded (Fig. 1.2) (Khvorova, Reynolds and Jayasena, 2003; Carthew and 
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Sontheimer, 2009). AGO proteins are central catalytic components of the RNA induced 
silencing complex (RISC) with other co-factors, including both TRBP and PACT, as well as 
the heat shock cognate 70/heat shock protein 90 (Hsc70/Hsp90) chaperone machinery (Miyoshi 
et al., 2005; Iwasaki et al., 2010). TRBP and PACT facilitate protein-protein interactions 
between Dicer and AGO and are thought to sense the thermodynamic asymmetry of the 
miRNA duplex, thus acting as key factors for efficient loading (Chendrimada et al., 2005; Lee 
et al., 2006; Noland, Ma and Doudna, 2011). Hsc70/Hsp90 are believed to trigger 
conformational opening of AGO proteins in an adenosine triphosphate (ATP)-dependent 
manner which in turn allows them to receive large miRNA duplexes (Iwasaki et al., 2010). 
 
 
The region in miRNA responsible for its function is called the ‘seed’ region. The seed region 
is a conserved sequence within nucleotide residues 1-8 at the 5′ end of the miRNA and is 
essential for the binding of the guide strand to the target mRNAs 3′ UTR (Fig. 1.3) (Bartel, 
2009). The large majority of miRNA/mRNA interactions occur between the 5′ miRNA seed 
and the mRNA 3′ UTR, although exceptions have been uncovered. Several miRNAs such as 
miR-314, miR-296 and miR-470 target naturally occurring miRNA seed sites outside of the 3′ 
UTR within the amino acid coding region to modulate expression of key regulatory genes of 
stem cell differentiation (Tay et al., 2008). In addition, multiple miRNAs have been 
demonstrated to function through 5′ UTR target sites, such as miR-10a which alleviates 
translational repression of ribosomal proteins during amino acid starvation (Lytle, Yario and 
Steitz, 2007; Orom, Nielsen and Lund, 2008).  
Watson-Crick pairing mediates interactions between miRNA seed regions and mRNA 
seed sites. Four canonical types of seed region/site interactions have been described; 6mer (a 
perfect match of nucleotide residues 2-7 on the seed site), 7mer-A1 (6mer plus an adenosine 
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(A) augmenting target position 1), 7mer-m8 (6mer with a match to nucleotide 8 of the miRNA) 
and an 8mer (6mer flanked by both an additional match to nucleotide 8 of miRNA and an A 
augmenting position 1) (Fig. 1.3) (Grimson et al., 2007). In addition, imperfect mismatches or 
G:U wobbles can be introduced within the seed region or along the length of the miRNA and 
although the RISC can tolerate small discrepancies, repression efficiency of the miRNA is 
usually reduced in a manner that is dependent on the extent of the mismatching (Brennecke et 
al., 2005).  
 
 
 
Figure 1.3. Canonical miRNA Seed Types. The large majority of miRNA:mRNA interactions occur in the 5′ 
miRNA seed and the mRNA 3′ UTR. There are four canonical types of interactions: 6mer (nucleotide residues 2-
7 on the seed site), 7mer-A1 (6mer plus an adenosine (A) at target position 1), 7mer-m8 (6mer plus match with 
nucleotide 8 of the miRNA) and an 8mer (6mer flanked by both an additional matches). 
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In humans, perfect binding of miRNA to mRNA in the presence of AGO2 can induce cleavage 
and degradation of target mRNA, hence preventing translation (Fig. 1.2) (Hammond, 2005). 
However, imperfect seed region complementarity is more prevalent in mammals leading to 
translational repression by disrupting ribosome binding usually by blockade of initiation 
factors, such as eukaryotic initiation factor (eIF) 4E (Fig. 1.2) (Humphreys et al., 2005). 
Interestingly, despite the uncommon endonuclease activity of AGO2 in human cells, when 
ectopic levels of miRNA are introduced a reduction in target mRNA levels frequently follows 
(Guo et al., 2010). Reduction of mRNA levels by miRNA occurs through well described 
mRNA degradation pathways where target mRNA is deadenylated commonly by the CCR4-
NOT deadenylase complex, uncapped usually by decapping protein 1 and 2 (DCP1/DCP2) 
decapping enzymes and degraded typically by 5′-3′ exoribonuclease 1 (XRN1) (Decker and 
Parker, 2012). The process of miRNA silencing was thought to occur in cytoplasmic 
multiprotein complexes known as processing bodies (P-bodies). Although, through 
perturbation of P-body formation, it is now known that miRNA silencing is diffused throughout 
the cytoplasm with the formation of P-bodies a consequence of miRNA silencing (Eulalio et 
al., 2007).  
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In 1998, when studying leaf development in a plant species called Arabidopsis thaliana, Bohert 
et al., 1998 likened the phenotype of AGO1 mutants to the tentacles of a pelagic small squid 
named Argonauta argo (Bohmert et al., 1998). AGO proteins are highly conserved between 
species with many organisms expressing multiple AGO genes (Carmell et al., 2002). They can 
be phylogenetically divided into two main subtypes: the PIWI subfamily that interact with 
piRNA that are largely involved in spermatogenetic transposon silencing, or the AGO 
subfamily that interacts with siRNA and miRNA (Hock and Meister, 2008; Ender and Meister, 
2010). In humans, there are four members of the ubiquitously expressed AGO, subfamily 
named AGO1, AGO2, AGO3 and AGO4, that contribute to the regulation of many cellular 
processes (Hutvagner and Simard, 2008). Interestingly, AGO1, AGO3 and AGO4 are grouped 
on chromosome 1, whereas the AGO2 gene is located on chromosome 8. It is unclear whether 
this clustering pattern indicates any differences in biological function (Carmell et al., 2002). 
The expression patterns of AGO isoforms across differing tissue and cell types remains unclear. 
In mice, it has been demonstrated that Ago2 is the most abundant epidermal Ago, with little 
Ago3 or Ago4 detected. However, a level of functional redundancy exists, with overexpression 
of Ago3 recovering keratinocyte growth defects in Ago1/Ago2 double knockout mice (Wang 
et al., 2012). In human skin, although protein comparisons have not been made, AGO1 and 
AGO2 transcript expression is comparable, whilst AGO3 and AGO4 are detected at low levels 
(Sand et al., 2012; Völler et al., 2016).  Levels of AGO proteins have been shown to be 
dysregulated in several cutaneous diseases. Changes in AGO levels or activity can lead to 
regulatory miRNA imbalances, with newly synthesised miRNAs becoming destabilised or a 
limited pool of AGO molecules preferring abundant miRNAs over sporadic ones (Wang et al., 
2012). A large study on multiple skin cancers, including squamous and basal cell carcinoma, 
determined that expression of AGO1 and AGO2 mRNA was significantly increased when 
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compared with healthy tissues (Sand et al., 2012). Contrastingly, work comparing melanoma 
and non-melanoma cell lines found that overall expression of AGO transcripts was severely 
reduced and that AGO2 was most affected (Völler et al., 2016). AGO2 has been implicated in 
the inflammatory disease psoriasis, with transcript levels severely reduced in psoriatic lesions. 
Recent work has supported this claim, showing that AGO1 and AGO2 mRNA levels in psoriasis 
lesions were significantly decreased when compared with non-lesional controls, although, the 
sample size for both studies was limited (n=5-10) (Roberts et al., 2013; Hessam et al., 2017). 
In contrast, recent RNA-sequencing (RNA-seq) derived gene expression data has suggested 
that AGO2 expression shows a moderate increase in lesional psoriasis samples when compared 
with non-lesional and healthy controls (Zhou et al., 2016). Finally, a very recent report has 
presented a role for AGO1 and AGO2 in hidradenitis suppurativa, which is a chronic 
inflammatory skin disorder where levels of both AGO1 and AGO2 transcripts are significantly 
diminished (Hessam et al., 2017). 
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AGO proteins generally have a molecular weight of around 100 kDa and have a bilobal 
structure that consists of four main domains including N-terminal, PAZ, Middle (MID) and 
PIWI domains (Fig. 1.4) (Kuhn and Joshua-Tor, 2013). The N-terminal, linked to the PAZ 
domain by a linker region, is thought to drive duplex unwinding by acting effectively as a 
wedge (Nilsen and Paulsen, 1990). The PAZ domain recognises and binds to protruding 3′-
nucleotides of pre-miRNA using a basic hydrophobic binding cavity within a Sm-like fold 
(Yuan et al., 2005). The PIWI domain shares extensive homology with the non-sequence 
specific bacterial RNase H domain, which is known to cleave RNA in an RNA/DNA mix. A 
subset of AGO proteins (AGO2 in humans) contribute to the target-cleavage ability of the RISC 
complex in most species. With the PIWI domain responsible for this “Slicer” activity, partly 
through a catalytic triad DDH motif (Asp597, Asp669 and His807) (Yuan et al., 2005; Hock and 
Meister, 2008; Boland et al., 2011). The MID domain forms a binding groove anchoring the 
5′-phosphate end of miRNA with a rigid loop, providing selective bias for uracil/adenosine 
(Jinek and Doudna, 2009). A key component to the RISC and therefore AGO function in 
humans is a scaffold protein known as trinucleotide repeat-containing gene 6 (TNRC6). The 
PIWI domain of AGO2 provides three tryptophan binding pockets for glycine/tryptophan 
(GW) rich argonaute binding domains present on the TNRC6 protein family (TNRC6A, B and 
C). TRNC6 proteins hold intrinsically disordered regions that influence interactions between 
AGOs and important effectors such as poly(A)-binding protein (PABP), an important factor 
that identifies and binds to poly(A) tails of mRNA, as well as the multiprotein deadenylase 
CCR4-NOT complex which removes mRNA poly(A) tails therefore repressing translation and 
marking mRNAs for degradation (Behm-Ansmant et al., 2006; Fabian et al., 2009; Sheu-
Gruttadauria and MacRae, 2018).  
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Figure 1.4. AGO:miRNA complex. AGO2 complexed with miR-20a indicating the N-terminal domain (blue), 
the PAZ domain (red), the Mid domain (green), and the PIWI domain (purple). miR-20a is located in the centre 
in a representation of miRNA binding (Elkayam et al., 2012). 
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AGO proteins are core components of the RISC and therefore indispensable to numerous 
cellular processes. The most defined role of AGO family members is the involvement in small 
RNA-mediated PTGS where they direct miRNAs to their target mRNA, ultimately leading to 
degradation (see 1.1.2). Loss of normal AGO function can have detrimental effects, with 
mutation of AGO orthologs in C. elegans resulting in a reduced amount of viable progeny, in 
addition to heterochrony in surviving cells (Grishok et al., 2001). Furthermore, Drosophila 
AGO1 loss-of-function mutants sustain late embryonic lethality, with those surviving 
presenting defects in both central and peripheral nervous systems (Kataoka, Takeichi and 
Uemura, 2001). In mice, total deletion of Ago2 results in loss of embryonic development, 
whereas single deletion of Ago1, 3 or 4 appears to be dispensable as shown by the maintenance 
of normalised growth (Cheloufi et al., 2010). Likewise, Ago2 deletion in murine embryonic 
stem cells results in delayed self-renewal and differentiation that lead to development defects 
(Shekar et al., 2011). Cutaneous ablation of murine Ago2 led to a striking reduction in global 
miRNA levels, a response exaggerated further by simultaneous knockdown of Ago1 and Ago2 
(Wang et al., 2012). 
RISC mediated silencing of mRNAs occurs through a combination of translational 
repression, deadenylation, decapping and 5′-3′ exonuclease degradation. In addition to the 
basic AGO core, the GW182 family of proteins, termed TNRC6 in humans, play a vital role in 
RISC complex function and are amongst the most well defined AGO partners. TNRC6 proteins 
function as scaffolds, overseeing interactions between AGOs and key downstream effectors 
such as the CCR4-NOT deadenylase complex and when silenced causes severe impairment of 
RISC function and target mRNA degradation (Liu et al., 2005; Sheu-Gruttadauria and MacRae, 
2018). The TNRC6 family have an increased affinity for RNA-loaded AGOs and can utilise 
three GW binding motifs to recruit multiple AGO/miRNA complexes thereby enhancing the 
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cooperative silencing of individual mRNA targets from multiple miRNA species (Elkayam et 
al., 2017). 
 
 
In addition to PTGS, AGO proteins are frequently found within the nucleus where they are 
reported to have numerous roles, including transcriptional gene activation (TGA) and 
transcriptional gene silencing (TGS). The discovery of small RNA-dependent TGA came from 
efforts to silence gene expression, with Li and colleagues noticing that a set of small RNAs 
targeted promoters leading to a loss of histone H3 lysine 9 (H3K9) methylation and specific 
transcription of target genes (Li et al., 2006). Furthermore, studies have shown that AGO2 is 
an essential component of TGA with knockdown resulting in a loss of target gene transcription 
compared with the minimal impact observed following loss of AGO1, 3 or 4 (Li et al., 2006; 
Chu et al., 2010). Additionally, recruitment of AGO2 at gene promoters leads to an enrichment 
of polII binding sites and an increase in histone H3 lysine 4 trimethylation (H3K4me3) 
chromatin modifications which is strongly correlated with transcriptional activity (Huang et 
al., 2012).  
TGS mediated by small RNAs has been studied extensively and was first described in 
plants, whereby transgene and viral RNAs where shown to guide the methylation of 
homologous DNA sequences. Later studies indicated that this DNA methylation is reliant on 
interfaces between AGO, dicer and H3K9 methylation (Wassenegger et al., 1994; Zilberman, 
Cao and Jacobsen, 2003; Henderson et al., 2006). Similarly, deletion of RNAi components 
equivalent to AGO and dicer in Saccharomyces pombe (S. pombe) resulted in a noticeable 
reduction of H3K9 methylation and a loss in silencing of heterochromatic repeats, leading to 
accumulation of nascent non-coding centromeric RNAs and subsequent heterochromatin 
disruption (Reinhart and Bartel, 2002; Volpe et al., 2002). In humans, both AGO1 and AGO2 
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are responsible for siRNA targeting of gene promoters where they induce histone methylation 
and inhibit gene expression (Janowski et al., 2006). More recently, a role for AGO2 in miRNA 
dependent TGS has been established resulting in accumulation of methyl transferase 
components at gene promoters and chromatin remodelling (Kim et al., 2008; Zardo et al., 
2012). Furthermore, in aging fibroblasts, AGO2 has been shown to translocate to the nucleus 
during senescence were it associates with transcriptionally repressed heterochromatin and acts 
to functionally silence Rb/E2F target genes, such as cyclin E, in a process known as 
senescence-associated TGS (SA-TGS) (Benhamed et al., 2012). Finally, although the nuclear 
function is unknown, AGO2 has been detected in the nucleus of primary human keratinocytes 
(monolayer and organotypic cultures) as well as in human epithelial tissue. Interestingly, in the 
continuous keratinocyte cell line HaCaT, presence of nuclear AGO2 was minimal (Sharma et 
al., 2016).  
 
 
The functional activity and stability of AGOs can be regulated post-translationally. Silencing 
activity of AGO proteins, particularly AGO2, can be significantly augmented through prolyl-
hydroxylation (Qi et al., 2008). In humans, hypoxia potently induces expression of prolyl 4-
hydroxylases resulting in hydroxylation of AGO2 at proline-700 (P700) and elevation of 
silencing capacity (Wu et al., 2011). In addition, several phosphorylation patterns have been 
shown to affect AGO activity. The 5′ phosphates of guide RNA strands are anchored to the 
RISC at the AGO MID domain, however, phosphorylation within the MID domain specifically 
at tyrosine-529 (Y529) prevents loading of small RNAs and ultimately RISC deactivation 
(Rudel et al., 2011). Phosphorylation of AGO2 serine 387 (S387), mediated by Akt3, 
suppresses AGO2 endonuclease activity, whilst enhancing translational repression through 
promoting assembly of distinct RISC complexes (Zeng et al., 2008; Horman et al., 2013). 
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Another phosphorylation event at tyrosine-393 (Y393), mediated by epidermal growth factor 
receptor (EGFR), prevents the interactions between AGO, Dicer and TRBP resulting in 
hindered miRNA maturation and accumulation of pre-miRNA (Shen et al., 2013). Multi-site 
phosphorylation of a highly conserved serine/threonine cluster (S824-S834) in the C-terminal 
region of AGO2 plays an important role in the functional recycling of the active AGO2 pool. 
Several phosphorylation events in this serine/threonine cluster by the serine/threonine kinase 
called Casein Kinase 1, Alpha 1 (CSNK1A1) negatively regulates association of AGO2 with 
target mRNAs. Conversely, dephosphorylation of this cluster by the serine/threonine 
phosphatase Ankyrin repeat domain-containing protein 52-Putative regulatory subunit of 
protein phosphatase 6 (ANKRD52-PPP6C) restores AGO2 target engagement effectively 
replenishing the pool of active AGO2 molecules (Golden et al., 2017; Quévillon Huberdeau et 
al., 2017). Finally, AGO activity can be modulated through ubiquitination leading to 
proteosomal degradation and a rapid decrease in global miRNA levels, a process utilised by T-
cells to quickly alter their miRNA expression patterns, resulting in enhanced clonal expansion 
during activation (Bronevetsky et al., 2013).  
  
37 
 
 
The skin is the largest organ covering the entire external surface of the human body. It plays a 
vital role in preventing loss of water and other bodily components as well as forming a barrier 
protecting the body from a range of environmental insults such as microorganisms, heat, 
chemical, mechanical and radiation damage (Eckert, Crish and Robinson, 1997). It is able to 
adapt to both long and short term environmental changes. For example, individuals in areas of 
high ultraviolet (UV) radiation indexes have darker skin, better protecting them from potential 
damage. Thickening at sites of repetitive trauma or friction provides enhanced protection and 
sweating in hot climates to better regulate body temperature (Menon, 2002). The skin consists 
of three major structural layers: the insulative fatty deposits of the subcutaneous layer, the deep 
connective tissues of the dermis and the outermost dynamic stratums of the epidermis (Eckert, 
1989).  
 
 
The epidermis is composed of continually self-renewing, stratified squamous epithelium that 
consists predominantly of keratinocytes although, other resident cells include melanocytes 
(pigment), merkel cells (mechanoreceptors) and langerhans cells (immunity) (Menon, 2002). 
These keratinocytes are organised into layers where they exist at varied stages of 
differentiation. These layers include; the stratum basale (basal layer), stratum spinosum 
(spinous layer), stratum granulosum (granular layer) and the stratum corneum (horny layer), as 
well as a layer specific to thicker skin, such as that present on the palms of hands and feet, 
called the stratum lucidium (clear layer) (Tobin, 2006). Keratinocytes undergo a continuous 
process of terminal differentiation through these transitional strata, ultimately forming non-
living, flattened, enucleated, terminally differentiated keratinocytes known as corneocytes. 
This differentiation process is kept under tight temporal and spatial control involving the 
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formation of a specialised keratin network, development of a cornified envelope (CE) and the 
creation of lipid lamellae (Fig. 1.5) (Eckhart et al., 2013). 
 
 
 
 
 
 
 
 
 
Figure 1.5. The dynamic stratums of the epidermis. The epidermis is a self-renewing tissue composed mainly 
of keratinocytes in various stages of terminal differentiation. TA cells are produced in the stratum basale (basal 
layer) by KSCs, and move outward through the epidermis, undergoing a programmed series of differentiation 
events involving production of specialised CE proteins, keratin network and lipid lamallae. 
 
 
 
 
The basal layer is located at the base of the epidermis, attached to the basal lamina (basement 
membrane) via specialised integrin-mediated attachment assemblies called hemidesmosomes. 
Continuously dividing keratinocyte stem cells (KSC) or basal keratinocytes reside within the 
basal layer connected by desmosomes [114]. As they divide, KSCs provide daughter cells for 
the outer differentiating layers with limited proliferative potential referred to as transit 
amplifying (TA) cells. TA cells can only divide a finite number of times and when this limit is 
reached, they delaminate from the basement membrane and are displaced centrifugally into the 
stratum spinosum, initiating the process of terminal differentiation (Fig 1.5) (Koster and Roop, 
2007; Arwert, Hoste and Watt, 2012). 
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Cells in the stratum spinosum, named from the visual appearance resulting from increased 
desmosomal interactions between adjacent cells, begin to express distinct markers of 
differentiation including transglutaminases and involucrin. Transglutaminases catalyse acyl 
transfer reactions between γ-carboxamide and ε-amino groups of glutamines and lysines of 
proteins, in a process known as ε(γ-glutamyl)lysine crosslinking. Involucrin is one of several 
substrates for transglutaminase, consisting of 45 lysine and 150 glutamine residues, and is the 
earliest cornfield envelope (CE) protein to be deposited and cross-linked at the cell periphery 
of the outer layers where it contributes to mechanical resistance and CE insolubility (Candi, 
Schmidt and Melino, 2005; Eckert et al., 2005). The eponymous product of keratinocytes, 
keratin, is a fibrous protein that contributes largely to the structural properties of skin. 
Expression of keratin subsets change dependent on the cellular status of keratinocytes, with K5 
and K14 the dominant keratins in the basal layer. As cells progress into the stratum spinosum 
this subset changes to K1 and K10, representing reorganisation of cytoskeletal intermediate 
filaments to increase tensile strength and a loss of hemidesmosome attachment sites (Fig 1.5) 
(Loschke et al., 2015). 
 
 
The stratum granulosum is the outermost nucleated layer and is identified by the presence of 
cytoplasmic granules called keratohyalin granules. These granules contain a major 
intermediate filament associated protein called profilaggrin, which upon modification and 
release into the cytoplasm as monomeric filaggrin plays a role in the aggregation and 
compaction of keratin filament bundles during terminal differentiation (Sandilands et al., 
2009). Another major differentiation marker produced in the stratum granulosum is loricrin, 
which migrates to cell peripheries of the outermost layers where it undergoes cross-linking 
40 
 
with several cornification proteins but mainly involucrin (Simpson, Patel and Green, 2011). 
Loricrin makes up most CE proteins, contributing to mechanical resistance and providing a 
scaffold for the deposition of extracellular lipid lamellae. The lipid lamellae, consisting of 
cholesterol, free fatty acids, sphingolipids, ceramides and various hydrolytic enzymes is 
produced in the upper layers of the stratum spinosum, as well as throughout the stratum 
granulosum. Following production, the lipid lamellae undergoes compartmentalisation into 
secretory organelles called lamellar bodies to prevent premature reactions with substrates (Fig 
1.5) (Menon, Lee and Lee; Kalinin, Kajava and Steinert, 2002). 
 
 
The stratum corneum requires a major transformation whereby living keratinocytes cease 
transcriptional and metabolic activity becoming flattened corneocytes in a crucially quick 
process involving the accumulated pools of differentiation related proteins, enzymes and lipids 
(Candi, Schmidt and Melino, 2005). Cells in the stratum corneum undergo a unique form of 
controlled cell death called cornification whereby their nucleus is fragmented and their 
organelles are degraded all whilst transglutaminases attach the pre-existing cross-linked protein 
structures together to create a large yet compact proteinaceus scaffold in the place of a living 
cell. Moreover, by using the protein scaffold as a base the extracellular lipid lamella seals the 
space between cells forming a protective cutaneous layer (Eckhart et al., 2013; Feingold and 
Elias, 2014). To maintain structural integrity corneocytes are shed constantly in a process called 
desquamation with the functional stratum corneum constantly regenerated from pools of 
suprabasal keratinocytes (Fig 1.5) (Elias, 1983).
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Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the 
population. In the UK, its prevalence rose over the past 15 years from 2.3% to 2.8% with all-
cause mortality ~20% higher than people without psoriasis (Springate et al., 2017). Multiple 
forms of psoriasis exist and differ in morphological and localisation traits, which include: 
guttate, pustular, inverse and erythrodermic psoriasis. However, the most frequent 
manifestation is psoriasis vulgaris characterised by scaly, demarcated, erythematosus (redness) 
and squamous plagues with histopathological features containing hyperkeratosis (thickening 
of stratum corneum), parakeratosis (retention of nuclei), acanthosis (hyperplasia), blood vessel 
dilation and accumulation of neutrophils (Nestle, Kaplan and Barker, 2009; Di Meglio, 
Villanova and Nestle, 2014).  
Originally, it was thought that psoriasis was solely associated with the skin, however, 
now there is evidence suggesting that it is a systematic disorder (Davidovici et al., 2010). 
Psoriasis has a huge impact on life quality, with psoriatic arthritis and other joint complaints 
present in around one fifth of patients (Gladman et al., 2005). Furthermore, cardiovascular 
comorbidities frequently feature in psoriasis patients with metabolic syndrome and diabetes 
particularly common (Yim and Armstrong, 2017). Additionally, autoimmune disorders such as 
inflammatory bowel disease and multiple sclerosis have been associated with psoriasis (Furue 
and Kadono, 2017). As well as physical comorbidities, psoriasis has been strongly linked to 
psychosomatic illnesses with depression affecting ~30% patients (Connor, Liu and 
Fiedorowicz, 2015).  
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Psoriasis is mediated through a dysregulated and intensifying crosstalk between immune cells 
and keratinocytes, however the initial cause is not fully understood. Studies from twins 
demonstrate the importance of genetic susceptibility with monozygotic twins exhibiting a 3 to 
5-fold higher risk of psoriasis when compared with dizygotic twins (Nestle, Kaplan and Barker, 
2009). Genome wide association studies (GWAS) have shown that heritability is linked in large 
to mutations in the PSOR1 loci, which encodes genes for major histocompatibility complexes 
(MHCs) including human leukocyte antigens (HLAs). Mutations within HLA alleles are linked 
with greater risk for severe psoriasis (Nestle, Kaplan and Barker, 2009; Roberson and 
Bowcock, 2010; Ray-Jones et al., 2016). On the other hand, other genetic susceptibility factors 
have been defined including mutations within CARD14 and IL36RN genes, most commonly 
present in pustular psoriasis (Tsoi et al., 2012). In addition to genetic predispositions, physical 
environmental stresses, including mechanical trauma, infection, medication and UV-exposure, 
have also been implicated in development of psoriasis in a process called Köbners phenomenon 
(Nestle, Kaplan and Barker, 2009; Di Meglio, Villanova and Nestle, 2014). 
A plethora of dysregulated pathways contributes to the cellular makeup of psoriasis 
with multiple layers of molecular complexity derived from involvement of both innate and 
adaptive immune systems. Coupled with copious cytokine interactions and reciprocal activities 
of keratinocytes, which is progressively amplified by positive and negative feedback loops (Di 
Meglio, Villanova and Nestle, 2014). Cytokines are the major intermediary in development of 
psoriasis and exert their effect by activating the expression of more than 1300 genes that are 
found to be dysregulated within psoriasis through triggering of molecular pathways including 
signal transducer and activation of transcription 1 and 3 (STAT1; STAT3) and NF-κβ (Krueger 
and Bowcock, 2005).  
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Originally, psoriasis was thought of as a T helper 1 (Th1) and interferon-gamma (IFNγ) 
dominant disorder. Despite this characteristic remaining true for disease onset, it is now 
believed that in the chronic inflammatory phase the interleukin axis (IL-23/IL-17/IL-22) and 
tumour necrosis factor alpha (TNF-α) play a critical role (Greb et al., 2016). During initial 
pathogenic steps, it is thought that stressed keratinocytes produce and release complexes of self 
RNA/DNA as well as antimicrobial peptides (AMPs) such as S100 proteins, β-defensins and 
cathelicidin (LL37) which attract and activate plasmacytoid dendritic cells (pDCs) (Morizane 
and Gallo, 2012). Activation of pDCs results in release of type I interferons, which along with 
keratinocyte-derived IL-1β, IL-6 and TNFα attract and mediate activation of dermal dendritic 
cells (DCCs), conventional dendritic cells (cDCs) and specialised epidermal dendritic cells 
called Langerhans cells (Lowes, Bowcock and Krueger, 2007; Morizane and Gallo, 2012). 
Stimulated DCCs, cDCs and Langerhans cells produce a range of key cytokines including IL-
12 and IL-23 that are responsible for linking innate and adaptive immune responses. IL-12 
stimulates differentiation of naïve CD4+ T-cells into Th1 subset cells leading to production of 
IFNγ and TNFα whereas IL-23 stimulates differentiation into Th17 and Th22 T cell lineages 
(Aggarwal et al., 2003; Lowes, Bowcock and Krueger, 2007; Teng et al., 2015). Th17 cells 
produce IL-17, which promotes production and release of factors that stimulate migration of T 
cells (chemokine C-C motif ligand 20; CCL20), and neutrophils (chemokine C-X-C motif 
ligand 1; CXCL1, CXCL2, CXCL5, CXCL8 and granulocyte-macrophage colony stimulating 
factor; GM-CSF) into the epidermal compartment (Aggarwal et al., 2003; Wilson et al., 2007; 
Di Meglio, Villanova and Nestle, 2014; Ha et al., 2014). Th22 cells produce IL-22 which 
promotes hyperproliferation of keratinocytes, normally to dispatch internal pathogens by 
increasing cell turnover. Enhanced levels of IL-22 causes epidermal hyperplasia in psoriasis 
were psoriatic keratinocytes reach the skin surface in as little as 6 days, as opposed to the 40 
days observed in normal cells (Zheng et al., 2007; Wolk et al., 2009). The altered cytokine 
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profile seems to not only cause the epidermal changes observed in psoriasis but also a self-
reliant feedback loop leading to the development and, ultimately, worsening of the disease.  
 
 
The role of miRNAs in epidermal homeostasis has received a lot of interest over the past decade 
with a link between miRNAs and psoriasis first suggested by Andor Pivarcsis laboratory in 
2007 with hundreds of miRNAs now described as abnormally expressed psoriatic lesions 
(Sonkoly et al., 2007).  
miR-203 
The first miRNA to be identified as skin specific, miR-203 is made solely by keratinocytes 
where it regulates terminal differentiation, with several studies describing miR-203 
dysregulation in patients with psoriasis (Sonkoly et al., 2007; Sonkoly et al., 2010; Zibert et 
al., 2010; Joyce et al., 2011). In addition to regulating keratinocyte differentiation by p63 
inhibition, miR-203 also targets suppressor of cytokine signaling 3 (SOCS3), which regulates 
STAT3, a transcription factor known to play a role within the development of psoriatic lesions. 
Increased miR-203 is associated with reduced SOCS3 and elevated STAT3 signalling within 
psoriasis (Sonkoly et al., 2010). However, studies have since challenged the ability of miR-203 
to successfully target SOCS3, presenting pro-inflammatory cytokines such as TNF-α and IL-
24 as main targets for elevated miR-203 in psoriasis (Primo et al., 2012).  
miR-21 
miR-21, an important oncogenic miRNA responsible for inhibiting apoptosis and promoting 
inflammation with studies describing elevated levels in psoriatic lesions (Sonkoly et al., 2007; 
Joyce et al., 2011). Recently, miR-21 has been shown to target Metalloproteinase inhibitor 3 
(TIMP3) which in turn elevates TNF-α by activation of the metalloproteinase, TNF-α-
converting enzyme (TACE), contributing to the increased levels of TNF-α observed in 
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psoriasis (Guinea-Viniegra et al., 2014). Furthermore, inhibition of miR-21 increased rates of 
apoptosis in activated human CD4+ T cells suggesting that overexpression of miR-21 in 
psoriasis may contribute T cell infiltration (Meisgen et al., 2012). Additionally, key 
components that adenylate and degrade miR-21 have been shown to be disrupted in psoriasis 
leading to enhanced miR-21 levels (Boele et al., 2014). 
miR-31 
MiR-31, an miRNA with a dramatic 40-fold upregulation in psoriatic lesions has been shown 
to modulate the production of cytokines and chemokines in keratinocytes by targeting 
serine/threonine kinase 40 (STK40). STK40 is a negative regulator of NF-κβ in keratinocytes. 
By targeting STK40 miR-31 regulates NF-κβ signaling and therefore production of 
keratinocyte-derived cytokines and chemokines (Joyce et al., 2011; Xu et al., 2013). 
Interestingly, miR-31 seems to self-regulate its own expression, with NF-κβ activity resulting 
in elevated proliferation and further upregulation of miR-31 expression (Yan et al., 2015). 
miR-146a 
One of the most highly upregulated miRNAs in psoriasis, miR-146a plays a key role in 
regulating immune responses, by directly targeting TNF receptor-associated factor 6 (TRAF6), 
IL-1 receptor-associated kinase 1 (IRAK1) and caspase recruitment domain-containing protein 
10 (CARD10) leading to diminished NF-κβ activity and reduced production of pro-
inflammatory cytokines such as IL-6 and TNF-α (Taganov et al., 2006; O'Connell, Rao and 
Baltimore, 2012; Rebane et al., 2014). Furthermore, transgenic miR-146a knockout mice 
exhibit an elevated Th1 type response that subsequently leads to autoimmunity (Lu et al., 
2010). Dysregulated miR-146a has been shown to have a strong positive correlation with IL-
17 expression in both psoriatic epidermal and dermal compartments as well as peripheral blood 
mononuclear cells (PBMCs) (Xia et al., 2012; Srivastava et al., 2017). Additionally, a single 
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nucleotide polymorphism (SNP) of precursor miR-146a has been associated with earlier onset 
of psoriasis (Srivastava et al., 2017).  
miR-125b 
miR-125b is an example of a downregulated miRNA associated with psoriasis, with levels 
significantly decreased in psoriatic skin and serum (Sonkoly et al., 2007; Xu et al., 2011; Koga 
et al., 2014). In primary human keratinocytes, reductions in endogenous miR-125b resulted in 
elevated proliferation and decreased differentiation, whereas overexpression suppressed 
proliferation and promoted expression of several differentiation markers, with these responses 
mediated by fibroblast growth factor receptor 2 (FGFR2) (Xu et al., 2011). In addition, a very 
recent study identified ubiquitin-specific peptidase 2 (USP2) as a target for miR-125b in 
psoriasis, showing that USP2 was upregulated in psoriatic lesions and that knockdown through 
miR-125b overexpression or targeted siRNA resulted in reduced proliferation and enhanced 
differentiation (Wei et al., 2017). Furthermore, TNF-α is a direct target of miR-125b, therefore, 
decreases in miR-125b in psoriatic lesions may contribute to elevated TNF-α observed in 
lesions (Tili et al., 2007).  
miR-210 
Increased levels of miR-210, a hypoxia related miRNA, have been observed in psoriasis where 
it contributes to pathogenesis by disrupting regulatory T (Treg) cell activity (Zhao et al., 2014). 
miR-210 is significantly upregulated in PBMCs and CD4+ T cells of psoriasis patients and is 
associated with increased levels of pro-inflammatory cytokines, such as IL-17, by direct 
targeting of forkhead box P3 (FOXP3) a master regulator of Treg cell function (Zhao et al., 
2014). In addition, a very recent study has demonstrated that elevated miR-210 results in 
enhanced Th1 and Th17 cells in peripheral blood and skin lesions of psoriasis patients as well 
as psoriatic mouse models, with miR-210 silencing preventing development of psoriasis-like 
inflammatory responses (Wu et al., 2018).  
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miR-184 
miR-184, a unique miRNA that can regulate expression of other miRNAs by direct targeting 
of AGO2, has been shown to be upregulated in psoriatic lesions.  The same study also 
demonstrated that expression of miR-184 can by induced by psoriasis-linked pro-inflammatory 
cytokines such as IL-22 and oncostatin M in primary human keratinocytes and reconstituted 
human epidermis. However, prior miRNA profiling studies failed to find a significant 
dysregulation of miR-184 in psoriatic skin and therefore its involvement remains unclear 
(Joyce et al., 2011; Roberts et al., 2013).  
 
 
Keratinocytes are kept under strict homeostasis to maintain normal biological functions with 
errors in this regulation leading to severe cutaneous disorders such as eczema (Proksch, Folster-
Holst and Jensen, 2006), psoriasis (Bowcock and Krueger, 2005), harlequin ichthyosis (Dale 
et al., 1990) and various cancers (Miller, 1991; Alam and Ratner, 2001). There are several 
established methods to culture keratinocytes and mimic their differentiation in vitro using 
monolayer or organotypic 3D cultures and addition of a differentiation agent such as calcium 
(Sun and Green, 1976).  
 
 
A fine balance between proliferation and differentiation underpins keratinocyte biology. The 
maintenance of this homeostasis requires precise coordination of molecular events. 
Differentiation is initiated when basal cells hit their proliferative capacity and exit the basal 
compartment. Traditionally, it is thought that keratinocytes leave the cell cycle, undergo growth 
arrest and commit to terminal differentiation. The cell cycle plays a key role in basal cell 
maintenance and is commonly deregulated upon the onset of differentiation with suprabasal 
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keratinocytes expressing cell cycle proteins such as cyclin E to support their enlargement 
(Zanet et al., 2010). Cell cycle progression is controlled largely by cyclins and cyclin dependent 
kinases (Cdks) with a group of molecules called cyclin dependent kinase inhibitors (CDKI) 
responsible for the control of the cell cycle at various stages (Sherr and Roberts, 2004).  
 
 
Nuclear transcription factors play a huge role in keratinocyte proliferation and differentiation 
by integrating signals from the cell surface using signal transduction pathways, these 
transcription factor include: AP-1 (Activator protein-1), AP-2 (Activator protein-2), Sp1 
(Specificity protein), NF-κB (Nuclear factor kappa B), CREB (cAMP response element-
binding protein) and NFAT (Nuclear factor of activated T cells). AP-1 and AP-2 are homo- or 
heterodimers that have been shown to be important for activating transcription of K1, K5, 
loricrin, involucrin, profilaggrin and transglutaminase (Eckert, Crish and Robinson, 1997). Sp1 
has been shown to regulate expression of transglutaminase, involucrin and K5 (Eckert, Crish 
and Robinson, 1997). Moreover, Sp1 is known to interact with the NFAT family of 
transcription factors which act as coactivators to positively regulate expression of p21 (Santini 
et al., 2001). NF-κB is essential during keratinocyte differentiation and is thought to protect 
keratinocytes from apoptosis as they undergo cornification with anti-apoptotic NF-κB gene 
targets such as those in the Bcl-2 family significantly upregulated during in vivo and murine 
epidermal differentiation (Lippens et al., 2011). NFAT family consists of five Ca2+-regulated 
members (NFAT1-5) closely related to the NF-κB family. NFAT regulates differentiation in 
several cell types by activating expression of a large array of genes. In human keratinocytes, 
NFAT1 localises to the nucleus during differentiation where it is believed to activate expression 
of a cohort of differentiation-linked genes (Santini et al., 2001; Al-Daraji et al., 2002). NFAT 
is important to the regulation of the cell cycle. In primary epidermal mouse keratinocytes, 
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NFAT1 and NFAT2 bind directly to a calcium-response element (CARE) in the p21 promoter 
during Ca2+-dependent differentiation leading to induction of p21 and initiation of 
differentiation through growth arrest (Santini et al., 2001). 
 
 
p21 was originally identified as an intermediary of p53-induced growth arrest particularly in 
cellular senescence and is now strongly associated with growth arrest during keratinocyte 
differentiation. In murine epidermal keratinocytes, when p21 is knocked down, proliferative 
potential is significantly elevated coupled with a drastic reduction in differentiation marker 
expression when these cells are differentiated (Missero et al., 1996). In addition, a later study 
demonstrated keratinocytes from transgenic mice lacking p21 exhibit enhanced proliferative 
potential with p21 knockout cultures presenting higher clonogenic properties than normal cells 
(Topley et al., 1999). Furthermore, it has been demonstrated that p21 downregulates 
proliferation-linked Wnt signalling by binding to its promotor and inhibiting expression 
(Devgan et al., 2005). In human skin, expression of p21 has been shown to accumulate in early 
differentiating layers and to promote growth arrest. However, when expression is maintained 
throughout later stages then differentiation is supressed, suggesting that p21 is tightly regulated 
and must be inactivated before late stage differentiation can proceed (Topley et al., 1999; 
Devgan et al., 2006). Additionally, in vitro keratinocyte growth led to induction of p21 and 
accumulation of G1-stage cells in a cell density-dependent manner (Cho et al., 2008). 
Furthermore, by removal of the differentiation stimulus, early stages of in vitro keratinocyte 
differentiation have been reversed, a process in which p21 appears to be critical, with a 
significantly elevated number of p21 knockout keratinocytes returning to a proliferating 
phenotype following differentiation agent removal when compared to normal cells (Topley et 
al., 1999).  
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An emerging body of work challenges traditional keratinocyte differentiation mechanisms and 
highlights the importance of cyclin E during keratinocyte differentiation (Fig. 1.6). Cyclin E, 
essential for G1-S phase transition, has been shown to accumulate in differentiating human 
epidermal keratinocyte and in outer layers of the human epidermis (Zanet et al., 2010; Freije 
et al., 2012). Moreover, overexpression of cyclin E in basal keratinocytes promoted expression 
of involucrin, reduced clonogenic potential and ultimately led to terminal differentiation 
(Murray, 2004; Freije et al., 2012). Furthermore, cyclin E overexpression has been shown to 
cause genetic instability in several cell types with the subsequent DNA damage response 
(DDR) programs responsible for the regulation of cellular differentiation (Hwang and Clurman, 
2005; Sherman, Bassing and Teitell, 2011). Genotoxic agents such as doxorubicin lead to DNA 
damage-induced terminal differentiation in human epidermal keratinocytes (Freije et al., 2012). 
A sensitive marker for DNA double-strand breaks (DSBs) and therefore a key component of 
DNA repair is the histone protein, H2AX (H2A histone family member X). A histone H2A 
family member that organises DNA into chromatin, H2AX in humans becomes rapidly 
phosphorylated on serine139 within the carboxyl terminus, at the sites of DSBs, becoming 
gammaH2AX (γH2AX) (Bonner et al., 2008). When cyclin E is abnormally elevated, levels of 
γH2AX are significantly elevated. Leading to increases in DDR elements such as p53 and p21, 
mitosis failure and ultimately terminal differentiation (Freije et al., 2012).  
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Figure 1.6. Molecular Mechanism of HPEK Differentiation. Cell cycle dysregulation resulting from cyclin E 
accumulation causes replication stress and DNA damage. DDR effectors such as p21 are recruited and inhibit 
mitotic factors such as cyclin A triggering mitosis checkpoints that prevents cell division. Consequently, cell size 
increases with DNA re-replication and terminal differentiation is triggered. Taken from Gandarillas, 2012 
(Gandarillas, 2012).
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The most commonly used technique to control keratinocyte differentiation in vitro is a 
calcium switch, whereby the levels of extracellular calcium in the growth medium are elevated. 
Early work on mouse epidermal keratinocytes by Hennings and colleagues documented that 
levels of calcium (Ca2+) <0.1 mM supress differentiation and allow keratinocytes to proliferate 
rapidly whereas high concentrations (>1.0 mM) induce terminal differentiation at varying rates 
(Hennings et al., 1980). Physiologically, Ca2+ forms a sharp gradient throughout the epidermis 
peaking within the stratum granulosum. Although,  Ca2+ levels within the stratum basale are 
expected to be the lowest, keratinocytes in fact have variable amounts when compared to the 
stratum spinosum, with a number of keratinocytes holding large amounts of free cytosolic 
calcium [Ca2+] which is thought to promote differentiation and migration from the basal layer. 
It is the sustained and steady increase of [Ca2+] that contributes to keratinocyte differentiation, 
with transient increase in [Ca2+] proving ineffective in reaching the required threshold (Bikle, 
Xie and Tu, 2012). Elevated [Ca2+] initiates differentiation by promoting expression of a large 
cluster of differentiation related genes, formation of desmosomes and activation of 
transglutaminases, as well as Ca2+-dependent proteases (Eckert, Crish and Robinson, 1997). In 
keratinocytes, interactions of various agonists with receptors can stimulate phospholipase C 
(PLC). Stimulation of PLC leads to hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) 
which in turn forms the secondary messengers inositol trisphosphate (IP3) and diacylglycerol 
(DAG), with IP3 inducing Ca
2+ release from the endoplasmic reticulum (ER) and DAG 
activating other pathways including protein kinase C (PKC) and mitogen-activated protein 
kinase (MAPK) (Bootman, 2012). Phorbol-12-myristate-13-acetate (PMA) and vitamin D 
(1,25(OH)2D3), are thought to have overlapping signalling responses with Ca
2+. PMA is known 
to promote keratinocyte differentiation through direct and potent activation of PKC, 
independent of extracellular Ca2+ levels. PKC, in turn, activates transciption factors such as 
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AP-1, Sp1, NF-κB and CREB, resulting in expression of key differentiation linked proteins 
such as K1 and p21 (Matsui et al., 1993; Bikle, 2011). Vitamin D, produced and processed 
solely in the epidermis, promotes differentiation through activation of genes containing the 
Vitamin D response element (VDRE) such as involucrin, by means of vitamin D receptor 
(VDR) transcriptional activity (Bikle, 2011).  
Store-operated calcium entry (SOCE), a primary source of Ca2+ signalling in 
nonexcitable cells, responds to the IP3-induced ER Ca
2+ depletion utilising Ca2+ release-
activated channel (CRAC) channels. Activation of IP3 receptor (IP3R) by IP3 leads to release 
of Ca2+ and a reduction in ER Ca2+ concentration. This decrease is recognised by stromal 
interaction molecule (STIM), specifically by Ca2+ binding EF-hand motifs, which undergo a 
conformational change promoting oligomerisation and relocalisation within the ER membrane 
towards ER-plasma membrane junctions, accumulating in puncta. STIM then swiftly recruits 
a CRAC known as ORAI which becomes reversibly trapped by physical interactions with 
STIM, causing conformational opening of ORAI and allowing entry of Ca2+ (Fig. 1.7) (Prakriya 
and Lewis, 2015). SOCE is a vital pathway for normal keratinocyte biology with knockdown 
of either STIM or ORAI leading to attenuated growth in basal keratinocytes and a lack of 
growth arrest during terminal differentiation (Numaga-Tomita and Putney, 2013). The NFAT 
signalling pathway is key downstream effector of SOCE. Sustained elevated [Ca2+] leads to 
activation of the bilobial Ca2+-effector protein, calmodulin (CaM), which contains four Ca2+ 
binding EF hands. Following activation, CaM interacts with the serine/threonine protein 
phosphatase, calcineurin (CaN) and releases the autoinhibitory domain from CaNs active site, 
which in turn dephosphorylates inactive NFAT, initiating nuclear translocation by exposing a 
nuclear localisation signal region. Following nuclear translocation, NFAT regulates the 
expression of responsive genes by binding to their target promoter regions individually or 
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together with other nuclear transcription factors (Fig. 1.7) (Rumi-Masante et al., 2012; Mognol 
et al., 2016).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Store-operated Calcium Entry (SOCE). A graphical depiction of SOCE whereby agonist 
stimulation of membrane receptors leads to activation of phospholipase C (PLC) that in turn produces inositol 
trisphosphate (IP3). IP3 stimulates the IP3 receptor (IP3R) and consequently causes depletion of endoplasmic 
reticulum calcium (Ca2+) stores. Stromal interaction molecule (STIM) senses reduced endoplasmic reticulum Ca2+ 
pools and translocates to puncta at ER-plasma membrane junctions were it activates the store-operated channel 
(SOC), ORAI, allowing influx of extracellular Ca2+. Sustained increases in cytoplasmic [Ca2+] results in activation 
of calmodulin (CaM) which in turn stimulates calcineurin (CaN). Activated CaN dephosphorylates nuclear factor 
of activated T-cells (NFAT) family members triggering nuclear translocation and expression of target genes. 
 
 
The activity of SOCE, and therefore processes dependent on SOCE, can be perturbed using 
inhibitors. The most commonly used SOCE modulators are the trivalent lanthanides including 
La3+ (lanthanum) and Gd3+ (gadolinium). Submicromolar concentrations are required for 
complete blockade of SOCE although they show inhibitory activity against other cationic ion 
channels, which therefore limits their reliability in SOCE specific experiments (Putney, 2010). 
Another widely used group of SOCE inhibitors are derivatives of pyrazole compounds with 
BTP2 (N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-
carboxamide) the most common. Although the mechanism of action has not been fully 
clarified, it is thought that BTP2 inhibits NFAT activity without effecting CaN, therefore 
suggesting likely effects on upstream Ca2+ signals such as inhibition of ORAI1. Like the 
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lanthanides, BTP2 is capable of inhibiting SOCE at submicromolar concentrations, but it has 
considerably more selectivity over other cationic ion channels (Vandenberghe et al., 2013). 
Cyclosporin A (CsA) is a commonly used downstream inhibitor for SOCE as it modulates 
NFAT activity. Once in the cell, CsA forms a complex with cyclophilin A which binds to CaN 
and inhibits its phosphatase activity, consequently preventing nuclear translocation of NFAT 
(Fig. 1.7)  (Matsuda and Koyasu, 2000).
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Increasing evidence suggests that miRNAs play a significant role within differentiation of 
epidermal stem cells (Hildebrand et al., 2011; Zhang et al., 2011). Depletion of proteins vital 
to miRNA function leads to the disruption of skin homeostasis leading to improper barrier 
formation and hyperproliferation (Ghatak et al., 2015).  
miR-203, is a well-known skin-preferred miRNA known to promote differentiation by 
limiting proliferative capacity and inducing cell-cycle exit within basal keratinocyte 
progenitors. miR-203 exerts its function through regulation of p63 (Lena et al., 2008; Yi et al., 
2008a). miR-205 has been shown to regulate clonal expansion of epidermal stem cells by 
targeting phosphoinositide 3-kinase/Akt pathway (PI3K/Akt), with downregulated miR-205 
promoting differentiation (Wang et al., 2013). MiR-24 has recently been identified as a key 
keratinocyte differentiation regulator expressed within suprabasal layers, with ectopic basal 
expression causing accelerated differentiation and premature cell-cycle exit. MiR-24 is thought 
to regulate actin cytoskeletal rearrangement promoting a shift from basal to suprabasal F-actin 
structures by targeting important cytoskeletal modulators (Amelio et al., 2012). Recently, miR-
214 has been shown to control epidermal stem cell activity, contributing to the regulation of 
skin morphogenesis by targeting β-catenin, a key component within the Wnt signalling 
pathway, with miR-214 overexpression inhibiting keratinocyte differentiation (Ahmed et al., 
2014). A very recent study demonstrates regulation of keratinocyte differentiation using miR-
23b which directly targets TGIF and consequently activates transforming growth factor beta 
(TGF-β) signalling, leading to keratinocyte differentiation (Barbollat-Boutrand et al., 2017). 
Comprehensive analysis of miRNA expression within keratinocyte differentiation has revealed 
a plethora of upregulated miRNAs, suggesting that many miRNAs work in situ contributing to 
gene regulation during keratinocyte differentiation, yet still our present understanding of global 
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miRNA expression and its role within keratinocyte biology remains restricted (Hildebrand et 
al., 2011). 
Robert Lavkers laboratory first proposed a role for miR-184 in the regulation of 
keratinocyte biology when they detected high levels of miR-184 in mouse corneal epithelium 
but not in foot-pad epithelium. Based on this discovery they later found miR-184 promotes 
proliferation of corneal epithelium by antagonising miR-205 and indirectly modulating SH2-
domain containing inositol 5-phosphatase 2 (SHIP2) (Ryan, Oliveira-Fernandes and Lavker, 
2006; Yu et al., 2008). In contrast, a recent study in retinal pigment epithelium has shown that 
miR-184 targets Akt2 to suppress proliferation and support differentiation (Jiang et al., 2016). 
Although miR-184 was not listed as a miRNA differentially expressed during epidermal 
differentiation a very recent study, published following the conception of this project, has 
shown miR-184 to be significantly elevated in the suprabasal layers of mouse epidermis 
(Hildebrand et al., 2011; Nagosa et al., 2017). Through use of loss- and gain-of-function mouse 
models, it was demonstrated that miR-184 maintains the equilibrium between proliferation and 
differentiation by direct regulation of factor inhibiting HIF (FIH) and K15. Loss of miR-184 
led to decreased expression of notch and its downstream targets as well as enhanced p63 
activity resulting in hyperplasia of the stratum spinosum. Over expression of miR-184 led to 
epidermal hypoplasia through heightened Notch signalling and reduced p63 expression 
(Nagosa et al., 2017). Although the ability of miR-184 to regulate proliferation and 
differentiation has been demonstrated in ocular keratinocytes, and despite recent work by 
Nagosa et al., miR-184’s role in the regulation of the proliferation:differentiation switch in 
epidermal keratinocytes has remained relatively unexplored. 
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Cell  migration plays a fundamental role in the development and maintenance of multicellular 
organisms. The migration of keratinocytes is a crucial step for processes such as wound 
healing, where keratinocytes migrate from the wound edge, and differentiation, where 
keratinocytes migrate upwards through stratified layers. Keratinocyte migration requires 
complex coordination of cytoskeletal dynamics and cellular adhesions whereby cellular 
polarisation and formation of protrusions, adhesion of newly formed protrusions to surrounding 
extracellular matrix (ECM) and adhesion deassembly to aid rear retraction, lead to cellular 
movement. Despite the emerging role for miR-184 in migration, in the context of epidermal 
keratinocyte migration the role of miR-184 is unknown.  
 
 
In recent years, the role of miRNAs in keratinocyte migration and wound healing have begun 
to surface. The initial phases of wound healing are dominated by inflammatory responses. A  
recent study has suggested that miR-132 supports transition from inflammatory to proliferative 
phases. Levels of miR-132 are downregulated in chronic wounds with replenishment 
ameliorating inflammation and promoting wound closure (Li et al., 2017). Upwards migration 
of keratinocytes through stratified layers is vital for normal differentiation and is facilitated 
through regulation of cell-cell connections called desmosomes. A recent study has shown that 
miR-29 disrupts formation of desmosomes by direct targeting of desmocollin-2 leading to 
pertubed barrier function (Kurinna et al., 2014). During wound healing, migration of 
keratinocytes is stimulated by changes in the local enviroment, including altered ECM (Eming, 
Martin and Tomic-Canic, 2014). Work on HaCaTs has implicated miR-21 in TGF-β induced 
keratinocyte migration (Yang et al., 2011). MiR-21 was shown to be upregulated by TGF-β, 
where it supported migration by directly targeting TIMP3, an inhibitor of a group of molecules 
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called matrix metalloproteinases (MMPs) that are responsible for ECM turnover, causing 
adhesive or non-adhesive phenotypic changes during migration (Yang et al., 2011). Another 
key factor in keratinocyte migration and wound healing is enhanced cellular proliferation 
behind the migration front/wound edge. A recent study has demonstrated that miR-31 is highly 
upregulated during re-epithelization and that the expression of epithelial membrane protein 1 
(EMP-1) is negatively correlated with miR-31 levels. It was shown that miR-31 directly targets 
EMP-1 and derepresses keratinocyte proliferation and migration, with silencing of EMP-1 
mimicking miR-31 overexpression (Li et al., 2015). Complex coordination of the actin skeleton 
is vital to cellular movement whereby actin polymerisation in the direction of migration allows 
for extension of the cells leading edge and attachment to new ECM, a process completed by 
quick depolymerisation in the trailing compartment (Petrie and Yamada, 2012). Work by 
Amelio and colleagues demonstrates that miR-24 causes actin remodelling through suppression 
of cytoskeletal modulators resulting in inhibition of keratinocyte migration (Amelio et al., 
2012). The final stages of migration rely on the arrest of migration and proliferation in order to 
regain homeostasis and prevent keratinocyte proliferation beyond closure of the wound. A 
study on mouse keratinocytes has shown that overexpression of miR-483-3p inhibits 
keratinocyte migration through modulation of proliferation-associated proteins such as Ki67 
(Bertero et al., 2011). 
There is a growing body of evidence suggesting that miR-184 can regulate migration 
with an early study in corneal epithelium demonstrating that suppression of miR-184 allows 
miR-205 to promote keratinocyte migration through repression of SHIP2 (Yu et al., 2010). 
Recent work backs up the tumour suppressive role of miR-184, showing that miR-184 reduced 
migration rates over 72 hours in retinal pigment epithelium by directly targeting Akt2 
signalling (Jiang et al., 2016). Conversely, a pro-invasive role for miR-184 has been 
demonstrated in cataracts of mice where suppression of the highly expressed miR-184 results 
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in attenuated expansion and migration of ocular epithelial tissue (Hoffmann et al., 2012). A 
recent study backs up the oncogenic role for miR-184 where migration and invasiveness is 
elevated in human glioma cell lines overexpressing miR-184 by the positive regulation of 
hypoxia-inducible factor-1 alpha (HIF-1α), through suppression of its inhibitor, FIH-1 (Yuan 
et al., 2014).  
 
 
In humans, miR-184 is located within region 25.1 on the q-arm of chromosome 15. Producing 
an 84 bp transcript, miR-184, is an example of an individually transcribed miRNA, whereby it 
is not clustered with or close to other miRNAs (Weitzel et al., 2011). Over the past decade the 
ability of miR-184 to regulate cellular growth and differentiation across numerous cells types 
has been documented. Initial miRNA profiling experiments showed miR-184 to be heavily 
downregulated in neuroblastoma and that overexpression of miR-184 in neuroblastoma cell 
lines led to disrupted cell cycle dynamics (Chen and Stallings, 2007). Similarly, in 
hepatocellular carcinoma cell lines, miR-184 has been shown to promote proliferation by 
significantly altering cell cycle dynamics (Wu et al., 2014). Furthermore, miR-184 has been 
shown to regulate the balance between proliferation and differentiation in adult neural stem 
cells by promoting notch signalling, with cells introduced to elevated levels miR-184 
differentiating into ~30% less astrocytes and neurons (Liu et al., 2010). Previous work in our 
group showed that miR-184 directly represses the central RISC protein known as AGO2 in 
both HaCaTs and HPEK (Roberts et al., 2013). A recent mice study confirms this finding, 
demonstrating that miR-184 directly targets Ago2 in pancreatic β cells, resulting in reduced β 
cell islet mass and subsequent decreases in circulating insulin levels (Tattikota et al., 2014).  
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The epidermis exists in a homeostasis between proliferating and differentiating keratinocytes 
and when this homeostasis is upset, it can lead to a plethora of cutaneous disorders. There 
remains an unmet need in dermatology for innovative topical agents that achieve better long-
term outcomes with fewer side effects. Recently, miRNAs have emerged as key regulators of 
keratinocyte biology and disease, acting as conceivable targets for patient-specific treatments. 
Previous work in our group demonstrated elevated levels of miR-184 in psoriatic lesions where 
it was thought to modulate the expression of AGO2 (Roberts et al., 2013). Very recent work 
by Shalom-Feuerstein and colleagues report miR-184 in differentiating keratinocytes (Nagosa 
et al., 2017). However, despite recent advances in the field, an understanding of the role of 
miR-184 in keratinocyte biology remains poorly described.  With this in mind, the aims of this 
thesis are: 
1. Investigate miR-184 expression during HPEK differentiation and elucidate the 
regulatory mechanisms. 
2. Examine the effects of ectopic miR-184 on HPEK proliferation and differentiation by 
utilising synthetic miR-184 mimics and miR-184 LNA inhibitors. 
3. Investigate miR-184 expression and function during HPEK migration. 
4. Explore epidermal AGO dynamics and examine the miR-184:AGO2 axis during HPEK 
differentiation  
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 Materials 
Materials and manufactures are listed by technique. All laboratory consumables were provided 
by Sarstedt, Leicester, UK unless otherwise stated. Pre-designed primers were all purchased 
from Qiagen, Manchester, UK.  
 Cell Culture 
 
Human Primary Epidermal Keratinocytes (HPEK) were either purchased from CellnTec, Bern, 
Switzerland or isolated from normal adult foreskin of multiple donors (Liverpool John Moores 
University Research Ethics Committee approval number 16/PBS/008). Circumcisions were 
transported in Dulbeccos Modified Eagle Medium (DMEM) containing 4500 g/L glucose and 
500 U/mL Penicillin/Streptomycin (P/S; Sigma-Aldrich, Gillingham, UK) with all further 
manipulations performed in a sterile type II biological safety cabinet using sterile instruments. 
To start with, foreskins were transferred to a 10 cm petri dish (Sigma, UK) and were washed 
in sterile phosphate buffered saline (PBS) containing 500 U/mL P/S. Next, the connective, 
vascular and adipose tissues were removed using forceps and a scalpel that were kept sterile 
with 100% ethanol (Sigma, UK) before another wash with sterile PBS plus P/S (Fig. 2.1). In 
order to separate the epidermis from the dermis, the foreskins were incubated in PBS containing 
500 U/mL P/S, 2.5 µg/mL amphotericin B (amp B; Sigma-Aldrich, UK) and 2 mg/mL dispase 
(Sigma-Aldrich, UK) overnight at 4°C. To increase dispase penetration the skin was scored 
through the epidermis in a grid pattern every 5 mm prior to incubation. The following day the 
foreskins were incubated further at room temperature for 1-2 hours before transferring to a 
sterile 10 cm petri dish (Fig. 2.1). Following this, the epidermis was peeled from the dermis 
using sterile forceps and added to a 15 ml universal tube containing 5 ml of accutase (CnT-
accutase-100; CellnTec, Switzerland) before a 10 minute incubation at 37°C, 5% CO2 (Fig. 
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2.1). After incubation, the universal tube was shaken vigorously and the accutase was 
deactivated using 10 ml of CnT-Prime media (CnT-Pri; CellnTec, Switzerland) prior to 
centrifugation at 260 Relative Centrifugal Force (RCF) for 5 minutes. Next, the supernatant 
was removed and the pellet was suspended in 15 ml of CnT-Pri supplemented with CnT-
IsoBoost (CnT-ISO-50; CellnTec, Switzerland), 500 U/mL P/S and 2.5 µg/mL amp B before 
transfer to a T75 tissue culture flask  and incubated at 37°C, 5% CO2 overnight (Fig. 2.1). The 
following day the media was aspirated and 20 ml of supplemented CnT-Pri was added before 
incubation at 37°C, 5% CO2. Isolated HPEKs were observed daily with supplemented CnT-Pri 
replaced every 2 days until reaching 70-80% confluence when they were subcultured for either 
cyrostorage or experimental work (described in 2.1.2). 
 
 
 
 
 
Figure 2.1: Isolation of HPEK. Using sterile instruments excess fatty and connective tissue was removed from 
circumcised human foreskin. Samples were cut into smaller pieces and the epidermis was repeatedly scored 
before overnight incubation in dispase. The following day, skin samples were incubated in dispase for a further 
1-2 hours before separation of the epidermis from the dermis. HPEK were then isolated by disassociation with 
accutase and growth in a selective epidermal medium. Taken from Choi et al., 2017. 
 
  
Removal of Adipose 
and Connective Tissue 
Incubation in Dispase Removal of Epidermis Isolation of HPEK 
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HPEKs from p1-5 were maintained in CnT-Pri without antibiotics/antimycotics and cultured 
in a sterile type II biological safety cabinet using sterile instruments, pre-warmed media and 
following aseptic practices. Upon reaching 70-80% confluenceHPEKs were passaged as 
follows: media was aspirated from the T75 flask and the monolayer was washed with 10 ml of 
PBS (without Calcium or Magnesium) for 3-5 minutes at room temperature to remove any 
residual media and protein that may affect the effectiveness of accutase. Next, PBS was 
aspirated and 4 ml of accutase was added to the monolayer with enzymatic dissociation taking 
place at 37°C, 5% CO2 for 5-10 minutes. Cell detachment was monitored using a light 
microscope until around 90% of cells had detached, at which point the accutase was deactivated 
using 5 ml of CnT-Pri with detachment aided by gentle tapping of the culture vessel. The cell 
suspension was then centrifuged at 180 RCF for 7 minutes. Following centrifugation, the 
supernatant was aspirated and the cell pellet was resuspended in 10 ml of CnT-Pri before 
seeding at a density of 4.0 x103 cells/cm2 and incubating at 37°C, 5% CO2 in a humidified 
atmosphere. Culture media was changed every 2-3 days. 
For cyrostorage, HPEK that had reached 70-80% confluence were passaged as 
previously described. Cells were made up to a concentration of 2.0 x106 cells/mL in CnT-Pri 
to which an equal volume of cold freezing medium (CnT-CRYO-50; CellnTec, Switzerland) 
was added dropwise whilst gently swirling the tube to mix. Following this, the suspension was 
left to osmotically equilibrate on ice for 5 minutes, before transfer to pre-cooled cryovials 
(Thermofisher Scientific, Runcorn, UK). Finally, cryovials were transferred to a Mr. Frosty 
(Thermofisher Scientific, UK) and stored at -80°C, before transfer to liquid nitrogen the 
following day. 
For thawing, 10 mL of CnT-Pri was added to a T75 flask and pre-equilibrated in a 37°C, 
5% CO2 incubator. A cyrovial was removed from the liquid nitrogen store and immediately 
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placed in a 37°C water bath to rapidly thaw the cells. To prevent the temperature from reaching 
over 4°C the cyrovial was gently swirled. Once only a few ice crystals remained the cells were 
resuspended gently 2-3 times, before adding dropwise to the pre-equilibrated T75 1 mL of 
CnT-Pri was used to collect any cells remaining in the cyrovial. 
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HPEK were seeded at a density of 2-3 x104 cells/cm2. Usually, after 2-3 days under basal 
conditions cells would reach 90% confluency, at which point the culture medium was aspirated 
and the monolayer was washed with PBS for 2-3 minutes at room temperature in order to 
remove any residual CnT-Pri media. Following this, a differentiation medium (Table 2.1) was 
added, before incubating at 37°C, 5% CO2 in a humidified environment for up to 5 days (Fig. 
2.2).  
 
 
HPEK were cultured as described in 2.1.2. or nucleofected as described in 2.2. and grown under 
basal conditions in 6-well dishes (Sarstedt, Leicester, UK) for 2 days in order to approach 
confluence. Using a p200 pipette tip, held at an angle of 30 degrees to limit width variation, 
linear scratches were made every 0.5 cm both vertically and horizontally in a lattice formation. 
Monolayers were then washed in PBS for 2-3 mins at room temperature to remove damaged 
cells and debris before addition of either basal or differentiation medium. Cells were allowed 
to migrate into the scratch for up to 5 days. 
 
 
Cells were cultured and grown under basal conditions for 2-3 days until around 90% 
confluency, at which point the medium was aspirated and the cells were washed in PBS for 2-
3 minutes at room temperature. Following this, cells were pre-treated for 1 hour with 1 µM of 
Gd3+, a trivalent cation which is a general inhibitor of Ca2+ influx pathways, or 1 µM BTP2 a 
pyrazole derivative which is a more potent blocker of Orai. Following treatment, cells were 
differentiated for up to 5 days by addition of 1.5 mM Ca2+. After 2.5 days cells were recharged 
with inhibitors. 
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Table 2.1. Differentiation Medium. *CnT-Pri was heat inactivated for 1 hour at 60°C with 
the aim of deactivating proliferation promoting growth factors 
Calcium  Phorbol Myristate Acetate (PMA) 
Heat inactivated CnT-Pri* Heat inactivated CnT-Pri* 
1.5 mM CaCl2 100 nM PMA 
Calcitriol (1,25-dihydroxyvitamin D3)  
 
Heat inactivated CnT-Pri* 
100 nM Calcitriol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Differentiation of HPEK Schematic. HPEK were seed at D0 and allowed to approach confluence 
for 2 days. On D3 media was switched for differentiation medium and cells were left to differentiate until D4 
and D8 when 1 d and 5 d time points were harvested for analysis. 
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Transfection is the process of introducing foreign nucleic acid directly into a eukaryotic cell 
using non-viral methods and can be separated into biological, chemical and physical techniques 
(Nayerossadat, Maedeh and Ali, 2012). Viral transduction is a biological procedure often 
grouped with transfection and involves use of viral vectors such as adenovirus and lentivirus 
resulting in a stably-transfected cell that continuously expresses a gene of interest (Chen and 
Goncalves, 2016). Non-biological methods tend to be transient resulting in temporary 
expression of genetic material, which is eventually diluted and lost through mitosis 
(Nayerossadat, Maedeh and Ali, 2012). Chemical methods including calcium phosphate 
(Graham and van der Eb, 1973), liposomal e.g. lipofection (Felgner et al., 1987), cationic 
polymers e.g. DEAE-Dextran (De Smedt, Demeester and Hennink, 2000) and magnetofection 
(Plank et al., 2003) rely on a similar process whereby chemical:genetic material complexes are 
attracted to cellular membranes and where uptake occurs via endocytosis. Physical approaches 
rely on perforating cellular membranes to deliver material and comprise of microinjection 
(Diacumakos, 1973), biolistics (Klein et al., 1987), electroporation (Wolf et al., 1994) and 
sonoporation (Bao, Thrall and Miller, 1997). Transfections in this study were performed using 
nucleofection, a transient, electroporation-based technique that relies upon optimised electrical 
pulses and cell specific reagents to deliver cargo into hard to transfect cells (Distler et al., 2005). 
Most non-biological transfection methods deliver nucleic acid directly into the cytoplasm. A 
significant proportion is either degraded by cytoplasmic nucleases or sequestered by lysosomes 
before entry to the nucleus. However, it is thought that nucleofection delivers transfection  
molecules directly into the nucleus, allowing for efficient and quick expression, bypassing the 
need for cell division, by puncturing both cell and nuclear membranes (Gresch et al., 2004). 
Nucleofection reagents, plasmids and consumables were purchased from Lonza, 
Slough, UK. hsa-miR-184 miRIDIAN miRNA mimic, miRIDIAN miRNA mimic negative 
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control, siAGO2 ON-TARGETplus siRNA, siORAI1 ON-TARGETplus siRNA and ON-
TARGETplus non-targeting siRNA were purchased from Dharmacon, Lafayette, USA. hsa-
miR-184 miRCURY Locked Nucleic Acid (LNA) Power Inhibitor and miRCURY LNA Power 
Inhibitor Negative Control were purchased from Exiqon, UK. AGO2 plasmids were a kind gift 
from Prof. Tyson Sharp (Queen Mary University of London, UK) .  
HPEK of p1-3 were passaged at least 3 days preceeding nucleofection, cultured until 
70-80% confluent with media being changed every other day. Prior to work supplement was 
added to P3 nucleofector solution and CnT-Pri (CellnTec, Switzerland) was added to a 6-well 
plate and pre-equilibrated at 37°C, 5% CO2 for at least 30 min. HPEKs were enzymatically 
dissociated by accutase (CellnTec, Switzerland) and enumerated using a haemocytometer. A 
volume containing 1.0 x106 cells was added to a 15 mL universal tube and centrifuged at 260 
RCF for 10 minutes at 4°C. The supernatant was aspirated and the resulting pellet was 
resuspended in 100 µL of P3 Nucleofector solution before transfer to a sterile nucleofection 
curvette. Prior to transfer the cells were mixed with either pmaxGFP (Green Fluorescent 
Protein) vector, hsa-miR-184 miRIDIAN miRNA mimic, hsa-miR-184 miRIDIAN miRNA 
hairpin inhibitor, miRIDIAN miRNA mimic negative control, siAGO2 ON-TARGETplus 
siRNA, siORAI1 ON-TARGETplus siRNA or ON-TARGETplus non-targeting siRNA at 
indicated concentrations. A mock control consisting of 1.0 x106 cells in 100 µL P3 
Nucleofector solution was used to assess the effect of the nucleofection procedure on HPEK. 
Next, the nucleofection curvette was lightly tapped to ensure the sample covered the bottom 
before transfer into the 4D-Nucelofectors X unit and by selecting the DS-138 program, 
nucleofection was performed. Following this, the sample was incubated for 10 minutes at room 
temperature before 400 µL of pre-equilibrated CnT-Pri was added to the nucelofection 
curvette. The sample was mixed and removed from the curvette using a dropper pipette and 
transferred to a 1.5 ml Eppendorf tube (Eppendorf, Stevenage, UK), where it was separated 
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dependent on experimental seeding requirements. Plates containing nucleofected HPEKs were 
then incubated at 37°C, 5% CO2, with the media changed the following day to remove any dead 
cells and changed every 2-3 days until harvest. 
 
 
 
 
Total RNA was isolated from HPEK using reagents purchased from Qiagen, Manchester, UK 
unless otherwise stated. Psoriasis patient samples (West Midlands, South Birmingham 
Research Ethics Committee approval number 15/WM/0388) were previously processed and 
total RNA isolated by Dr. Tyng Han. The following solutions were prepared prior to isolation. 
Lysis buffer: 20 µL of 2M dithiothreitol (DTT; Sigma-Aldrich, UK) were added to 1 mL of 
buffer RLT plus. Wash buffers: 44 ml of molecular biology grade 100% ethanol (Thermofisher 
Scientific, Runcorn, UK) was added to 11 ml of concentrated buffer RPE and 42 ml of 
isopropanol (Sigma-Aldrich, UK) was added to 14 ml of concentrated buffer FRN. DNase: 550 
µL of RNase-free water (Fisher Scientific, UK) was used to dissolve lyophilised DNase I stock 
(1500 kunitz units) with gentle inversion to mix, before separation into aliquots to prevent 
freeze-thaw degradation. 
For cell lysis, media was completely aspirated from cells grown in 6- or 12-well plates, 
before addition of PBS (Sigma-Aldrich, UK) to ensure complete removal of any residual 
media. Next, 350 µL of lysis buffer was added to each sample well and incubated for 1-2 
minutes at room temperature. The resulting lysate was collected by scraping the well with a 1 
mL pipette tip and rinsing, before transferring to 1.5 mL Eppendorf tubes (Eppendorf, UK). 
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Eppendorfs containing sample lysates were then vortexed for 1 minute, ensuring no cell clumps 
remained before either continuing with isolation or storage at -80°C. 
For isolation, sample lysates were thawed on ice and briefly vortexed to maintain 
homogeneity before transfer to an Allprep DNA mini spin column and centrifugation at MAX 
(16,000) RCF for 30 seconds. The sample that had passed through the column termed flow-
through, was then transferred to a 2 mL microcentrifuge tube. 50 µL of proteinase K and 200 
µL of 100% ethanol (Fisher Scientific, UK) were added to the lysate and mixed, before 
incubation for 10 minutes at room temperature. Following incubation, a further 400 µL of 
100% ethanol (Fisher Scientific, UK) was added to the lysate and mixed before transfer to 
RNeasy mini spin columns. The column was then spun for 15 seconds at MAX (16,000) RCF 
and the flow-through was discarded. Next, 500 µL of buffer RPE was added to the column and 
centrifuged for 15 seconds at MAX (16,000) RCF with the flow-through discarded. Following 
this, 10 µL of DNase I stock was diluted in 70 µL of buffer RDD and then added directly to 
the RNeasy mini spin column membrane, before incubating at room temperature for 15 
minutes. After incubation, 500 µL of buffer FRN was added directly to the column membrane 
and spun at MAX (16,000) RCF for 15 seconds. To ensure isolation of small RNAs, the flow-
through was added to the column again with the centrifugation repeated. Following this, a 
second wash was performed with buffer RPE. Next, 500 µL of 100% ethanol (Fisher Scientific, 
UK) was added to the column, before centrifugation for 2 minutes at MAX (16,000) RCF. To 
make sure no ethanol is carried over, the column was added to a new 2 mL collection tube and 
spun for a further 2 minutes at MAX (16,000) RCF. Finally, the column was transferred to a 
1.5 mL RNase-free microcentrifuge tube before adding 30 µL of RNase-free ddH20 directly to 
the column and then centrifuging for 1 minute at 11,600 RCF. To obtain a higher RNA 
concentration, the eluent were re-added to the column and spun at 11,600 RCF for 1 minute. 
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The quality and concentration of isolated RNA was determined using a Nanodrop™ 
2000 ultraviolet-visible (UV-Vis) spectrophotometer (Thermo Fisher, UK), with optical 
densities (OD) of 260 and 280 nm averaged from triplicate readings. RNA nucleotides absorb 
UV light in specific patterns. The absorbency ratio between 260/280 nm was used to determine 
the quality of the isolated RNA, with ratios of 1.9-2.1 denoting RNA of good quality. Isolated 
RNA was stored at -80°C until further work. 
 
 
Isolated RNA was reverse transcribed into complementary DNA (cDNA) using reagents 
purchased from Qiagen, Manchester, UK, unless stated otherwise. Template RNA was thawed 
on ice whilst 10x miScript nucleics mix, RNase-free water and 5x miScript HiFlex Buffer were 
thawed at room temperature. HiFlex Buffer was chosen as opposed to HiSpec Buffer for the 
subsequent quantification of mature miRNA and mRNA from the same sample. Next, a master 
mix was prepared consisting of 4 µL 5x miScript HiFlex Buffer, 2 µL 10x miScript Nucleics 
Mix, 2 µL miScript Reverse Transcriptase Mix and was scaled up depending on the sample 
size (Table 2.2). miScript Reverse Transcription Mix was removed from the -20°C freezer just 
before addition to the master mix. To assess whether any genomic DNA (gDNA) 
contamination was present in the cDNA preparation, a second master mix was prepared without 
the presence of miScript Reverse Transcriptase Mix. Following this, 8 µL of the master mixes 
were aliquoted into 0.2 mL RNase/DNase-free PCR tubes and 400 ng of template RNA was 
added before making the final volume up to 20 µL with RNase-free water. After this, the 
samples were centrifuged briefly and incubated at 37°C for 60 minutes. Finally, samples were 
heated to 95°C for 5 minutes to inactivate miScript Reverse Transcriptase mix and terminate 
the reaction. 
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Table 2.2. Reverse Transcription Mastermix. 
 
Component Volume/reaction 
5x miScript HiFlex Buffer 4 µL 
10x miScript Nucleics Mix 2 µL 
miScript Reverse Transcriptase Mix 2 µL 
RNase-free water Variable 
Template RNA Variable 
Total Volume  20 µL 
 
 
 
 
Unless otherwise stated RT-qPCR was performed using reagents and consumables bought from 
Qiagen, Manchester, UK. At all stages of experimental setup, filtered RNase-free pipette tips 
and RNase-free environment was used. The resultant cDNA from reverse transcription was 
diluted 10-fold in RNase-free ddH2O prior to addition to the RT-qPCR reaction. All PCR 
reactions were carried out in 0.1 mL PCR strip tubes. RT2 qPCR Primer assays came as a 
solution with miScript Primer assays briefly centrifuged and reconstituted in 1.1 mL of TE 
buffer (Table 2.3). Where primers were supplied by Thermo Fisher, UK the primer mixes were 
reconstituted in TE buffer to a master stock concentration of 100 µM and diluted 10-fold to 
give a 10 µM working stock, in order to minimalize freeze/thaw cycles (Table 2.4). All primer 
products will be referred to as Primer mix.  
To start, 2x Quantitect SYBR Green PCR Master Mix, 10x miScript Universal Primer, 
RNase-free water, template cDNA and Primer mix were thawed on ice before gently mixing to 
ensure homogeneity. Depending on whether miRNA or mRNA was the target of interest, two 
PCR master mixes were made. For mRNA, 10 µL 2x Quantitect SYBR Green PCR Master 
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Mix was added to 6 µL of RNase-free water. For miRNA, 10 µL 2x Quantitect SYBR Green 
PCR Master Mix was added to 4 µL of RNase-free water. To either PCR mastermix 2 µL of 
Primer mix was added. The reactions could be scaled depending on sample size. Where primers 
provided were by Thermo Fisher, 2 µL of each forward and reverse primers was added to 10 
µL of 2x Quantitect SYBR Green PCR Master Mix and 4 µL of RNase-free water. Next, 18 
µL of master mix was aliquoted into PCR tubes followed by addition of 2 µL of template 
cDNA, either manually or using a Qiagility semi-manual liquid handling robot (Qiagen, UK) 
if there was a large sample size. Reactions were performed in duplicate to protect against run 
failure and recognise any variances in PCR efficiency. A no template control was added to each 
run to identify any contaminating DNA in the reaction reagents by substituting template cDNA 
with 2 µL of RNase-free ddH20.  
Following this, the tubes were sealed with caps and transferred to a 72-well rotor-disk 
which was placed inside of a Rotor-Gene Q real time cycler, supported by Rotor-Gene Q 
version 2.1.0.9 software (Qiagen, UK). RT-qPCR was set-up as follows: 95°C for 15 mins 
followed by 40-45 cycles of 94°C for 15 s (Denaturation), 55°C for 30 s (Annealing) and 70°C 
for 30 s (Extension). SYBR Green is one of the most common fluorescent probes in RT-qPCR. 
It is thought to intercalate with the minor groove of double-stranded DNA, absorbing blue light 
at 494 nm and emitting green light at 521 nm. Data was captured when SYBR Green 
fluorescent signal accumulated enough to cross the background threshold. Cycle threshold (Ct) 
values were calculated when PCR was in exponential phase during amplification. Upon 
completion of amplification, melt curve analysis of the product was performed where tubes 
were subject to a 1°C per second temperature increase starting at 60°C and terminating at 95°C. 
As the increase in temperature denatures double-stranded DNA causing SYBR green to 
dissociate, melt curve analysis allows quantification of the resultant loss of fluorescence. The 
melting temperature (Tm) varies depending on the base composition of each target DNA, 
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giving an indication to target specific binding and allowing any anomalies to be removed in 
further analysis. Results were normalised to a housekeeping gene, whose expression remained 
relatively stable between samples and experiment. The average Ct for the housekeeping gene 
was 15.16 (±1.14, SD) for mRNA data (GAPDH) and 23.65 (±1.20, SD) for miRNA data 
(SNORD72) across all experiments. RT-qPCR data was quantified and depicted relative to the 
experimental control group using the comparative Ct method, 2–ΔΔCt. Briefly, ΔΔCt= 
ΔCttreated-ΔCtuntreated. ΔCttreated is the mean Ct of the gene of interest (GOI) minus the 
mean Ct of the housekeeping control (CtGOI-CtControl) from duplicate analysis of the 
experimental treatment groups. Whilst ΔCtuntreated is the mean Ct of the GOI minus the mean 
Ct of the normalisation control (CtGOI-CtControl) from duplicate analysis of the experimental 
control group (Schmittgen and Livak, 2008). 
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Table 2.3. Pre-designed Qiagen Primers. 
 
Name  Cat. No. 
GAPDH PPH00150F 
LOR PPH06894F 
IVL PPH01911A 
CCNE1 PPH00131A 
CCNE2 PPH00955B 
CCNB PPH00126C 
AGO1 PPH16729A 
AGO2 PPH21840A 
AGO3 PPH13995A 
AGO4 PPH20751A 
SNORD72 MS00033719 
SNORD61 MS00033705 
miR-26a MS00029239 
miR-184 MS00003640 
miR-205 MS00003780 
miR-21 MS00009079 
 
 
 
Table 2.4. Thermo Fisher Primers. 
 
  
Name Sequence 
CDKN1A (p21) Forward 5’-TCAGGCTTGGGCTTTCCACC-3’ 
Reverse 5’-CCATGCACTTGAATGTGTACCCAGA-3’ 
ORAI1 Forward 5’-GAGCATGCAAAACAGCCCAGG-3’ 
Reverse 5’-GGCTCATCACCTCGGAGTAACTCT-3’ 
NFAT2c 
(NFAT1) 
Forward 5’-GGGCTGGGAGATGAACATGAA-3’ 
Reverse 5’-AAATCAATAGCCCAATAGAGGTTCTAGAAAG-3’ 
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Preceding isolation, Radio Immuno Precipitation Assay buffer (RIPA) was prepared as 
follows: 150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulphate (SDS), 50 mM Tris, pH 8.0 and stored at 4°C with 1 mM sodium 
orthovanadate and 1 complete mini, EDTA-free protease inhibitor cocktail tablet (Sigma-
Aldrich, UK) added to 50 mL of RIPA prior to use. 
For lysis, cells grown in a 6-well plate were placed on ice and media was aspirated, 
followed by addition of ice cold PBS for 1-2 minutes to remove residual media. Next, PBS was 
aspirated and 120 µL of ice cold RIPA buffer was added. The plate kept on ice was then 
transferred to an orbital shaker to maintain constant agitation for 30 minutes. Following this, 
cells were scraped with a 1 mL pipette tip and transferred to pre-cooled micro-centrifuge tubes 
(Eppendorf, UK) before storage at -80°C, until further work.  
For quantification, cell lysates were centrifuged at 4°C, 11,600 RCF for 20 minutes 
with the resulting supernatant transferred to new pre-cooled micro-centrifuge tubes. Cell 
lysates were then quantified using the Pierce BCA protein assay kit (Thermofisher scientific, 
UK) following the manufactures instructions. In brief, a range of bovine serum albumin (BSA) 
standards were prepared from 0-2000 µg/mL. Working reagent consisting of a highly alkaline 
bicinchoninic acid (BCA) solution and copper(II) sulphate was made at a ratio of 50:1. 10 µL 
of BSA standards and unknown samples were pipetted in duplicate into a 96-well plate then 
200 µL of working reagent was added to each well, before incubation at 37°C for 30 minutes. 
The plate was cooled at room temperature and absorbance was measured at 562-590 nm on a 
CLARIOstar plate reader (BMG Labtech, Aylesbury, UK). 
 
79 
 
 
Protein from the cytoplasm and nucleus was separated using reagents from the ab113474- 
nuclear extraction kit (Abcam, Cambridge, UK), unless otherwise stated. The following 
solutions were prepared on ice prior to isolation. 1X Pre-extraction buffer: 1 mL of 10X Pre-
extraction buffer was diluted in 9 mL of ddH2O with addition of 10 µL of 1000X DTT solution 
and 10 µL of 1000X PIC (protease inhibitor cocktail). Nuclear extraction buffer: 1 µL of 1000X 
DTT solution and 1 µL of 1000X PIC was added to 998 µL of Extraction buffer.  
To start, HPEK grown in 6-well dishes were enzymatically dissociated as previously 
described in 2.1.2. using appropriate reagent volumes, before centrifugation at 180 RCF for 5 
minutes. The supernatant was discarded and the cell pellet was resuspended in 150 µL of ice 
cold 1X Pre-extraction buffer, before transfer to a micro-centrifuge tube and incubation on ice 
for 10 minutes. The lysate was then vortexed for 10 seconds before being centrifuged for 1 
minute at 11,600 RCF. Following centrifugation, the cytoplasmic extract was carefully 
removed from the nuclear pellet and transferred to a pre-cooled micro-centrifuge tube. Next, 
25 µL of ice cold nuclear extraction buffer was added to the remaining pellet and incubated on 
ice for 15 minutes, whilst vortexing for 10 seconds every 3 minutes. Following incubation the 
lysate was vortexed for a further 20 seconds and sonicated for 3 x 10 seconds, before transfer 
to a -80°C freezer until further work. 
 
 
Western blotting was performed using reagents, consumables and equipment purchased from 
Bio-Rad, Watford, UK unless otherwise stated. The following solutions were prepared prior to 
western blotting. Running buffer: 25 mM Tris base, 190 mM glycine, 0.1% SDS pH ~8.3. 
Transfer buffer: 48 mM Tris base, 39 mM glycine, 0.04% SDS, 20% methanol. 10X Tris 
buffered saline (TBS): 200 mM Tris base, 1500 mM sodium chloride, pH ~7.6. TBS+Tween 
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20 (TBST): 1:10 dilution of 10X TBS with addition of 0.1% (v/v) Tween20. The pH of 
solutions were adjusted using 1 M sodium hydroxide or 1 M hydrochloric acid.  
For electrophoresis, 20-40 µg of sample lysate was diluted in the appropriate amount 
of 4X Laemmli buffer containing 100 mM DTT, before heating at 95°C for 5 minutes to reduce 
and denature the sample. Following this, the sample/laemmli buffer mix was loaded into a well 
of a 12% polyacrylamide mini-PROTEAN TGX precast gel setup within an electrophoresis 
chamber filled with running buffer. Precision plus protein kaleidoscope molecular weight 
marker was loaded into another well. The gel was run at 150 V for 45 minutes or until the 
migration front reached the bottom of the gel.  
For semi-dry protein transfer, a polyvinylidene difluoride (PVDF) membrane was 
activated for 2 minutes in methanol and equilibrated in ice cold transfer buffer along with the 
gel for 5 minutes prior to transfer. The gel and membrane was sandwiched between blotting 
paper (membrane closest to positive electrode) and soaked in transfer buffer before rolling to 
remove air bubbles. Protein was transferred onto the membrane using Trans-blot turbo transfer 
apparatus run at 25 V constant and up to 1.0A for 30 minutes. All steps involving the PVDF 
membrane were performed using tweezers to avoid contamination.  
For protein visualisation, the membrane was submerged in 10 mL of blocking buffer 
(5% (w/v) fat-free milk in TBST), covered and agitated on an orbital shaker for 1 hour at room 
temperature. Next, the membrane was washed in 10 mL TBST and incubated with primary 
antibody (Table 2.5), diluted in blocking buffer overnight at 4°C, whilst being kept on a Stuart 
roller shaker (Cole-Parmer, Straffordshire, UK). The following day, to remove any remaining 
primary antibody, the membrane was washed in TBST for 5 x 5 minutes, before incubation in 
horse radish peroxidase (HRP)-conjugated secondary antibody (Table 2.5) diluted with TBST 
agitated on an orbital shaker at room temperature for 1 hour. Following this, the secondary 
antibody was removed and to prevent any interference of residual secondary antibody during 
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the visualisation process, the membrane was washed for 5 x 5 minutes in TBST. Following 
washing, HRP substrate was prepared by mixing components of the Clarity western ECL 
substrate kit in a 1:1 ratio (2 ml: 2 ml). This was then added to the protein side of the membrane 
and incubated for 5 minutes at room temperature. The membrane was then removed from the 
substrate solution and placed in a ChemiDoc XRS+ digital imager where it was visualised. 
 
Table 2.5. Western Blotting Antibodies. 
Antigen Speciation Reactivity Clonality Supplier Dilution 
Involucrin Mouse Human Monoclonal Abcam 1:1000 
Cyclin E1 Rabbit Human Monoclonal Santa Cruz 1:750 
Cyclin E2 Mouse Human Monoclonal R&D Systems 1:750 
AGO2 Rabbit Human Polyclonal Abcam 1:500 
p21 Mouse Human Monoclonal Bio-Rad 1:200 
ORAI1 Rabbit Human Polyclonal Bio-Rad 1:200 
γH2AX Mouse Human Monoclonal Millipore 1:500 
GAPDH Rabbit Human Monoclonal Cell signalling 
technology 
1:5000 
β-Actin Mouse Human Monoclonal Sigma-Aldrich 1:1000 
Anti-Mouse 
IgG 
Goat Mouse Polyclonal Sigma-Aldrich 1:2000 
Anti-Rabbit 
IgG 
Donkey Rabbit Polyclonal Thermo Fisher 
Scientific 
1:2000 
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Propidium iodide (PI; Thermo Fisher Scientific, UK), a fluorescent molecule that binds to 
nucleic acids, was used to analyse the cell cycle. PI binds in proportion to the amount of nucleic 
acid present within the cell allowing clear distinction between G1 (diploid, 2n), S (DNA 
synthesis) and G2 (tetraploid, 4n).  
HPEKs were nucleofected as previously described in 2.2. and enzymatically 
disassociated. Following centrifugation, cells were washed in 5 ml of PBS and spun at 260 
RCF for 10 minutes. Next, the supernantant was aspirated and 300 uL of ddH2O was used to 
resuspend the resultant pellet. To fix, ice cold 100% ethanol was added dropwise, whilst 
swirling the tube to minimise cell clumping and incubated at 4°C for a minimum of 48 hours, 
to allow complete dehydration to occur. Following this, samples were centrifuged at 320 RCF 
for 10 minutes, supernatant removed with the pellet washed in PBS, then samples were 
centrifuged again under the same conditions. The resultant pellet was resuspended in 100 
µg/mL PI solution and incubated in the dark for 45 minutes at room temperature, before 
conducting analysis using a BD Accuri C6 flow cytometer (BD Biosciences, Berkshire, UK). 
Data was collected for 10,000 gated events using the FL2 channel (488 nm laser and 585/40 
nm band pass (BP) filter). Cell debris were excluded using forward scatter (FSC) vs side scatter 
(SSC) gates with cell aggregates omitted using FSC height (FSC-H) vs FSC area (FSC-A) gates 
(Fig. 2.3). To minimise cell loss, sample preparation was performed in 15 mL universal tubes 
and subjected to extended centrifugation (from 5 to 10 minutes) before transfer to 1.5 mL 
microcentrifuge tubes for analysis. To provide improved accuracy for cell cycle model fitting, 
data was analysed using the Dean-Jett-Fox (DJF) univariate algorithm on FlowJo version 10.0 
(FlowJo, LLC, Ashford, USA). The DJF model, like the common alternative Watson pragmatic 
model, uses gaussian curves to fit both G1 and G2 stages of the cell cycle, but whereas the 
83 
 
Watson model makes no assumptions for S-phase using a direct fit, the DJF model fits a 
polynomial curve that can be used to measure S-phase distribution for synchronous cell 
populations (Fig. 2.3D). 
 
 
 
 
Figure 2.3: Gating strategies used for flow cytometry data analysis. The major density of events was 
captured in P1 (A) before single cells were isolated in P4 (B). Cell cycle data was collected using FL-2A (C) 
which was gated P4 in P1. R1 (A) was to include for any apoptotic cells which usually shrink during this 
process and was analysed separately to healthy cells. Cell cycle data was collected and gated before analysis 
using the univariate Dean-Jett-Fox model on FlowJo v10.0 (D). 
 
  
A B 
C D 
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MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) provides an indication 
of cellular metabolic activity and, under defined conditions, a crude representation of cell 
viability. It relies on the reduction of soluble MTT to insoluble formazan by NADPH-
dependent oxidoreductases of which levels are affected by altered proliferation rates. To start, 
cells were nucleofected as described in 2.2. and seeded in triplicate 3 x104/well of a 96-well 
plates for 72 hours. Following this, media was aspirated and 100 uL of media along with 10 uL 
of 12 mM MTT was added to each well, before incubating in the dark at 37°C for 4 hours. 
Next, media was carefully removed so not to disturb the formazan crystals and allowed to air 
dry for 1-2 minutes. To solubilise, dimethyl sulfoxide (DMSO) was added to each well and 
mixed gently on an orbital mixer for 5 minutes, before reading the absorbance at 540 nm on a 
CLARIOstar plate reader (BMG labtech, UK).   
 
 
 
The following solutions were made prior to IF. 4% (w/v) paraformaldehyde (PFA) solution: 4 
g of PFA (Sigma Aldrich, UK) was dissolved in 100 mL of ddH2O whilst stirring at 60°C, 
solution was cleared with 1 M sodium hydroxide and the pH adjusted to 7.4. Blocking buffer 
PBS containing 0.1% Tween20 (PBST) with 10% goat serum. Antibody buffer: PBST 
containing 2% goat serum. 
Cells were cultured on Nunc Lab-Tek permanox 8-well chamber slides (Thermofisher 
scientific, UK) or glass cover slips before fixation using 4% PFA for 15 minutes at room 
temperature. Following fixation, cells were washed three times for 5 minutes with PBS 
(without Ca2+ or Mg2+) before permeabilising in PBS containing 0.2% Triton X-100 for 10 
minutes at room temperature. Non-specific antigens were blocked by the addition of blocking 
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buffer for 1 hour at room temperature. Blocking buffer was removed and primary antibody, 
diluted in antibody buffer, was added before incubating at 4°C overnight.  
The following day, primary antibody was removed and wells were washed three times 
with PBST for 5 minutes at room temperature. Samples were then incubated with the relevant 
fluorescently-conjugated secondary antibody diluted in antibody buffer for 1 hour at room 
temperature in the dark. Following incubation, secondary antibody was aspirated and, to 
remove any residual antibody, wells were washed 3 x 5 minutes with PBST. Finally, nuclei 
were counterstained with 4ʹ, 6-diamidino-2-phenylindole (DAPI; Ex358, Em461) for 5 minutes 
at room temperature, before mounting with Fluoromount-G mounting medium (Southern 
Biotech, Birmingham, USA). Images were collected from at least 5 fields of view per sample 
condition using a fluorescent microscope (Leica DMI6000B, Leica, London, UK). For DNA 
damage, images of γH2AX stained samples were captured from 10 fields of view containing 
at least 20 cells, before analysis and quantification by Dr. Carlos Rubbi (University of 
Liverpool, Liverpool, UK) using proprietary software. 
 
 
Table 2.6. Immunofluorescent Antibodies. 
 
Antigen Speciation Reactivity Clonality Supplier Dilution 
AGO2 Rabbit Human Polyclonal Abcam 1:500 
γH2AX Mouse Human Monoclonal Millipore 1:500 
Alexa Fluor 647 Goat Mouse Polyclonal Invitrogen 1:1000 
Alexa Fluor 488 Goat Rabbit Polyclonal Invitrogen 1:1000 
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Prior to live cell-imaging experiments, a stage incubator attached to a Leica DMI6000B 
inverted microscope was equilibrated to 37°C, 5% CO2 whilst maintaining humidity. Cells 
were seeded in 6-well plates in accordance with experimental requirements at least 1 d prior to 
imaging. Plates were transferred carefully into the microscope incubator and placed onto the 
microscope stage. Using the Mark & Find function on LAS X software at least four locations 
from around each individual well was selected and saved. Time-lapse images were then 
automatically taken at each pre-selected location every 30 min for 3 days.  
 
 
Experiments were conducted in biological triplicate on three independent occasions. All data 
is presented as mean ± SEM unless otherwise stated. Data was assessed for normality. 
Statistical analysis was carried out using GraphPad Prism 6 software (California, USA). Unless 
otherwise stated, unpaired students t-test was utilised when 2 groups were present with one-
way analysis of variance (ANOVA) used when more than 2 groups were present. to correct for 
multiple comparisons, Tukey’s post hoc test was applied when using ANOVA in order to 
compare all groups. A p value of p<0.05 determined significance.   
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3. Investigation of miR-184 Expression in 
HPEKs and Psoriasis 
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The most commonly used technique to trigger keratinocyte differentiation in vitro is a calcium 
switch, whereby the levels of extracellular Ca2+ in the growth medium are elevated. Early work 
on epidermal mouse keratinocytes by Hennings and colleagues documented that levels of 
calcium <0.1 mM supress differentiation and allow keratinocytes to proliferate rapidly, 
whereas high concentrations (>1.0 mM) induce terminal differentiation at varying rates 
(Hennings et al., 1980). As keratinocytes undergo terminal differentiation, they express 
specialised differentiation markers such as involucrin (IVL) and loricrin (LOR) which form 
part of the protective cornified envelope (Candi, Schmidt and Melino, 2005; Eckert et al., 
2005). Studies have also shown that inhibiting mediators of calcium-induced differentiation 
such as protein PKC (Lee et al., 1997) result in a considerable reduction in the levels of these 
differentiation makers. Strict control of the cell cycle is an important feature of keratinocyte 
differentiation, and recent work by Freije and colleagues has shown that cyclin E accumulation 
causes growth arrest, re-replication and DNA damage. This results in the onset of 
differentiation by inhibiting mitotic regulators such as cyclin B and cdk1, as well as activating 
the p21/p53 pathway (Freije et al., 2012). 
Several miRNAs have been shown to play key roles in keratinocyte differentiation 
including miR-205 (Wang et al., 2013), miR-203 (Lena et al., 2008; Yi et al., 2008b), miR-24 
(Amelio et al., 2012). Moreover, a comprehensive analysis by Hildebrand and colleagues 
indicates that at least 55 miRNAs are upregulated in human epidermal keratinocytes treated 
with 1 mM Ca2+ for 7 days, although miR-184 was not listed (Hildebrand et al., 2011). More 
recently, miR-184 was shown to be present in reconstituted human epidermis (RHE) with 
levels modulated by the pro-inflammatory cytokines, IL-22 and Oncostatin M (OSM), 
suggesting that miR-184 may play a role in keratinocyte stratification (Roberts et al., 2013). In 
addition, a very recent report, published following the inception of this work, has shown 
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presence of miR-184 in the suprabasal layers of neonatal mouse epidermis as well as in cultured 
human keratinocytes (Nagosa et al., 2017). 
An indispensable form of Ca2+ entry in epidermal keratinocytes is called SOCE. Recent 
work by Vandenberghe and colleagues demonstrates the importance of SOCE to normal 
keratinocyte biology with disruption of CRAC channels leading to disrupted keratinocyte 
migration and differentiation (Vandenberghe et al., 2013). A common CRAC channel protein 
is ORAI1, consisting of three dimeric subunit pairs which together form a hexamer channel 
complex. Intermembrane coupling with the Ca2+-sensor STIM protein following ER Ca2+ 
depletion activates ORAI1, consequently opening the central pore and allowing Ca2+ entry 
(Prakriya and Lewis, 2015). The NFAT signalling pathway is key downstream effector of 
SOCE. Following elevated [Ca2+], the serine/threonine protein phosphatase, CaN is activated 
by CaM and consequently dephosphorylates NFAT, which in turn localises to the nucleus 
where it regulates gene expression (Rumi-Masante et al., 2012; Mognol et al., 2016). Despite 
its vital role in keratinocyte biology little is known about SOCE as a regulatory miRNA 
pathway.  
Psoriasis is a chronic inflammatory cutaneous disorder involving complex pathological 
processes between keratinocytes and immune cells that affects around 2% of the UK 
population, with the first link between miRNAs and its pathogenesis occurring over a decade 
ago (Sonkoly et al., 2007). As recently reviewed by Hawkes and colleagues, several miRNAs 
have been shown to be upregulated in psoriasis, including miR-184 (Hawkes et al., 2016). 
Recent work by Roberts and co-workers has shown elevated levels of primary and mature miR-
184 in psoriatic lesions, albeit with a small sample size (Roberts et al., 2013). Evidence suggest 
that miR-184 is involved in the regulation of other miRNAs through targeting a central protein 
of the RISC complex known as AGO2 (Roberts et al., 2013).  
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Previous evidence confirms that miR-184 regulates ocular keratinocyte systems. 
However, despite recent attempts by Nagosa and co-workers indicating elevated levels of miR-
184 within differentiating mouse epidermal keratinocytes, little is known about the 
mechanisms of miR-184 induction or miR-184 expression patterns and how these change in 
psoriasis (Nagosa et al., 2017). 
 
 
• To optimise calcium-dependent HPEK differentiation  
• Investigate expression of miR-184 during HPEK differentiation in response to Ca2+ and 
other differentiation agents  
• Examine the impact of SOCE on miR-184 expression 
• Assess expression of miR-184 in psoriatic lesions 
 
 
 
Initially, based on work by Hennings et al., HPEKs were stimulated with 1.2 mM Ca2+ for 3 
days (Hennings et al., 1980). As shown in Figure 3.1A, expression of IVL was increased 6.8-
fold (±4.1) over 3 days, with no considerable change in LOR. However, errors were inconsistent 
suggesting that 3 d at 1.2 mM Ca2+ is insufficient to promote adequate differentiation of HPEK. 
However, transmitted light microscope observations revealed varied morphologies over 3 days 
suggesting that a mix of proliferating and differentiating HPEK may have been present (Fig. 
3.1B), although to validate this claim visualisation of markers for basal cells (K1) and early 
differentiated cells (K10) could be performed.  
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Figure 3.1: Effect of stimulation with 1.2 mM Ca2+ for 3 days on HPEKs. (A) Phase contrast or bright field 
images were captured for a period of 1-3 days at x200 magnification (objective plus eyepiece). Scale represents 
100 µm. (B) RT-qPCR analysis of IVL (left) and LOR (right) in HPEKs treated with 1.2 mM Ca2+ for 1-3 days. 
Values were normalised to GAPDH and depicted relative the basal control. Data is pooled from three independent 
experiments (+SEM).  
0.070 mM Ca2+ 1 d 1.2 mM Ca2+ 
2 d 1.2 mM Ca2+ 3 d 1.2 mM Ca2+ 
A 
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Given that 1.2 mM of Ca2+ caused insufficient induction of both differentiation markers, the 
concentration was increased to 1.5 mM and the stimulation time was extended from 3 days to 
5 days. After 5 days of 1.5 mM Ca2+, HPEKs showed a strong induction of IVL at 42.3-fold 
(±14.9) higher than basal HPEKs. LOR showed an induction of 54.8-fold (±31.3) higher than 
basal HPEK, although expression levels between repeats were inconsistent (Fig. 3.2A). 
Transmitted light microscopy images show a substantial morphological change between basal 
and 5 d 1.5 mM treated HPEKs indicative of terminal differentiation (Fig. 3.2B).  
   
 
               
 
    
 
 
 
Figure 3.2: Effect of stimulation with 1.5 mM Ca2+ for 5 days on HPEKs. (A) Phase contrast images captured 
after a period of 5 days at x200 magnification (objective plus eyepiece). Scale represents 100 µm. (B) RT-qPCR 
analysis of IVL (left) and LOR (right) in HPEKs treated with 1.5 mM Ca2+ for 5 days. Values were normalised to 
GAPDH and depicted relative to the basal control. Data is pooled from three independent experiments (+SEM).  
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The cell cycle is commonly dysregulated during differentiation and a hallmark of suprabasal 
cells is the accumulation of cyclin E. Therefore, the expression of G1/S phase cyclin E1 
(CCNE1) and cyclin E2 (CCNE2), as well as the mitotic cyclin B (CCNB), was analysed in 
differentiating HPEKs. As shown in Figure 3.3, following 1 d exposure to 1.5 mM Ca2+, levels 
of both CCNE1 and CCNE2 were unchanged. However, after 5 days a 2.0- and 2.4-fold 
increase in the expression of both CCNE1 and CCNE2 was observed. Expression of CCNB 
transcript 1 d post calcium switch was elevated ~2-fold before decreasing considerably to 0.26-
fold over 5 days.  
 
 
Figure 3.3: Impact of differentiation on cyclin E1, E2 and B transcript expression. RT-qPCR analysis of 
CCNE1, CCNE2 and CCNB in HPEKs treated with 1.5 mM Ca2+ for 5 days. Values were normalised to GAPDH 
and depicted relative to the proliferating control. Data was pooled from three independent experiments (±SEM) 
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As recently reviewed by Lui and colleagues, transcript levels by themselves are not enough to 
predict protein expression (Liu, Beyer and Aebersold, 2016). Therefore, to determine whether 
elevated transcript levels translate into increased protein, involucrin and cyclin E proteins were 
analysed by western blot. A strong time-dependent increase of both involucrin and cyclin E 
was observed following treatment with 1.5 mM Ca2+ for 5 days when compared with basal 
conditions (Fig. 3.4). Taken together, these results confirm commitment of HPEK to terminal 
differentiation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Effect of differentiation on involucrin and cyclin E protein expression. Western blot analysis of 
HPEKs under basal conditions or treated with 1.5 mM Ca2+ for 1-5 days. Whole cell lysates (40 µg) were examined 
using primary antibodies for Involucrin and Cyclin E with β-Actin used as a loading control.  
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Although miR-184 was not detected in proliferating HPEK monolayers in early work (Ryan, 
Oliveira-Fernandes and Lavker, 2006), it was found in RHE suggesting a role for miR-184 in 
epidermal stratification (Roberts et al., 2013). We therefore hypothesised that miR-184 also 
plays a role HPEK differentiation. Therefore, the expression of miR-184 in basal HPEKs and 
those stimulated with common differentiation agents was investigated.  
Initially, miR-184 expression was examined in HPEKs differentiated with 1.2 mM Ca2+ 
for 3 days. After 1 day a 2-fold (±0.2) induction was observed. The expression of miR-184 then 
returned to basal levels before a strong reduction to 0.3-fold (±0.2) following 3 days of 1.2 mM 
Ca2+ stimulation (Fig. 3.5).  
 
Figure 3.5: Effect of 1.2 mM Ca2+ treatment on miR-184 expression. RT-qPCR analysis of miR-184 in HPEKs 
treated with 1.2 mM Ca2+ for 3 days. Values were normalised to SNORD72 and depicted relative to HPEK grown 
in 0.07 mM Ca2+ for 3 days. Data was pooled from three independent experiments (±SEM). 
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Since treatment with 1.2 mM Ca2+ for 3 days did not promote adequate differentiation (Fig. 
3.1), miR-184 expression was analysed in HPEK differentiated for 5 days with 1.5 mM Ca2+. 
A striking 26-fold (±1.3) induction of miR-184 with a 2.8-fold (±1.7) induction at 1 d was 
observed, consistent with work by Nagosa and colleagues (Nagosa et al., 2017) (Fig. 3.6). 
 
 
 
Figure 3.6: Effect of 5 days 1.5 mM Ca2+ treatment on miR-184 expression. RT-qPCR analysis of miR-184 
in HPEKs treated with 1.5 mM Ca2+ for 5 days. Values were normalised to SNORD72 and depicted relative to 
HPEK grown in 0.07 mM Ca2+ for 3 days. Data was pooled from three independent experiments (±SEM). 
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To assess the impact of calcium-independent keratinocyte differentiation on miR-184 
expression the effect of three other common differentiation agents, interferon gamma (IFN-γ) 
(Karlsson, Vahlquist and Torma, 2010), vitamin D (1,25(OH)D3) (Bikle, 2004) and phorbol 
myristate acetate (PMA) (Karlsson, Vahlquist and Torma, 2010) was examined. Following 
stimulation for 5 days with 100 nM of PMA, following work by Torma and colleagues, despite 
a robust induction of IVL (Fig. 3.7A), miR-184 expression was relatively unchanged (Fig. 
3.7B).  
 
 
Figure 3.7: Impact of PMA treatment on miR-184 expression. RT-qPCR analysis of (A) IVL or (B) miR-184 
in HPEKs treated with 100 nM PMA for 5 days. Values were normalised to SNORD72 for miR-184 or GAPDH 
for IVL and depicted relative to HPEK grown in 0.01% DMSO for 5 days. Data was pooled from three independent 
experiments (±SEM). 
A 
B 
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Contrastingly, based on work by Hill and co-workers, 100 nM 1,25(OH)D3 provided a notable 
decrease in expression of miR-184 to 0.4-fold (±0.2; Fig. 3.8B), with a similar induction of IVL 
(Fig. 3.8A). However, treatment with IFN-γ (10 ng/ml) failed to show any induction of miR-
184, with low levels detected within basal HPEK reduced to an undetectable level. 
Collectively, these results suggest that the induction of miR-184 observed after 5 days of 
stimulation with 1.5 mM Ca2+ seems to be associated with Ca2+-dependent pathways and not 
simply the process of keratinocyte differentiation. 
 
 
 
Figure 3.8: Effect of 1,25(OH)D3 on miR-184 expression. RT-qPCR analysis of (A) IVL or (B) miR-184 in 
HPEKs treated with 100 nM 1,25(OH)D3 for 5 days. Values were normalised to SNORD72 for miR-184 or 
GAPDH for IVL and depicted relative to HPEK grown in 0.07 mM Ca2+ for 5 days. Data was pooled from three 
independent experiments (±SEM). 
A 
B 
99 
 
 
The Ca2+ sensor STIM1 and Ca2+ channel ORAI facilitates SOCE and maintain epidermal 
homeostasis. Since the miR-184 induction observed during keratinocyte differentiation was 
dependent upon Ca2+, the relationship between SOCE and Ca2+-dependent miR-184 induction 
was examined. The expression of miR-184 was therefore analysed in HPEKs maintained for 5 
days in 1.5 mM Ca2+ and treated with the SOCE blocker, Gd3+ or the ORAI1 specific 
pharmacologic inhibitor, BTP2.  
The trivalent cation, Gd3+ is a non-selective ion channel inhibitor that blocks ORAI1-
dependent Ca2+ entry at 1–5 µM (Putney, 2010). Pre-treatment with 1 µM Gd3+ prior to 
stimulation with 1.5 mM Ca2+ significantly reduced miR-184 expression by 80% to 0.2-fold 
(±0.03), as depicted in Fig. 3.9A. Furthermore, pre-treatment of differentiating HPEKs with 
the ORAI1 inhibitor, BTP2, suppressed expression of miR-184 by 70% to 0.3-fold (±0.05; Fig. 
3.10A). The levels of IVL transcript was analysed in Gd3+ and BTP2 treated HPEK. A ~50% 
decrease was observed when compared with the control (Fig. 3.9B and 3.10B).  
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Figure 3.9: Effect of Gd3+ on miR-184 expression during calcium induced differentiation. RT-qPCR analysis 
of (A) IVL and (B) miR-184 from HPEKs pre-treated for 1 hour with 1 µM Gd3+ followed by stimulation with 1.5 
mM Ca2+ for 5 days. Values were normalised to SNORD72 for miR-184 or GAPDH for IVL and depicted relative 
to the appropriate control. Data is pooled from three independent experiments (+SEM) for miR-184 analysis and 
two for IVL analysis. 
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Figure 3.10: Effect of BTP2 on miR-184 expression during calcium induced differentiation. RT-qPCR 
analysis of (A) miR-184 and (B) IVL from HPEKs pre-treated for 1 hour with 1 µM BTP2 followed by stimulation 
with 1.5 mM Ca2+ for 5 days. Values were normalised to SNORD72 for miR-184 or GAPDH for IVL and depicted 
relative to the appropriate control. Data is pooled from three independent experiments (+SEM) for miR-184 
analysis and two for IVL analysis. 
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To confirm the observations from the SOCE inhibitors, siORAI1 was nucleofected into HPEK 
and the levels of miR-184 were analysed (Prakriya et al., 2006). A strong decrease of miR-184 
expression to 0.3-fold (±0.07) was observed in 5 d differentiated HPEKs introduced to 100 nM 
siORAI1 when compared to HPEKs treated with 100 nM of control oligonucleotide. Similarly 
to the SOCE inhibitors, levels of IVL were reduced by around 50% in differentiated HPEK 
transfected with siORAI1.  
 
Figure 3.11: Impact of ORAI1 knockdown on miR-184 expression during calcium induced differentiation. 
RT-qPCR analysis of miR-184 and IVL from HPEKs nucleofected with 100 nM of siORAI1 followed by 
stimulation with 1.5 mM Ca2+ for 5 days. Values were normalised to SNORD72 for miR-184 or GAPDH for IVL 
and depicted relative to the appropriate control. Data is pooled from three independent experiments (+SEM). 
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To investigate the influence of downstream SOCE effectors upon miR-184 induction, the 
calcineurin inhibitor, CsA, was used to impede NFAT function. Pre-treatment with 1 µM CsA 
resulted in a reduction of miR-184 expression to 0.3-fold (±0.1) when compared with the 
control (Fig. 3.12).  Taken together, these results suggest the miR-184 induction observed 
during Ca2+-dependent differentiation is reliant upon SOCE and the downstream transcriptional 
activity of the calcineurin/NFAT axis.  
 
 
 
Figure 3.12: Effect of NFAT1 inhibition on miR-184 expression during calcium induced differentiation. 
RT-qPCR analysis of miR-184 from HPEKs treated with 1 µM CsA followed by stimulation with 1.5 mM Ca2+ 
for 5 days. Values were normalised to SNORD72 for miR-184 depicted relative to the DMSO control. Data is 
pooled from three independent experiments (+SEM). 
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Finally, the levels of ORAI1 was assessed primarily as a control for siORAI knockdown, but 
also to evaluate whether ORAI1 inhibitors interfere with the channels expression levels over 5 
days of inhibition. Following inhibition of SOCE for 5 days under basal condition, Gd3+ 
reduced levels of ORAI1 transcript by around 45% (Fig. 3.13A), although this could be down 
to the non-specific actions of Gd3+ as BTP2 caused little effect on ORAI1 expression (Fig. 
3.14A). Encouragingly, following 5 days of inhibition with exposure to 1.5 mM Ca2+ neither 
Gd3+ (Fig. 3.13B) nor BTP2 (Fig. 3.14B) caused any notable change in ORAI1 transcript levels. 
As expected, ORAI1 expression following treatment with 100 nM siORAI1 was reduced by 
71% to 0.29-fold (±0.11; Fig. 3.15A) in proliferating HPEK and by 55% to 0.45-fold (±0.01; 
Fig. 3.15B) in differentiated cells.  
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Figure 3.13: Effect of Gd3+ treatment on ORAI1 transcript expression. RT-qPCR analysis of ORAI1 in HPEKs 
pre-treated for 1 hour with 1 µM Gd3+ before differentiating with 1.5 mM Ca2+ for 5 days. Values were normalised 
to GAPDH and depicted relative to the vehicle control (Water). Data is pooled from three independent experiments 
(±SEM). 
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Figure 3.14: Effect of BTP2 treatment on ORAI1 expression. RT-qPCR analysis of ORAI1 in HPEKs pre-
treated for 1 hour with 1 µM BTP2 before treatment with 1.5 mM Ca2+ for 5 days. Values were normalised to 
GAPDH and depicted relative to the vehicle control (DMSO). Data is pooled from three independent experiments 
(±SEM). 
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Figure 3.15: Impact of siORAI1 nucleofection on ORAI1 transcript expression. RT-qPCR analysis of ORAI1 
in HPEKs nucleofected with 100 nM siORAI1 before stimulation with 1.5 mM Ca2+ for 5 days. Values were 
normalised to GAPDH and depicted relative to the control oligo. Data is pooled from three independent 
experiments (±SEM). 
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Expression of miR-184 in psoriasis has previously been reported (Joyce et al., 2011; Roberts 
et al., 2013). However, the role of miR-184 in psoriasis remains poorly described. Therefore, 
expression of mature miR-184 was examined by RT-qPCR in non-lesional (PN) and lesional 
(PP) areas from the skin of patients with psoriasis. 
 Initially, mature miR-184 expression was examined from eight patients and data was 
presented as mean expression. A 4-fold (±0.9) increase of miR-184 was observed in PP 
biopsies when compared to PN however this method of analysis fails to clearly show inherent 
patient variance.  
 
 
 
Figure 3.16: Mean expression of miR-184 in psoriatic lesions. Levels of mature miR-184 was analysed by RT-
qPCR in psoriatic non-lesional (PN) and lesional (PP) biopsies. Values were normalised to SNORD72 and 
depicted relative PN. Data is pooled from eight independent biopsies (+SEM). 
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Therefore, to better depict this variance, miR-184 levels previously recorded from eight patient 
biopsies were reanalysed. As shown in figure 3.17A, miR-184 was upregulated in every PP 
sample when compared to PN ranging from 1.4-fold higher (patient number 02) to 8.1-fold 
higher (patient number 04). Although still upregulated, observations here do not emulate the 
substantial 40-10,000-fold increase detected by Roberts and colleagues (Roberts et al., 2011). 
To show the range present within PN and PP samples, box and whiskers charts were used. 
When plotting normalised Ct values known as -ΔCt (CtmiR-184-CtSNORD72) there is a significant 
increase of miR-184 (decrease in -ΔCt) with a median of 8.8 in PP when compared with the 
median of 10.5 in PN. There is large variance present amongst PP samples when compared to 
PN, with minimum values of 6.1 and 8.9 in addition to maximum values of 10.4 and 10.9 
respectively (Fig. 3.17A).  
 
 
Figure 3.17: Patient variation of miR-184 expression in psoriatic lesions. Levels of mature miR-184 was 
analysed by RT-qPCR from psoriatic non-lesional (PN) and lesional (PP) biopsies taken from eight patients. 
Values were normalised to SNORD72 and plotted relative to their corresponding PN values (red line; A). Box 
and whiskers were plotted using -ΔCt (CtmiR-184 – CtSNORD72) The top and bottom of each box represent the 75th 
and 25th percentile and the middle line represents the median value with the extended lines depicting the range 
(B). * represents p ≤ 0.05.
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The first aim of this thesis was to establish a model for in vitro epidermal keratinocyte 
differentiation. Keratinocyte differentiation can be induced by adjusting the concentration of 
Ca2+ in the media with Hennings and colleagues demonstrating that 1.2 mM of Ca2+ for 3 days 
is sufficient (Hennings et al., 1980). Conflictingly, in initial experiments differentiation 
associated genes such as IVL were inconsistently induced by 1.2 mM Ca2+ after 3 days (Fig. 
3.2). Later work demonstrated that elevated Ca2+ along with extended exposure times provides 
a more consistent approach to reproducible differentiation (Borowiec et al., 2013).  
Consistently, involucrin was induced at both mRNA and protein level using 1.5 mM 
Ca2+ for 5 d. Loricrin, on the other hand, was less reproducible (Fig. 3.2B). However, other 
differentiation markers could have been assessed such as K1, K10 and fillagrin. In addition to 
the induction of differentiation-associated genes, cell cycle changes are important to 
keratinocyte differentiation, supporting their enlargement through re-replication and promotion 
of growth arrest (Zanet et al., 2010). Work by Freije and colleagues has shown that cyclin E 
accumulates in suprabasal keratinocytes where it causes DNA damage, consequently activating 
p53/p21 DDR pathways, which in turn inhibits mitotic regulators such as cyclin B and cdk1, 
ultimately leading to growth arrest and terminal differentiation (Freije et al., 2012). Taken 
together, our data is consistent with this study whereby we show elevated cyclin E at both 
transcript and protein level, in addition to severely diminished cyclin B mRNA levels following 
5 days of Ca2+-induced differentiation.  
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Expression of miR-184 was induced during terminal differentiation, and this induction was 
only observed when stimulated with Ca2+. An early mouse study found that miR-184 was 
undetectable in the epidermis and only present in ocular keratinocytes (Ryan, Oliveira-
Fernandes and Lavker, 2006). However, recent work has implicated miR-184 in epidermal 
keratinocyte differentiation, reporting a 4-fold increase of miR-184 levels in primary human 
keratinocytes following 7 days of high Ca2+. This is consistent with our finding, as we both 
report elevated levels of miR-184 in human epidermal keratinocytes following Ca2+-induced 
differentiation. However, we observed a much stronger induction of miR-184 at around 25-
fold, but the differentiation conditions used by Nagosa and colleagues were poorly defined, i.e. 
Ca2+ concentration, with the disparity between levels of miR-184 likely arising from 
differences in experimental design (Nagosa et al., 2017).  
Our data show the exclusive ability of elevated extracellular Ca2+ to promote miR-184 
expression. The other common differentiation agents, PMA and 1,25(OH)D3, failed to induce 
miR-184. Contrastingly, previous work by Sonkoly and co-workers have demonstrated that 
levels of miR-203, can be elevated by treatment with Ca2+, 1,25(OH)D3 and a phorbol ester 
analogue similar to PMA (Sonkoly et al., 2010). Both Ca2+ and PMA are potent activators of 
PKC. By activating PKC independent of Ca2+, PMA promotes keratinocyte differentiation 
(Matsui et al., 1993). This suggests that induction of miR-184 observed following Ca2+ 
stimulation is somewhat uncoupled from PKC and AP-1 pathways. However, further work 
including inhibition of PKC/AP-1 activity during Ca2+-induced differentiation, as well as 
activation of PKC/AP-1 in basal cells could be performed to validate this finding. 
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The ability of SOCE to regulate epidermal homeostasis has been assessed (Vandenberghe et 
al., 2013). The putative miRNAs induced specifically by SOCE has not been defined. 
Conversely, the regulation of miRNA expression by SOCE is unknown. Moreover, a link 
between miRNAs and SOCE in epidermal keratinocytes has not yet been reported. We have 
shown that miR-184 is induced during HPEK differentiation and that this induction is 
dependent on Ca2+. SOCE is a predominant form of Ca2+ entry in keratinocytes. 
 Our data indicates that SOCE mediates the induction of miR-184 observed during Ca2+-
dependent differentiation, whereby levels of miR-184 are considerably reduced when factors 
important to SOCE activity are inhibited. Previous work has demonstrated the importance of 
miRNAs in the regulation of SOCE activity, with a recent study indicating that Dicer, a major 
miRNA biogenesis protein, is vital for SOCE function with its ablation in CD4+ T cells leading 
to downregulation of ORAI1, and consequently reduced Ca2+ entry, through SOCE-dependent 
mechanisms (Zhang et al., 2016). However, this is the first time to our knowledge that SOCE 
has been shown to directly regulate the expression of a miRNA. Additionally, it is the first time 
a link between miRNAs and SOCE in keratinocytes has been demonstrated. SOCE activity 
varies in proliferating and differentiating keratinocytes, suggesting that SOCE and its 
downstream pathways are key to the induction and fine-tuning of differentiation-associated 
miRNA expression. Although as of yet, there is little evidence to support this claim and 
therefore it could represent an exciting separate study, whereby miRNA profiling in 
keratinocytes with perturbed SOCE activity, could illuminate other miRNAs regulated in this 
fashion.  
The transcription factor NFAT, is a major downstream effector of SOCE and a recent 
computational study has predicted that NFAT promotes the expression of 32 miRNAs, 12 of 
which overlap miRNAs expressed during in vitro epidermal keratinocyte differentiation 
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(Hildebrand et al., 2011; Kannambath, 2016). Nevertheless, miR-184 was not mentioned in 
either study. However, we show inhibition of NFAT using CsA, an inhibitor of the NFAT 
activator called calcineurin, leads to a striking reduction of miR-184 in keratinocytes following 
5 days of high Ca2+. This suggests that miR-184 expression during epidermal keratinocyte 
differentiation is highly dependent on NFAT activity.  
When HPEKs were treated with SOCE inhibitors the induction of involucrin observed 
5 days post calcium switch is severely diminished. Only a few studies have analysed involucrin 
expression in differentiating epidermal keratinocytes following inhibition of SOCE. 
Vandenberghe and co-workers report a striking increase of involucrin in primary human 
keratinocytes exposed to siORAI1 following a 24 h Ca2+ switch (Vandenberghe et al., 2013). 
However, our data, demonstrating reduced levels of involucrin in 5 d differentiated HPEK pre-
transfected with siORAI1, is in opposition with this work, although the differences in time 
points used between studies prevents a direct comparison. Recent work by Numaga-Tomita 
and Putney partially supports our finding showing a similar reduction in differentiation-
associated genes, specifically the early differentiation marker K1, in keratinocytes with 
diminished ORAI1 activity after 7 days of Ca2+ (Numaga-Tomita and Putney, 2013). Taken 
together this suggests a possible regulatory role for ORAI1 in the progression from early to late 
differentiation. Furthermore, this data raises the question of whether it is reduced SOCE 
activity that is directly responsible for the reduction of miR-184 expression, or whether it is 
simply as a result of a dampened differentiation response.  
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Consistent with the literature, our data show that miR-184 expression was elevated in psoriasis.  
We observed a ~4-fold increase of miR-184 in PP samples when compared with PN. 
Contrastingly, a deep sequencing study by Joyce and co-workers describes an increase of miR-
184 in psoriatic samples when compared with healthy skin (Joyce et al., 2011). Interestingly, 
levels of miR-184 between PP and PN were relatively the same. This could be down to 
differences in chosen methods, with Joyce et al., employing a next generation sequencing 
(NGS) approach and our data representing RT-qPCR (Joyce et al., 2011). Additionally, recent 
work has demonstrated elevated levels of miR-184 in the epidermis of psoriatic lesions when 
compared with non-lesional skin (Roberts et al., 2013). Moreover, miR-184 can be upregulated 
in HaCaTs and RHE by pro-inflammatory cytokines implicated in psoriasis, such as IL-22 
(Roberts et al., 2013). Given that miR-184 was induced during HPEK differentiation, the 
elevated levels of miR-184 observed in psoriasis and following IL-22 stimulation may be a 
compensatory mechanism to recover a differentiated phenotype.  
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4. Function of miR-184 During HPEK 
Differentiation 
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The ability of miR-184 to regulate the balance between proliferation and differentiation has 
been reported in a variety of cell types over the past decade. An early study has shown that 
miR-184 prevented differentiation of adult neural stem cells, with those overexpressing miR-
184 differentiating into ~30% less astrocytes and neurons (Liu et al., 2010). Work on 
hepatocellular carcinoma cell lines implicated miR-184 in proliferation. With ectopic 
expression of miR-184 leading to increased cell colonies, enhanced MTT signal and an 
elevated number of cells present in S phase accompanied by reduced G1/G0 percentages (Wu 
et al., 2014). A recent study on mice by Tattikota and colleagues uncovered a role for miR-184 
in pancreatic β-cell proliferation, where miR-184 suppressed expression of Ago2 resulting in 
reduced β-cell islet mass and consequently decreased levels of circulating insulin (Tattikota et 
al., 2014).  
Lavker and co-workers proposed a role for miR-184 in the regulation of corneal 
keratinocytes when they detected high levels of miR-184 in mouse corneal epithelium but not 
in foot-pad epithelium (Ryan, Oliveira-Fernandes and Lavker, 2006). They later found miR-
184 modulates proliferation of corneal epithelium by indirectly elevating SHIP2. This in turn 
acts as a negative regulator of Akt signalling leading to decreased cellular growth and survival. 
However, they did not detect miR-184 in epidermal keratinocytes (Yu et al., 2008). In contrast, 
work by Ross and colleagues showed miR-184 in RHE and HaCaTs (Roberts et al., 2013).  
Furthermore, a very recent study by Nagosa and co-workers showed miR-184 was significantly 
elevated in the suprabasal layers of mouse epidermis (Nagosa et al., 2017). Furthermore, 
through use of loss- and gain-of-function mouse models Shalom-Feuerstein and co-workers, 
were able to show that miR-184 maintains the equilibrium between proliferation and 
differentiation by direct regulation of the Notch and p63 pathways (Nagosa et al., 2017).  
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Early work by Missero and colleagues in p21 null mice revealed that early p21 
expression is required to commit keratinocytes to terminal differentiation (Missero et al., 1996). 
E-type cyclins are components of core cell cycle machinery and consist of two functionally 
redundant proteins, cyclin E1 and cyclin E2, encoded by CCNE1 (ch.19q12) and CCNE2 genes 
(ch.8q22.1). Cyclin E1 is the most abundant protein form and herein represents cyclin E in 
protein analysis. During keratinocyte differentiation, cyclin E accumulation causes DNA 
damage predominately through activation of p21/p53 pathways and this DNA damage is vital 
for successful keratinocyte stratification (Freije et al., 2012; Freije et al., 2014). Although we 
and others have shown miR-184 in differentiating epidermal keratinocytes, the role of miR-
184 within the proliferation:differentiation switch has remained relatively unexplored.  
 
 
 
• To optimise miR-184 nucleofection of HPEKs 
• Investigate the impact of perturbed miR-184 activity on keratinocyte growth 
• Examine the effect of dysregulated miR-184 upon differentiation  
 
 
 
To determine nucleofection efficiencies, HPEKs were nucleofected with 2 µg of pmaxGFP 
vector and the expression levels were investigated after 2 and 5 days. When quantified the 
proportion of GFP-positive cells exhibited a modest increase from 29.7% (±0.5%) at 2 days to 
34.8% (±1.0%; P=0.012) at 5 days (Figure 4.1), suggesting some cells that had taken up the 
plasmid, but those which were not expressing GFP at day 2, were able to express GFP at a later 
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time point. The morphology of the cells appeared normal, suggesting that nucleofection did not 
have adverse effects (Fig. 4.1A-D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Figure 4.1: Effect of time on GFP expressing HPEKs. HPEKs 2 days (A-B) or 5 days (C-D) post-nucleofection. 
A and C phase contrast images, same field of view. B and D fluorescent images of pmaxGPF vector, same field 
of view. Scale represents 100 µM. Chart (Bottom) represents percentages of GFP-positive cells quantified using 
ImageJs cell counting tool. Data represents averages from four fields of view taken from three independent 
experiments. (+SEM). * represents p ≤ 0.05. 
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Nucleofection with small synthetic oligonucleotides such as miRNA mimics or siRNA is 
thought to have increased efficiencies when compared with GFP. Therefore, the levels of 
mature miR-184 following nucleofection with miR-184 mimic were analysed by RT-qPCR. 
Initially, HPEK were nucleofected with 20 nM of miR-184 mimic which elevated expression 
of mature miR-184 by 3.9-fold (±1.8) when compared with the control, although the variance 
between replicates was high (Fig.4.2A). To further elevate the levels of miR-184, HPEKs were 
exposed to the upper limit of miR-184 mimic used by Ross and colleagues at 100 nM, resulting 
in a striking 4787-fold (±1618) increase (Fig. 4.2B) (Roberts et al., 2013).  
 
    
  
Figure 4.2: Effect of miR-184 mimic on basal miR-184 expression. HPEKs nucleofected with 20 nM (A) or 
100 nM (B) of control oligonucleotide or miR-184 mimic and grown 0.07 mM Ca2+ for 1 day before analysis by 
RT-qPCR. Values were normalised to SNORD72 and depicted relative to the control oligo. Data represents two 
independent experiments (+SEM). 
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To examine the longevity of synthetic miR-184, nucleofected HPEKs were grown for extended 
periods of time before analysis by RT-qPCR. As expected 3 days post nucleofection the levels 
of mature miR-184 remained elevated at 1386-fold when compared with the control 
oligonucleotide (Fig. 4.3A). Interestingly, when compared with 1 d nucleofection (Fig. 4.2B), 
miR-184 levels were reduced by ~70%. As shown in Figure 4.3B, the expression of miR-184 
following 5 days of growth was further reduced to 68.8-fold when compared with the control 
oligonucleotide. Even though nucleofection with miR-184 mimic displayed a reduction over 5 
days, supraphysiological levels would still be present with amounts at 5 days at least 2-fold 
higher than the uppermost biological levels during differentiation (Fig. 3.6). 
 
 
Figure 4.3: Impact of miR-184 mimic on miR-184 expression over 5 days. HPEKs nucleofected with either 
100 nM control oligonucleotide (white bars) or 100 nM miR-184 mimic (grey bars) and grown in 0.07 mM Ca2+ 
for ether 3 d (A) or 5 days (B) before analysis by RT-qPCR. Values were normalised to SNORD72 and depicted 
relative to the control oligo. Data represents two independent experiments (+SEM). 
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miR-184 has been shown to suppress cell viability and growth in several cell types (Tattikota 
et al., 2014; Tung et al., 2016; Wang et al., 2017). Therefore, HPEK were transfected with 100 
nM of miR-184 mimic. Cell viability and growth were measured by MTT and trypan blue 
exclusion assays. Nucleofection with miR-184 mimic showed a decrease in MTT signal with 
a ~40% reduction compared with the control, though this failed to reach significance (p=0.06; 
fig. 4.4B). In trypan blue assays, miR-184 mimic reduced cell viability by 16.2% to 83.8% 
(+0.4%; p≤0.0001) compared to the control oligonucleotide. Taken together data suggests that 
introduction of miR-184 mimic may have a toxic effect on HPEK reducing cellular viability.  
 
 
Figure 4.4: Effect of miR-184 on cellular health. HPEKs were nucleofected with 100 nM of control 
oligonucleotide or miR-184 mimic grown and grown in 0.07 mM Ca2+ for 2 days before analysis by either 
exclusion trypan blue (A) or MTT (B). Values were depicted relative to the control. Data represents three 
independent experiments (+SEM). **** depicts significance p≤ 0.0001. n.s. indicates no significance. 
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Given that miR-184 reduces cell viability it was hypothesised that miR-184 would have an 
impact on cell cycle progression in epidermal keratinocytes. HPEKs loaded with miR-184 were 
stained with the DNA-binding dye propidium iodide (PI) and analysed by flow cytometry. The 
proportion of cells in G1-phase was 76.7% when loaded with miR-184 mimic, compared with 
63.4% of the control oligonucleotide. A corresponding drop from 21.6% to 16% during S-
phase and 13.4% to 7.4% in G2 was also observed in cells with elevated miR-184 (Fig. 4.5). 
This suggests that miR-184 causes cells to accumulate and/or arrest in G1-phase of the cell 
cycle.
 
Figure 4.5: The effect of miR-184 on cell cycle dynamics. HPEKs were transfected with 100 nM of either 
control oligonucleotide or miR-184 mimic and grown under basal conditions for 2 days before staining with 100 
ug/ml propidium iodide for 45 minutes and analysed by flow cytometry. Data represents three independent repeats 
(+SEM). **** depicts significance p≤ 0.0001 and * indicates significance p≤ 0.05. 
 
 
 
 
  
123 
 
 
 
To assess the effect of miR-184 on differentiation markers, involucrin was analysed by RT-
qPCR. When proliferating HPEK are loaded with synthetic miR-184, IVL transcript is reduced 
in a dose dependent manner, with 20 nM leading to a modest reduction in IVL levels to 0.75-
fold (Fig. 4.6A). Strikingly, 100 nM led to a 75% reduction when compared with the control 
oligonucleotide (Fig. 4.6B).  
 
 
Figure 4.6: Effect of miR-184 on involucrin transcript expression in HPEKs. HPEKs were nucleofected with 
either 20 (A) or 100 (B) nM of control oligonucleotide or miR-184 mimic grown in 0.07 mM Ca2+ for 2 days 
before analysis by RT-qPCR. Values were normalised to GAPDH and depicted relative to the 0.07 mM Ca2+ 
control. Data represents two repeats (+SEM). 
 
 
 
  
A B 
124 
 
Next, to evaluate translational activity, involucrin protein levels were determined by western 
blot in cells overexpressing miR-184. Ectopic miR-184 induced a 3.4-fold (±0.5) elevation of 
involucrin after 5 days (Fig. 4.7A) and represented 79.5% of the overall chemiluminescent 
signal compared to 20.5% of the control oligonucleotide (Fig. 4.7B). 
 
 
 
 
 
     
Figure 4.7: Impact of miR-184 overexpression on Involucrin in HPEKs. HPEKs were nucleofected with 100 
nM of control oligonucleotide or miR-184 mimic and grown in 0.07 mM Ca2+ for 5 days before analysis by 
western blot (A). Values were normalised to β-Actin and density proportions were calculated from the total 
densities of the samples (B). Data represents three independent experiments (+SEM). *** depicts significance 
were p≤ 0.001. 
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Cyclin E plays a vital role in keratinocyte differentiation (Freije et al., 2012). When compared 
with the control oligonucleotide both CCNE1 and CCNE2 transcripts remained unchanged in 
basal HPEKs possessing miR-184 (Fig. 4.8, 4.9). At the protein level, cyclin E in proliferating 
cells exposed to 100 nM miR-184 mimic was 3.1-fold (±0.7) higher when compared with the 
control oligonucleotide (Fig. 4.10). 
 
Figure 4.8: Effect of miR-184 on cyclin E1 transcript expression in HPEKs. HPEKs were nucleofected with 
either 20 (A) or 100 (B) nM of control oligonucleotide or miR-184 mimic grown in 0.07 mM Ca2+ for 5 days 
before analysis by RT-qPCR. Values were normalised to GAPDH and depicted relative to the 0.07 mM Ca2+ 
control. Data represents three independent experiments (+SEM). 
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Figure 4.9: Effect of miR-184 on cyclin E2 transcript expression in HPEKs. HPEKs were nucleofected with 
either 20 (A) or 100 (B) nM of control oligonucleotide or miR-184 mimic grown in 0.07 mM Ca2+ for 5 days 
before analysis by RT-qPCR. Values were normalised to GAPDH and depicted relative to the 0.07 mM Ca2+ 
control. Data represents three independent experiments (+SEM). 
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Figure 4.10: Effect of miR-184 on Cyclin E protein in HPEKs. HPEKs were nucleofected with 100 nM of 
control oligonucleotide or miR-184 mimic and grown in 0.07 mM Ca2+ for 5 days before analysis by western blot 
with fold changes worked out based on density and normalised to β-Actin (A). Values were normalised to β-Actin 
and density proportions were calculated from the total densities of the samples (B). Data represents three 
independent experiments (+SEM). ** depicts significance were p≤ 0.01. 
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p21, an inhibitor of cyclin E, plays an important role in the regulation of keratinocyte 
proliferation and differentiation (Missero et al., 1996; Devgan et al., 2006; Freije et al., 2014). 
Consequently, the expression of p21 transcript in HPEK treated with miR-184 mimic was 
analysed. As shown in Figure 4.11, following introduction of synthetic miR-184, p21 levels 
were elevated 2.5-fold when compared to the control oligonucleotide.  
 
Figure 4.11: Impact of miR-184 on p21 transcript in HPEKs. HPEKs were nucleofected with 100 nM of 
control oligonucleotide or miR-184 mimic grown in 0.07 mM Ca2+ for 2 days before analysis by RT-qPCR. Values 
were normalised to GAPDH and depicted relative to the 0.07 mM Ca2+ control. Data represents two repeats 
(±SEM). 
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As with p21 transcript levels it was believed that p21 protein would also be elevated. To 
determine this lysates from proliferating HPEKs exposed to 100 nM of miR-184 were analysed 
by western blot. A 2.0-fold (±0.1) induction of p21 was observed in cells transfected with 
synthetic miR-184 (Fig. 4.12). Taken together, elevated involucrin (Fig. 4.8), cyclin E (Fig. 
4.10) and p21 (Fig. 4.12) all point to a differentiation phenotype. 
 
   
 
 
 
 
 
 
        
 
Figure 4.12: Impact of miR-184 on p21 protein in HPEKs. HPEKs were nucleofected with 100 nM of control 
oligonucleotide or miR-184 mimic and grown in 0.07 mM Ca2+ for 5 days before analysis by western blot (A). 
Values were normalised to β-Actin and density proportions were calculated from the total densities of the samples 
(B). Data represents three independent experiments (+SEM). *** depicts significance were p≤ 0.001. 
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Ectopic miR-184 causes induction of cyclin E, p21 and involucrin in proliferating HPEKs (Fig. 
4.7-4.12). Given that miR-184 was induced during HPEK differentiation (Fig. 3.6) the effects 
of miR-184 inhibition were examined. To ascertain the role of miR-184 during differentiation, 
physiological miR-184 induction was repressed by loading HPEKs with a miR-184 targeting 
LNA inhibitor before differentiation with 1.5 mM Ca2+ for 5 days. As revealed in Figure 4.13, 
expression of involucrin was significantly reduced by 60% to 0.4-fold when physiological miR-
184 was inhibited. Cyclin E was also significantly reduced by 90% in miR-184 inhibitor 
samples to 0.1-fold when compared with the control oligonucleotide (Fig. 4.14). Levels of 
cyclin E inhibiting p21 were reduced by 50% to 0.5-fold in cells with inhibited miR-184 (Fig. 
4.15). Taken together, suppression of involucrin (Fig. 4.13), cyclin E (Fig. 4.14) and p21 (Fig. 
4.15) by inhibition of physiological miR-184 confirms a role in the regulation of proteins 
related differentiation. 
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Figure 4.13: Impact of miR-184 inhibition on involucrin in HPEKs. HPEKs were nucleofected with 100 nM 
of control oligonucleotide or miR-184 inhibitor and grown in 0.07 mM Ca2+ for 5 days before analysis by western 
blot (A). Values were normalised to β-Actin densitometry was performed (B). Data represents three independent 
experiments (+SEM). *** depicts significance were p≤ 0.001. 
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Figure 4.14: Effect of miR-184 inhibition on Cyclin E in HPEKs. HPEKs were nucleofected with 100 nM of 
control oligonucleotide or miR-184 inhibitor and grown in 0.07 mM Ca2+ for 5 days before analysis by western 
blot (A). Values were normalised to β-Actin densitometry was performed (B). Data represents three independent 
experiments (+SEM). *** depicts significance were p≤ 0.001. 
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Figure 4.15: Effect of miR-184 inhibition on p21 in HPEKs. HPEKs were nucleofected with 100 nM of control 
oligonucleotide or miR-184 inhibitor and grown in 0.07 mM Ca2+ for 5 days before analysis by western blot (A). 
Values were normalised to β-Actin densitometry was performed (B). Data represents three independent 
experiments (+SEM). * depicts significance were p≤ 0.05. 
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DNA damage is a key feature of terminal differentiation and previous work has indicated the 
role cyclin E/p21 has in promoting genomic damage and growth arrest. Both cyclin E and p21 
protein were upregulated in cells loaded with miR-184 suggesting that miR-184 encourages 
differentiation through cyclin E/p21-related DNA damage. To investigate whether miR-184 
causes DNA damage, expression and activity levels of phosphorylated H2AX (γH2AX), a 
histone marker that localises to double stranded breaks and promotes recruitment of DNA 
repair factors was measured (Bonner et al., 2008). Proliferating cells transfected with miR-184 
mimic were examined by western blot, with the levels of γH2AX quantified. Cells loaded with 
miR-184 had significantly elevated levels of γH2AX at 1.8-fold when compared to the control 
oligonucleotide (Fig. 4.16). In contrast, levels of γH2AX were modestly reduced to 0.7-fold 
when physiological miR-184 was inhibited (Fig. 4.17).  
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Figure 4.16: Effect of miR-184 mimic on γH2AX levels in HPEKs. HPEKs were nucleofected with 100 nM of 
control oligonucleotide or miR-184 mimic and grown in 0.07 mM Ca2+ for 5 days before analysis by western blot 
(A). Values were normalised to β-Actin densitometry was performed (B). Data represents three independent 
experiments (±SEM). *** depicts significance were p≤ 0.001. 
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Figure 4.17: Effect of miR-184 Inhibitor on γH2AX levels in HPEKs. HPEKs were nucleofected with 100 nM 
of control oligonucleotide or miR-184 inhibitor and grown in 1.5 mM Ca2+ for 5 days before analysis by western 
blot (A). Values were normalised to β-Actin densitometry was performed (B). Data represents three independent 
experiments (±SEM). ** depicts significance were p≤ 0.001. 
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To confirm increased levels of γH2AX was associated with characteristic DNA damage foci, 
fluorescent images of HPEK with ectopic miR-184 were captured before quantification of 
γH2AX foci. On average, cells transfected with miR-184 had over double the amount of 
fluorescent γH2AX foci at 7.6 compared to 3.6 present in the control oligonucleotide samples 
(Fig. 4.19A) with a clear difference between images (Fig. 4.18). When miR-184 was inhibited 
in differentiating cells, the levels of γH2AX foci remained relatively unchanged, suggesting 
that DNA damage cannot readily be reduced beyond physiological levels (Fig. 4.19B). 
 
    
    
Figure 4.18: Impact of miR-184 overexpression upon γH2AX foci. HPEKs were nucleofected with 100 nM of 
miR-184 mimic (B) or miR-184 inhibitor (D) along with the corresponding controls (A, C) before growth in either 
0.07 mM (A-B) or 1.5 mM (C-D) Ca2+ for 5 days followed by γH2AX staining and nuclear counterstaining with 
DAPI. Fluorescent images were taken at 20x magnification from 10 fields of view per sample. 
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Figure 4.19: Quantification of fluorescent γH2AX foci. HPEKs were nucleofected with either 100 nM of  miR-
184 mimic (A), miR-184 inhibitor (B) or respective controls and grown in 0.07 mM Ca2+ (A) or 1.5 mM Ca2+(B) 
for 5 days before staining with γH2AX. Fluorescent images were taken from 10 fields of view at 20x magnification 
from control (white) and miR-184 mimic (grey) samples. Data represents relative foci per nucleus (+SEM) 
quantified from three independent experiments. 
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The first aim of this chapter was to optimise transfection of HPEK in order to manipulate levels 
of miR-184. Taken together our data gives important insights into the levels of miR-184 
following transfection of HPEKs with miR-184 mimic and how long miR-184 mimic persists 
in the cell. Primary human keratinocytes are notoriously hard to transfect, especially when 
compared to immortalised cell lines such as HaCaTs (Distler et al., 2005). In addition to being 
more susceptible to toxic reagents, where any damage can cause irreversible differentiation 
primary cells are thought to degrade exogenous RNA at an elevated rate (Hunt et al., 2010).  
Our data shows that nucleofection with a GFP plasmid was successful, although transfection 
efficiencies at 35% were lower than the 56% reported by Distler and colleagues (Fig. 4.1) 
(Distler et al., 2005). Several factors may contribute to lower transfection efficiencies, such as 
keratinocyte donor variation and nucleofector condition/solution differences, though it is 
important to note that GFP expression was not lost over the course of 5 days.  
RNAi activity relies on binding of delivered cargo to the RISC complex. The levels of 
miR-184 in HPEKs following transient transfection are relatively undescribed. However, very 
recent work on nasopharyngeal carcinoma cell lines has demonstrated ~500-fold increase of 
miR-184 2 days after transfection with miR-184 mimic (Zhu et al., 2018). Our data shows that 
nucleofection with a synthetic miR-184 mimic increased levels of mature miR-184 in a dose 
dependent manner, with 100 nM providing a more consistent elevation up to ~4800-fold after 
1 d (Fig. 4.2). A recent review by Jin and colleagues has highlighted the pitfalls of using 
miRNA mimics, showing that transfection of synthetic miRNAs at high concentrations 
increases miRNA levels by a factor of several hundred, leads to accumulation of high molecular 
weight RNA and ultimately results in non-specific changes in gene expression (Jin et al., 2015). 
We used cel-miR-67, a non-targeting control isolated from C. elegans known to have minimal 
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sequence identity with miRNAs in humans, to allow differentiation between mimic activity 
and non-specific background effects. However, cel-miR-67 still causes accumulation of RNA 
species and therefore a miR-184 mimic with a mutant seed region could have been used 
throughout to validate specific effects from the active miR-184 mimic (Jin et al., 2015). 
Furthermore, although miR-184 was still present at elevated levels, there was a drastic 
reduction observed over the course of 5 days. This may suggest that miR-184 is reduced 
through cellular division or that excess free-floating miR-184 mimic not bound to the RISC 
complex is rapidly degraded.  
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The regulation of normal keratinocyte proliferation is critical in the maintenance of the 
epidermis. Previous studies have demonstrated that miR-184 plays an important role in the 
regulation of proliferation, acting as both tumour suppressor and onco-miR in several cell 
types. Early work by Stallings and co-workers demonstrated that overexpression of miR-184 
reduces viability and proliferation in human glioma cell lines (Chen and Stallings, 2007). 
Moreover, a very recent study has shown that miR-184 reduces proliferation by promoting 
apoptosis in human colon cancer cell lines (Wang et al., 2017). In contrast, work on 
hepatocellular carcinoma lines has shown that miR-184 promotes proliferation through direct 
targeting of SRY-Box 7 (SOX7) (Wu et al., 2014). In addition, a very recent study has 
supported this role with overexpression of miR-184 in tongue squamous carcinoma cell lines 
promoting proliferation through targeting of SOX7 (Chen et al., 2018). It is evident that miR-
184 plays a context-dependent role in human cancer proliferation. In epidermal keratinocytes, 
recent work has demonstrated that miR-184 modulates growth with miR-184-null mice 
exhibiting epidermal hyperplasia. The same study also shows that forced tetracycline-inducible 
expression of miR-184 reduces proliferation by activation of Notch signalling resulting in 
epidermal hypoplasia (Nagosa et al., 2017)    
 We have shown that HPEKs loaded with miR-184 mimic have reduced MTT signal 
although this failed to reach significance. A major pitfall of the MTT assay is the metabolic 
state of the cell whereby any changes in MTT signal may be directly proportional to cell 
number but equally could reflect metabolic changes induced by addition of external stimuli. 
To confirm changes in HPEK growth and to complement MTT data, trypan blue exclusion was 
performed. Our data indicates that when transfected with synthetic miR-184 cell viability was 
significantly reduced (Fig. 4.4A).  To our knowledge, there is no literature evaluating the effect 
of miR-184 on cells by trypan blue exclusion assay although, it has been demonstrated that the 
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membranes of terminally differentiating keratinocytes become permeable to trypan blue 
(Parkinson and Emmerson, 1982). Given that miR-184 induces the differentiation marker, 
involucrin (Fig. 4.7), this suggests that the HPEKs loaded with miR-184 have an elevated 
population of terminally differentiated cells. 
 Cell cycle regulation is vitally important for every aspect of keratinocyte growth, not 
only maintaining normal proliferation but also supporting growth arrest at the onset of 
differentiation (Zanet et al., 2010). Our data indicates that miR-184 causes proliferating HPEK 
to accumulate in G1-phase of the cell cycle, consequently decreasing S and G2 proportions 
(Fig. 4.5). Recent work by Nagosa and colleagues on epidermal keratinocytes from miR-184-
null mice validates our finding, reporting accumulation of cells in S- and G2-phases in addition 
to a reduced G1-phase proportion (Nagosa et al., 2017). Consistent with our finding, a recent 
study in glioma cell lines show that cells loaded with miR-184 accumulate in G1-phase of the 
cell cycle (Cheng et al, 2015). Contrastingly, work on hepatocellular carcinoma cell lines has 
shown that miR-184 differentially regulates the cell cycle, causing a shift in cycling dynamics 
and elevating levels of S-phase cells (Wu et al., 2014). Taken all together, we have 
demonstrated for the first time in monolayer HPEKs, a potential role for miR-184 in the 
regulation of proliferation, relying predominately on shifted cell cycle dynamics. However, 
with the limitations of the methods used, to confirm the role of miR-184 in the control of 
proliferation additional work evaluating proliferation markers for example Ki67, proliferating 
cell nuclear antigen (PCNA) and K5/K14 or assessing changes in proliferation further, using 
techniques such as BrdU incorporation assay, could be performed. Moreover, although recent 
work has illuminated the role of miR-184 in the proliferation of murine epidermis, further work 
using human organotypic models could provide an interesting insight into the effects of miR-
184 in a fully stratified human system.   
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Precise, co-ordination of keratinocyte proliferation and differentiation is essential to epidermal 
homeostasis. Early work detected miR-184 in RHE but not monolayers suggesting that miR-
184 may play a role in keratinocyte stratification (Roberts et al., 2013). Very recent work has 
described expression patterns of miR-184 in murine epidermis, reporting none in both basal 
and terminally differentiated compartments and high amounts in early-differentiated layers 
(Nagosa et al., 2017). Moreover, they demonstrate Ca2+-dependent induction of miR-184 
during primary human keratinocyte differentiation where it targets Notch1 signalling to support 
differentiation (Nagosa et al., 2017).  
Our data shows that levels of involucrin can be regulated in proliferating and 
differentiating HPEKs by perturbation of miR-184 levels (Fig. 4.7, 4.13). A recent study 
optimising keratinocyte differentiation conditions have reported elevated expression of both 
p21 and involucrin following sustained treatment with high Ca2+ (Borowiec et al., 2013). 
Furthermore, it has been demonstrated in HPEKs that overexpression of cyclin E leads to 
induction of involucrin (Freije et al., 2012). Consistent with the literature, we have shown 
concomitant induction of involucrin with cyclin E and p21, in differentiating HPEKs loaded 
with control oligonucleotide. We also show that miR-184 can induce involucrin in proliferating 
HPEKs (Fig. 4.7), suggesting that miR-184 alone is sufficient to trigger a differentiation 
response in the absence of high Ca2+ or other differentiation reagents. Interestingly, levels of 
involucrin transcript did not parallel its respective protein amounts, with a reduction in 
transcript, coupled with elevated protein, being observed in cells with elevated levels of miR-
184. In contrast, recent work reported a significant increase of involucrin transcript in primary 
human keratinocytes, following transfection with synthetic miR-184, though protein levels 
were not assessed (Nagosa et al., 2017). However, this observed increase of involucrin 
transcript was in differentiating keratinocytes loaded with miR-184 mimic, preventing a direct 
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comparison with our data. In contrast, we show upregulated levels of both p21 mRNA and 
protein (Fig. 4.11-12) in proliferative HPEKs treated with miR-184, though there is not always 
a proportional relationship between transcript and protein levels (Liu, Beyer and Aebersold, 
2016). Although miR-184 was not described, previous work has demonstrated that miRNAs 
can upregulate translation of certain mRNAs in mammalian cells (Bukhari, Truesdell and 
Vasudevan, 2018). Conceivably, miR-184 plays a potential regulatory role in the translation of 
involucrin, that differs between proliferative and differentiated HPEKs or IVL transcription is 
not as dynamic as other transcripts, especially in monolayer HPEKs where naturally some cells 
have elevated levels of involucrin mRNA. Further experiments such as fractional sequencing, 
whereby interaction of miR-184 with IVL transcripts could be analysed in both unbound and 
ribosomal bound pools of mRNA, would be required for further investigation of these ideas. 
In contrast, our data shows that the induction of involucrin protein observed in differentiating 
HPEKs, can be inhibited by antagonising normal miR-184 activity (Fig. 4.13). Recent work is 
consistent with this finding showing that inhibition of miR-184 during primary human 
keratinocyte differentiation reduces levels of involucrin transcript (Nagosa et al., 2017). 
Our data shows that loading proliferating HPEKs with miR-184 mimic results in 
upregulation of cyclin E (Fig. 4.10). Given that cyclin E is a regulator of G1/S-phase transition, 
this may explain the ability of miR-184 to promote accumulation of G1-phase cells. 
Conversely, inhibition of physiological miR-184 during HPEK differentiation results in a 
drastic reduction (Fig. 4.14). A previous study on murine epidermis has shown that cyclin E 
accumulates in suprabasal layers supporting cellular enlargement through endoreplication 
(Zanet et al., 2010). Similarly, an in vitro study demonstrated that cyclin E accumulates in 
differentiating HPEKs where it induces mitosis failure and differentiation (Freije et al., 2012). 
This suggests that elevated levels of cyclin E in proliferating HPEKs loaded with miR-184 is 
a similar differentiation response. Both studies by Zanet et al., 2010 and Freije et al., 2012 
145 
 
suggest that primary keratinocytes accumulate in G2- not G1-phase when undergoing 
differentiation. However, they use the proto oncogene, c-myc, to differentiate keratinocytes 
and their data represents terminally differentiated and not early differentiating cells. To our 
knowledge a link between miR-184 and cyclin E has not yet been reported. However, miR-184 
is known to inhibit NFAT1 in umbilical cord CD4+ T-lymphocytes. Given that NFAT1 acts as 
a repressor of G1/S-phase effectors such as cyclin E in several cell types it may be speculated 
that miR-184 targets NFAT1 in HPEKs allowing for accumulation of cyclin E (Baksh, 
DeCaprio and Burakoff, 2000; Horsley et al., 2008; Weitzel et al., 2009; Teixeira et al., 2016). 
Although there is little evidence to support this and as such it could represent an interesting 
further study.  
Elevation of cyclin E is normally coupled with induction of its inhibitor, p21. An 
increase of p21 was observed in basal HPEKs loaded with miR-184 (Fig. 4.12). Conversly, p21 
induction during Ca2+-dependent HPEK differentiation was reduced in the presence of miR-
184 inhibitor (Fig. 4.15). Studies from the Gandarillas laboratory have demonstrated that p21 
is induced during the onset of keratinocyte differentiation and is associated with cyclin E 
accumulation. Moreover, overexpression of cyclin E was sufficient to induce expression of p21 
(Freije et al., 2012; Freije et al., 2014). Consistent with the literature, our data show that miR-
184 mediates the induction of p21 observed during differentiation. Multiple cyclin/cdk 
complexes are targets for p21 inhibition, with a recent study reporting that immunodepletion 
of p21, at the onset of differentiation, results in removal of mitotic cyclin A with significant 
amounts of cyclin E remaining (Freije et al., 2012). Therefore, our data suggests that miR-184-
dependent p21 induction acts to support differentiation by inhibiting mitotic cyclins rather than 
cyclin E, although evaluation of cyclin A levels in HPEKs with perturbed miR-184 would 
further support this idea. Consistent with our observations, overexpression of miR-184 induces 
expression of p21, which in turn supports growth arrest of lung cancer cell lines (Liu et al., 
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2014). Likewise, later work has demonstrated that miR-184 causes growth arrest in glioma and 
breast cancer cell lines in part due to an induction of p21 (Feng and Dong, 2015).
Emerging evidence suggests that DNA damage is an important factor in keratinocyte 
differentiation. Overexpression of cyclin E has been shown to promote DNA damage to an 
irreversible threshold, inducing a mitosis block and ultimately leading to terminal 
differentiation (Freije et al., 2012). In our work, HPEKs loaded with miR-184 seem to undergo 
differentiation by inducing cyclin E, p21 and involucrin. Given the ability of cyclin E to induce 
genomic damage we predicted that this miR-184-induced differentiation occurs in a DNA 
damage-dependent manner. Our data shows that miR-184 induces DNA damage as measured 
by elevated expression and activity of γH2AX. To our knowledge, this is the first time a direct 
link between miR-184 and DNA damage has been reported and it expands our understanding 
of miR-184s functional activity within epidermal keratinocytes. We have shown that miR-184 
upregulates expression of cyclin E, which has previously been shown to induce 
phosphorylation of γH2AX indicative of DNA damage (Freije et al., 2012). Moreover, we have 
shown that expression of the DNA damage effector, p21 is elevated in cells loaded with miR-
184. Sustained miR-184-dependent accumulation of cyclin E may result in the induction of the 
DDR pathway, of which p21 is a component, leading to the expression of differentiation 
markers like involucrin. In contrast, inhibition of physiological miR-184 during keratinocyte 
differentiation has little effect on γH2AX activity, suggesting that levels of cyclin E and/or 
DNA damage cannot be reduced beyond endogenous levels. Although speculative, further 
work evaluating DDRs in depth, using comet assays, observing miR-184 induced changes in 
other DNA damage markers or assessing DNA damage in cyclin E deficient HPEKs loaded 
with miR-184 could validate these findings.  
Taken together, we have provided evidence that miR-184 promotes differentiation by 
concomitant induction of cyclin E, p21 and involucrin. Furthermore, we propose (Fig. 4.20) 
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that miR-184 induced differentiation is dependent on DNA damage whereby cyclin E 
hyperactivity results in accumulation of activated γH2AX, which in turn leads to a p21 DDR, 
growth arrest and early differentiation by means of involucrin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: Schematic Representation of Proposed miR-184:Differentiation Pathway. miR-184 causes 
accumulation of Cyclin E possibly through direct inhibition of NFAT1. Cyclin E leads to hyperactive cell cycle 
progression consequently resulting in replicative stress and DNA damage. DNA damage activates DNA damages 
responses including p21 that in turn inhibits mitotic Cyclin A. Sustained DNA damage and growth arrest reaches 
an irreversible threshold and triggers keratinocyte differentiation. Based on Fig. 1.6 from Gandarillas, 2012. 
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5. The Effect of miR-184 on HPEK 
Migration 
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Following cutaneous injury, a large array of processes which facilitate tissue repair take place, 
with the migration of keratinocytes from the wound edge into the denuded wound surface 
central to successful reepithelization and restoration of barrier function. A popular method for 
assessing collective cell migration is the wound healing or scratch assay. A cell-free zone is 
created by mechanical damage that consequently promotes migration of surrounding cells. The 
scratch assay is a cheap and relatively simple way to screen treatment conditions on overall 
cell migration. A major limitation of the scratch assay is reproducibility; unless methods are 
described in sufficient detail, other groups can struggle to emulate results (Liang et al., 2007). 
The roles of miRNAs in keratinocyte migration and wound healing have begun to 
surface. Recent work by Li and colleagues has shown miR-132 to be down regulated in chronic 
wounds and also that replenishment reduced inflammation and promoted wound closure (Li et 
al., 2017). Work on murine wound biopsies have shown considerably raised levels of miR-21 
present within the wound edge 7 days post wounding (Yang et al., 2011). Human wound 
biopsies have shown significantly elevated levels of miR-31 7 days following injury (Li et al., 
2015). Conversely, expression of miR-198 is heavily downregulated over 24 hours of wound 
healing in organotypic culture (Sundaram et al., 2013). Likewise, in human primary 
keratinocytes, expression of miR-200c is significantly reduced during in vitro scratch wound 
assay. Moreover, the same study describes severely reduced levels of miR-200c in the 
epidermis of mice following 7 days of wounding (Aunin et al., 2017). In contrast, work by 
Amelio and colleagues show that migration can be blocked by miR-24 causing actin 
remodelling through suppression of cytoskeletal modulators (Amelio et al., 2012). 
Furthermore, overexpression of miR-483-3p inhibits keratinocyte migration through 
modulation of proliferation-associated proteins (Bertero et al., 2011). More recently, work by 
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Wu and colleagues has found the microRNA Let-7b to inhibit keratinocyte migration by 
modulating insulin-like growth factor (IGF) expression (Wu et al., 2017).  
Despite its emerging roles in migration of various cell types, the function of miR-184 
in epidermal keratinocyte migration has not been evaluated. Early work by Robert Lavkers 
group suggests that miR-184 impairs keratinocyte migration in corneal epithelium (Yu et al., 
2010). Recent work by Zhoa and colleagues demonstrated that miR-184 reduced migration 
rates over 72 hours in an epithelial retinal pigment cell line (Jiang et al., 2016). Conversely, 
inhibition of miR-184 in mouse lens epithelial cells suppresses cell migration (Hoffmann et al., 
2012). Furthermore, transfection of miR-184 into human glioma cell lines results in enhanced 
migration (Yuan et al., 2014). Migration plays a role in keratinocyte differentiation where 
keratinocytes migrate upwards from the basal layer. The ability of miR-184 to regulate 
keratinocyte biology by promoting early differentiation has been shown in chapter 4 and by 
Nagosa et al., 2017 (Nagosa et al., 2017). 
In recent years, studies have emerged suggesting that a group of RNA molecules around 
200 nt in length with no protein coding capacity, termed long non-coding RNAs (lncRNAs), 
play a role in cellular migration. Of these the lncRNA, Urothelial cancer associated 1 (UCA1), 
has received particular attention as it has been shown to impact migration of several cell/tissue 
types (Wang et al., 2008; Fan et al., 2014; Zuo et al., 2017). The interesting property of this 
particular lncRNA is the ability to inhibit miR-184 function, effectively acting as a miR-184 
sponge (Zhou et al., 2017). A recent RNA profiling study has demonstrated that expression of 
UCA1 is relatively low in HPEKs and elevated considerably in HaCaTs. In contrast, the same 
study shows negative expression values of UCA1 in skin samples (Katayama et al., 2015). 
Therefore, we hypothesised that UCA1 may contribute to processes vital to keratinocyte 
biology, such as migration. 
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• Examine expression of miR-184 in HPEKs following scratch assay  
• Elucidate the impact of SOCE on miR-184 expression  
• Inspect UCA1 expression following scratching 
• Investigate the effects of perturbed miR-184 activity on migration 
 
 
 
To evaluate the impact of wounding on miR-184, expression was analysed in basal and 
differentiated keratinocytes subjected to scratch assays. When cultured in low Ca2+ for 5 days, 
scratching promoted a 47-fold induction of miR-184 compared with the unwounded control 
where miR-184 was barely detectable. Conversely, wounded differentiated keratinocytes 
cultured for 5 days in high Ca2+ exhibited a modest 11-fold increase of miR-184 when 
compared with the unscratched control (Fig. 5.1). As high Ca2+ promotes miR-184 expression 
(Fig. 3.6), this suggests that keratinocytes may already be desensitised to miR-184 inducing 
stimuli upon wounding, or the induction observed may be dampened by the pre-existing high 
levels of miR-184.  
 Given that, induction of miR-184 during differentiation is dependent on SOCE (Fig. 
3.9-12), we hypothesised that SOCE would also impact miR-184 levels during wounding. 
Treatment with the SOCE inhibitors, Gd3+ and BTP2, in proliferating keratinocytes eliminated 
the induction of miR-184 during wounding, with Gd3+ presenting similar levels (Fig. 5.1C) and 
BTP2 reducing miR-184 beyond basal levels by around 50% (Fig. 5.1D) when compared with 
the unscratched control. 
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Figure 5.1: Impact of HPEK wounding on expression of miR-184. HPEKs were scratched and maintained in 
either 0.07 mM Ca2+ (A) or 1.5 mM Ca2+ (B) for 5 days. To inhibit SOCE, HPEK were pre-treated with Gd3+ (C) 
or BTP2 (D) and maintain in low Ca2+ for 5 days. Levels of miR-184 were assessed by RT-qPCR. Values were 
normalised to SNORD72 and depicted relative to the corresponding 5 day unscratched control. Data is pooled 
from three independent experiments (+SEM). 
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The lncRNA UCA1 acts as a sponge for miR-184 and has also been reported to regulate 
migration in several cell types. Given that miR-184 was induced during HPEK migration (Fig. 
5.1), the effects of scratch assay on the levels of UCA1 in HPEKs was also investigated. 
Keratinocytes scratch-wounded and maintained in basal conditions for 5 days had 11-fold 
higher levels of UCA1 than their unscratched counterparts (Fig. 5.2). Thus, UCA1 seems to be 
co-induced with its miR-184 target.  
 
 
 
 
Figure 5.2: Impact of HPEK wounding on expression of UCA1. HPEKs were scratched and maintained in 0.07 
mM Ca2+ for 5 days before analysis be RT-qPCR. Values were normalised to GAPDH and depicted relative to the 
corresponding 5 day unscratched control. Data is pooled from three independent experiments (+SEM). 
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To determine whether the observed UCA1 induction was also dependent on SOCE, levels of 
UCA1 in keratinocytes treated with Gd3+ or BTP2 were analysed. UCA1 expression seems to 
be SOCE-dependent, as when treated with SOCE inhibitors UCA1 levels are effectively halved 
to 5-fold in both Gd3+ (Fig. 5.3A) and BTP2 (Fig. 5.3B). 
 
 
 
 
 
 
 
Figure 5.3: Effect of SOCE inhibitors on UCA1 expression during wounding. HPEKs were pre-treated with 
Gd3+ (A) or BTP2 (B) for 1 h before scratching with cultures maintained in 0.07 mM Ca2+ for 5 days before 
analysis be RT-qPCR. Values were normalised to GAPDH and depicted relative to the corresponding 5 day 
unscratched control. Data is pooled from three independent experiments (+SEM). 
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Given the induction of miR-184 observed during wound healing (Fig. 5.1) the effects of 
perturbed miR-184 activity on keratinocyte migration were examined. To assess this, a 
synthetic miR-184 mimic was transferred into keratinocytes prior to scratch assay. Migration 
was assessed over the course of 72 h with images captured every 30 min. Images of scratched 
keratinocyte monolayers were divided into three sections and the cells that breached the middle 
section were quantified over the entire time course (Fig. 5.4).  
Exogenous miR-184 led to a striking 3-fold increase in the rate of migration after 12 
hours when compared with the 12 h control oligonucleotide. At 24, 36 and 48 h timepoints 
migration continued to increase at 11-, 15- and 20-fold higher, respectively, when compared 
with the same 12 h control. When compared with the equivalent control time points, the rate 
of migration in miR-184 treated cells was 50-75% higher (Fig. 5.9). However, at 72 h in 
monolayers overexpressing miR-184, artificial wounds were completely closed when 
compared with cells nucleofected with control oligonucleotide (Fig. 5.5-5.6), therefore these 
timepoints were not included in analysis (Fig. 5.9).  
Next, the impact of miR-184 inhibition on wound closure was assessed by using a LNA 
miR-184 inhibitor and assessing migration over 72 h. Blockade of miR-184 activity at 12 h did 
not affect migration when compared with the control inhibitor. At 24, 36 and 48 h time points 
and when compared with the same 12 h control inhibitor, migration increased marginally at 
1.4-, 1,8- and 3.9-fold, respectively. Although, when compared with the control 
oligonucleotide at the respective 24, 36 and 48 h time points a substantial reduction in 
migration rates of at least 50% was observed in cells treated with miR-184 inhibitor (Fig. 5.9).  
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Figure 5.4: Example analysis of live cell images of scratched HPEKs. HPEKs were nucleofected and 
cultured in 0.07 mM Ca2+ with light microscopy images (20x) took every 30 min for up to 3 days. Analysis was 
performed by creating three sections of equal width starting from the edges of the wound with cells breaching 
the middle section quantified.  
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Figure 5.5: Impact of control oligonucleotide upon wounded keratinocytes. Cells were loaded with 100 nM 
of control oligonucleotide and cultured for 3 days in low Ca2+ with light microscopy (20x) images took every 30 
min. 
  
t = 48 h t = 36 h t = 24 h 
t = 12 h t = 6 h t = 0 h 
t = 72 h 
158 
 
 
 
 
 
 
Figure 5.6: Effect of miR-184 mimic on wounded HPEKs. Cells were nucleofected with 100 nM of miR-184 
mimic and cultured for 3 days in low Ca2+ with light microscopy (20x) images took every 30 min. 
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Figure 5.7: Effect of control inhibitor on wounded HPEKs. Cells were loaded with 100 nM of miR-184 
mimic and cultured for 3 days in low Ca2+ with light microscopy (20x) images took every 30 min. 
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Figure 5.8: Effect of miR-184 inhibitor on wounded HPEKs. HPEKs were nucleofected with 100 nM of 
miR-184 mimic and cultured for 3 days in low Ca2+ with light microscopy (20x) images took every 30 min. 
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Figure 5.9: Effect of miR-184 perturbation on wound closure. Cells were exposed to 100 nM of either control 
oligonucleotide (black), miR-184 mimic (red), control inhibitor (grey) or miR-184 inhibitor (blue). Cells were 
scratch upon approaching confluence and cultured for 2 days in low Ca2+ with light microscopy (20x) images took 
every 30 min. Migration rates were normalised to the number of cells breaching the middle section at 12 h. Data 
represents three independent experiments. 
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Keratinocyte migration is of vital importance to both successful stratification, where 
keratinocytes migrate upwards from the basal layer, and efficient wound repair, where 
keratinocytes migrate into the denuded wound surface. A recent review has highlighted the 
importance of miRNAs to the migration of keratinocytes (Mulholland, Dunne and McCarthy, 
2017). We have shown that miR-184 regulates keratinocyte differentiation (Chapter 4) and 
with migration playing a role in epidermal stratification we hypothesised that miR-184 may 
also regulate keratinocyte migration. Therefore, our first aim for this chapter was to determine 
miR-184 levels in proliferating and differentiating HPEKs following scratching.  
Our data shows that miR-184 was induced in both proliferating and differentiating 
HPEKs (Fig. 5.1). However, this induction was less profound in differentiated cells, 
presumably as endogenous miR-184 has already desensitised HPEKs to miR-184-inducing 
stimuli or that comparisons made against unscratched HPEK with high pre-existing miR-184 
dulls fold-change differences. Interestingly, an early study by Lavker and co-workers 
implicated miR-184 in the migration of corneal keratinocytes, where it impaired actin-based 
motility pathways by repressing miR-205 activity (Yu et al., 2010). However, they failed to 
report endogenous miR-184 levels during a scratch wound assay hence whether levels of miR-
184 induction in wounded epidermal and corneal keratinocyte monolayer are similar remains 
to be determined.   
SOCE has previously been shown to regulate migration of epidermal keratinocytes. A 
study by Reynolds and colleagues has demonstrated that inhibition of SOCE, using siRNA for 
STIM1 or downstream inhibition of NFAT using CsA, leads to reduced migration in response 
to pro-migratory stimuli (Jans et al., 2013). In contrast, very recent work has shown that 
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ablation of STIM1 in mice elevates long-term wound healing abilities, seemingly due to 
dampened immune responses and elevated activated keratinocytes (Putney et al., 2017). We 
have shown that induction of miR-184 during HPEK differentiation is reliant on SOCE (Fig. 
3.9-3.12). Therefore, we anticipated that the induction of miR-184 observed following 
scratching would also be dependent on SOCE. Our data shows that induction of miR-184 
during keratinocyte migration occurs in a SOCE-dependent fashion (Fig. 5.1). This is the first 
time to our knowledge that SOCE has been implicated in the expression of miRNAs during 
keratinocyte migration. Moreover, this finding supports our previous data (Fig. 3.9-3.12), 
suggesting a role for SOCE in the regulation of miR-184 in the context of keratinocyte biology.  
 
 
Emerging evidence suggests that the lncRNA, UCA1, is dysregulated in several cell types, 
whereby it seems to support migration (Wang et al., 2008; Fang et al., 2014; Zhou et al., 2017). 
We have shown that miR-184 was induced by scratching (Fig. 5.1) and with UCA1 acting as a 
sponge for miR-184 we anticipated that it may be co-induced with its miR-184 target. 
Moreover, with miR-184 induced in a SOCE-dependent manner during both HPEK 
differentiation (Fig. 3.9-3.12) and migration (Fig. 5.1) we predicted that changes in UCA1 
levels might also be reliant on SOCE.  
Indeed, we found that UCA1 was induced in basal HPEKs following scratching and 
that this induction was impaired by treatment with inhibitors of SOCE (Fig. 5.2-5.3). Consistent 
with the literature (Wang et al., 2008; Fang et al., 2014; Zhou et al., 2017) we show that UCA1 
was upregulated during migration. This is the first time to our knowledge that UCA1 has been 
described in migration of keratinocytes. Similar to Katayama and colleagues who showed low 
levels of UCA1 in epidermal keratinocytes, we also demonstrate relatively low levels of UCA1 
in unscratched proliferating HPEKs (Katayama et al., 2015). Both elevated UCA1 and miR-
184 was observed following 5 days of scratching. However, to what extent the two interact is 
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still unclear. Further work examining interactions of UCA1 with miR-184 using methods such 
as luciferase assays, would help understand this relationship in the context of keratinocyte 
migration. 
 
 
Previous work has demonstrated that miR-184 reduces migration in several cell types. In 
human glioma cell lines, transfection with miR-184 mimic reduces migration into an artificial 
scratch by 50%, whereas inhibition of miR-184 effectively doubles migration rates (Cheng et 
al., 2015). Similarly, in human umbilical cord vein endothelial cells (HUVEC) treatment with 
miR-184 mimic results in significantly less coverage of the wound surface compared with the 
control when assessed by scratch assay (Zong et al., 2016). Likewise, nasopharyngeal 
carcinoma cell lines loaded with miR-184 exhibit severely diminished migration rates during 
wounding (Zhu et al., 2018). We have shown that miR-184 was induced in HPEKs following 
scratch wounding (Fig. 5.1). It was unclear whether miR-184 was promoting migration or the 
induction was a compensatory response by the cell to reduce the migratory actions of 
keratinocytes.  
 Therefore, we loaded keratinocytes with miR-184 mimic and observed significantly 
elevated migration over 48 h when assessed by a scratch wound assay. Conversely, inhibition 
of endogenous miR-184 using a LNA miR-184 inhibitor during scratch wound healing resulted 
in severely reduced HPEK migration (Fig. 5.9). This is the first time to our knowledge that 
miR-184 has been shown to regulate migration of epidermal keratinocytes. Early work by Yu 
and colleagues has shown that miR-184 can modulate migration of human corneal epithelial 
keratinocytes by antagonising miR-205 activity, consequently impairing actin-based migration 
pathways (Yu et al., 2010). This suggests a differential role for miR-184 within epidermal 
keratinocytes although further work utilising transcriptomic and proteomic approaches could 
help delineate the migration pathways modulated by miR-184 in HPEKs.  
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Argonaute proteins form the catalytic core of the RISC complex, and as the RISC is essential 
to miRNA function are indispensable to cell homeostasis. AGO2 is the only AGO in humans 
that possesses endonuclease activity and for this reason receives the most attention, with 
remarkably little consideration paid to other AGOs. Initially Argonaute proteins were 
implicated in development. Early work by Bohmert and colleagues observed an altered 
phenotype in the developing leaves of AGO1 mutated Arabidopsis thaliana (Bohmert et al., 
1998). Furthermore, mutation of Argonaute orthologs in C. elegans results in a reduced viable 
progeny (Grishok et al., 2001). In mice, deletion of AGO2 causes embryonic death post 
implantation whereas deletion of AGO2, 3 and 4 results in viable embryos (Cheloufi et al., 
2010; Modzelewski et al., 2012). However, the ability of the AGO to regulate other cellular 
functions such as differentiation is now apparent. AGO1 or AGO2 overexpression induces 
spontaneous differentiation of neuroblastoma cell lines (Parisi et al., 2011). Similarly, in human 
monocytes inhibition of AGO2 activity results in perturbed differentiation (Iosue et al., 2013). 
In the skin, a study has highlighted AGO2 as the most abundant mammalian AGO, associating 
with the largest pool of miRNAs in both mouse epidermis and human melanoma cells. 
Furthermore, ablation of AGO2 led to a ~30% reduction of global miRNA levels with co-
ablation of AGO1 and AGO2 leading to an 80% decrease and causing severe epidermal 
thickening (Wang et al., 2012).  
The majority of studies assume AGO function is based entirely in the cytoplasm. 
However, emerging work demonstrates the functional activity of AGO within the nucleus. A 
prominent study by Bischof and co-workers has shown that AGO2 accumulates in the nucleus 
of aging fibroblasts repressing genes related to growth (Benhamed et al., 2012). Likewise, 
recent work demonstrates dominant nuclear AGO2 activity in primary keratinocyte cultures 
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and human epidermis (Sharma et al., 2016). Nonetheless, the mechanisms of AGO2 
localisation in HPEK have received little attention. 
Analysis of the miRNAome in psoriasis revealed expression of miR-184 to be 
upregulated in psoriatic lesions (Joyce et al., 2011). We show that miR-184 levels on average 
are 4-fold higher in psoriatic lesions (Fig 3.6). Previous work in our group showed that miR-
184 directly targets and represses AGO2 in both HaCaTs and HPEKs, and this has been 
confirmed in pancreatic β cells (Roberts et al., 2013; Tattikota et al., 2014). Ross and colleagues 
also demonstrated AGO2 insufficiency coupled with miR-184 overexpression in psoriasis 
(Roberts et al., 2013). Despite this surprisingly little is known about the expression of AGO1-
4 in psoriasis.  
 
 
• To examine the expression of AGO1-4 during HPEK differentiation  
• Study Argonaute levels is psoriatic lesions 
• Investigate AGO2 function during differentiation  
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Several miRNAs have been implicated in keratinocyte differentiation. Work on mice has 
demonstrated the vital role AGOs play in epidermal homeostasis with co-ablation of AGO1 
and AGO2 resulting in 80% less miRNA levels (Wang et al., 2012). Given that, AGOs are 
essential to miRNA function we hypothesised that their expression patterns would change over 
the course of differentiation. Therefore, the expression of AGO1-4 in basal and differentiating 
HPEKs was examined. We and others have shown that miR-184 is induced during keratinocyte 
differentiation (Fig.3.6) (Nagosa et al., 2017) and so particular interest was paid to AGO2.  
 Initially, levels of AGO2 were examined in HPEKs differentiated for 3 days with 1.2 
mM Ca2+. However, expression of AGO2 was relatively unchanged at all time points (Fig. 
6.1A). Since stimulation for 3 days with 1.2 mM Ca2+ did not promote an adequate 
differentiation response (Fig. 3.1), levels of AGO2 was assessed during differentiation with 1.5 
mM Ca2+ for 5 days. Although, variance between experiments was large, after 1 day a 2-fold 
induction was observed. However, AGO2 levels then returned to those similar to proliferating 
HPEK at both 4 and 5 days (Fig. 6.1B).  
 
 
 
 
 
Figure 6.1: Effect of differentiation on AGO2 expression. HPEKs were grown in 0.07 mM, 1.2 mM (A) and 
1.5 mM (B) Ca2+ for up to 5 days before analysis by RT-qPCR. Values were normalised to GAPDH and depicted 
relative to the proliferating control. Data represents three independent experiments (+SEM). 
A B 
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Next, expression of AGO1, AGO2 and AGO4 was analysed in HPEKs treated with 1.5 mM 
Ca2+ for up to 5 days. Levels of AGO1 transcript were relatively unaffected by Ca2+-induced 
HPEK differentiation or any effect was concealed by large variations in SEM (Fig. 6.2A). 
However, expression of AGO3 displayed an upwards trend in expression to 2-fold at 4 days 
before reducing to 1.5-fold at 5 days (Fig. 6.2B). Expression of AGO4 exhibited a modest 
downwards trend with levels reduced by 60% to 0.4-fold at 5 days following treatment with 
1.5 mM Ca2+ (Fig. 6.2C).  
 
 
 
 
 
Figure 6.2: Impact of differentiation on AGO1, AGO3 and AGO4 expression. HPEKs were grown in 0.07 
mM or 1.5 mM Ca2+ for up to 5 days before levels of AGO1 (A), AGO3 (B) and AGO4 (C) were analysed by RT-
qPCR. Values were normalised to GAPDH and depicted relative to the proliferating control. Data represents three 
independent experiments (+SEM).  
A B 
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To gain insight into the relative expression of the four AGOs during HPEK differentiation, the 
data was re-evaluated to determine AGO expression levels in relation to each other during 
differentiation. As depicted in figure 6.3, when compared with the weakly expressed AGO3 
levels observed in cells maintained in 0.07 mM Ca2+, levels of AGO4 were 34-fold higher than 
AGO3, compared to AGO2 which was only 3-fold higher. Differentiation did not have a 
significant effect on AGO4 levels. Expression of AGO2 increased to 7-fold following 1 day of 
1.5 mM Ca2+ stimulation before returning to normal 3-fold expression at 4 and 5 days when 
compared with proliferating AGO3 levels. Expression of both AGO1 and AGO3 were 
comparable at all time points. Taken together these results suggest that AGO4 is the most 
abundant transcript in monolayer HPEKs and is most effected during differentiation. 
 
Figure 6.3: Effect of Differentiation on AGO Expression. HPEKs were grown in 0.07 mM or 1.5 mM Ca2+ for 
up to 5 days before analysis by RT-qPCR. Values were normalised to GAPDH and depicted relative AGO3 levels 
in 0.07 mM Ca2+. Data pooled from three independent experiments (+SEM). 
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A recent review by Hawke and colleagues has described multiple miRNAs as dysregulated in 
psoriasis (Hawkes et al., 2016). Moreover, a very recent study has shown that factors involved 
in miRNA biogenesis such as Dicer are upregulated in psoriatic lesions (Rostami Mogaddam 
et al., 2017). Work by Roberts and colleagues have shown that AGO2 was downregulated in 
psoriasis possibly in response to upregulation of miR-184 (Roberts et al., 2013). Despite this 
the levels of AGOs expressed in psoriasis is relatively unclear. Therefore, expression of AGO1-
4 was assessed in lesional (PP) and non-lesional (PN) psoriasis. 
 As shown in figure 6.4, when compared with their corresponding PN sample, 
expression of AGO1 in PP samples was reduced below 0.4-fold in 4 out of 8 patient samples, 
elevated at 3.5-fold in 1 out of 8 patients and relatively unchanged in the remaining 3 lesional 
samples (Fig. 6.4A). In order to compare PN and PP side-by-side and to better assess variation 
within the dataset, box and whisker charts were used. When plotting -ΔCt (CtAGO1-CtGAPDH), 
there is a significant decrease of AGO1 in PP samples when compared with PN with medians 
of 7.3 and 5.4 respectively, although expression variation was elevated in the PP samples 
demonstrated by minimum values of 4.7 and maximum values of 7.8 compared with 4.0 and 
5.9 of PN (Fig. 6.4B). When compared with their relative PN sample, expression of AGO2 in 
PP samples was decreased below 0.5-fold in 4 out of 8 patients, elevated 4-6-fold in 2 out of 8 
patients and relatively unchanged in the remaining 2 samples (Fig. 6.5A). However, when all 
8 patients were compared, there was no significant difference detected in AGO2 between PP 
and PN samples presumably due to elevated variation in both PP and PN between patients.  
 
172 
 
 
 
 
Figure 6.4: Expression of AGO1 in Psoriatic Lesions. Levels of AGO1 from psoriatic non-lesional (PN) and 
lesional (PP) biopsies taken from eight patients were analysed by RT-qPCR. Values were normalised to GAPDH 
and plotted relative to their corresponding PN values (red line; A). Box and whiskers were plotted using -ΔCt 
(CtAGO1 – CtGAPDH). The top and bottom of each box represent the 75th and 25th percentile and the middle line 
represents the median value with the extended lines depicting the range (B). * represents p ≤ 0.05. 
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Figure 6.5: Expression of AGO2 in Psoriatic Lesions. Levels of AGO2 from psoriatic non-lesional (PN) and 
lesional (PP) biopsies taken from eight patients were analysed by RT-qPCR. Values were normalised to GAPDH 
and plotted relative to their corresponding PN values (red line; A). Box and whiskers were plotted using -ΔCt 
(CtAGO2 – CtGAPDH). The top and bottom of each box represent the 75th and 25th percentile and the middle line 
represents the median value with the extended lines depicting the range (B). * represents p ≤ 0.05. 
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Expression of AGO3 in PP samples was decreased below 0.5-fold in 5 out of 8 patients, 
elevated 2-3-fold 2 out of 8 patients and somewhat unaffected in the remaining sample (Fig. 
6.6A). However, there was no significant difference between pooled PP and PN –ΔCts (Fig. 
6B). AGO4 expression was reduced below 0.5-fold in all but one PP sample, which was 
elevated by 2.8-fold (Patient 6), when compared with relative PN samples (Fig. 6.7A). When 
–ΔCts from PP and PN were compared there was significantly decreased levels of AGO4 
present within PP samples with a median of 3.6 compared to 1.7 observed in PN. Variation 
between patient samples was low and consistent in both PN and PP with minimum values of 
0.6 and 2.8 in addition to maximum values of 3.0 and 5.2 respectively (Fig. 6.7B) 
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Figure 6.6: Expression of AGO3 in Psoriatic Lesions. Levels of AGO3 from psoriatic non-lesional (PN) and 
lesional (PP) biopsies taken from eight patients were analysed by RT-qPCR. Values were normalised to GAPDH 
and plotted relative to their corresponding PN values (red line; A). Box and whiskers were plotted using -ΔCt 
(CtAGO3 – CtGAPDH). The top and bottom of each box represent the 75th and 25th percentile and the middle line 
represents the median value with the extended lines depicting the range (B). * represents p ≤ 0.05. 
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Figure 6.7: Expression of AGO4 in Psoriatic Lesions. Levels of AGO4 from psoriatic non-lesional (PN) and 
lesional (PP) biopsies taken from eight patients were analysed by RT-qPCR. Values were normalised to GAPDH 
and plotted relative to their corresponding PN values (red line; A). Box and whiskers were plotted using -ΔCt 
(CtAGO4 – CtGAPDH). The top and bottom of each box represent the 75th and 25th percentile and the middle line 
represents the median value with the extended lines depicting the range (B). ** represents p ≤ 0.01. 
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AGO2 associates with most miRNAs and plays an essential role in epidermal growth (Wang 
et al., 2012). Previous work has shown that miR-184 targets AGO2 and given that we have 
shown miR-184 induction during Ca2+-dependent HPEK differentiation, we anticipated that 
AGO2 may play a role in the differentiation of HPEKs. Therefore, the expression of cyclin E 
and involucrin transcripts was assessed in differentiating HPEKs loaded with siAGO2.  
 Initially, to assess the ability and longevity of siAGO2, expression of AGO2 was 
analysed in siAGO2-loaded proliferating and differentiating HPEKs. When compared with the 
siControl, levels of AGO2 were downregulated by 80% to 0.2-fold in proliferating HPEKs 
introduced to siAGO2 (Fig. 6.8A). When HPEKs were differentiated for 1 day in 1.5 mM Ca2+, 
levels of AGO2 increased in those pre-treated with siControl at 2.8-fold when compared with 
the proliferating siControl. However, this induction of AGO2 was diminished in cells loaded 
with siAGO2 were levels remained comparable to those found in the proliferating siControl 
(Fig.6.8). After 5 days of differentiation, expression of AGO2 in the siControl returned to basal 
levels whereas in cells loaded with siAGO2 levels reduced by 50% to 0.5-fold (Fig. 6.8A). To 
evaluate the specificity of siAGO2, expression of AGO4 was examined in proliferating and 
differentiating HPEKs pre-treated with siAGO2. Positively, levels of AGO4 were relatively 
unchanged between siControl and siAGO2 at all time points (6.8B). 
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Figure 6.8: Effect of siAGO2 on Expression of AGO2 and AGO4 During Differentiation. HPEKs 
nucleofected 100 nM of siControl or siAGO2 and grown 0.07 mM or 1.5 mM Ca2+ for up to 5 days. Levels of 
AGO2 (A) and AGO4 (B) were analysed by RT-qPCR. Values were normalised to GAPDH and depicted relative 
to proliferating siControl. Data represents three independent experiments (+SEM). 
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AGO2 has been shown to regulate cell cycle factors such as cyclin E (Benhamed et al., 2012). 
Control of the cell cycle during early commitment to terminal differentiation is an essential 
process with strong evidence suggesting that cyclin E is somewhat responsible (Zanet et al., 
2010; Freije et al., 2012). Therefore, both CCNE1 and CCNE2 expression was analysed in 
proliferating and differentiating HPEKs loaded with siAGO2. In proliferating HPEKs, CCNE1 
(Fig. 6.9A) and CCNE2 (Fig. 6.9B) were considerably elevated in cells loaded with siAGO2 at 
4.0- and 3.0-fold respectively when compared with the proliferating siControl. As expected, 
when HPEKs were differentiated with 1.5 mM Ca2+ for 5 days both CCNE1 (Fig. 6.9A) and 
CCNE2 (Fig. 6.9B) were elevated in siControl at 1.7- and 3.0-fold respectively. Conversely, in 
cells loaded with siAGO2 a strong decrease in CCNE2 to 0.3-fold was observed although 
CCNE1 exhibited a more moderate reduction at 0.6-fold after 5 days of 1.5 mM Ca2+. After 1 
day of Ca2+ stimulation, a moderate 2-fold increase in CCNE1 and a modest decrease in CCNE2 
to 0.7-fold was observed in cells treated with siAGO2. In cells treated with siControl, no 
change was observed in CCNE1 with a 1-5-fold increase observed in CCNE2 (Fig. 6.9). These 
findings suggest that AGO2 regulates cyclin E and this regulatory role differs between 
proliferating and differentiating states. 
 
  
 
Figure 6.9: Effect of siAGO2 on Cyclin E Expression During Differentiation. HPEKs nucleofected 100 nM 
of siControl or siAGO2 and grown 0.07 mM or 1.5 mM Ca2+ for up to 5 days. Levels of Cyclin E1 (CCNE1; A) 
and Cyclin E2 (CCNE2; B) were analysed by RT-qPCR. Values were normalised to GAPDH and depicted relative 
to proliferating siControl. Data represents three independent experiments (+SEM). 
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Next, the effect of reduced AGO2 levels on the keratinocyte differentiation marker, involucrin 
was assessed. In proliferating HPEKs loaded with siAGO2, a 50% reduction of IVL transcript 
to 0.5-fold was observed when compared with the siControl. However, when differentiated 
with 1.5 mM Ca2+, IVL expression was relatively unchanged in HPEKs loaded with siAGO2 
when compared with the siControl at both 1 and 5 d time points (Fig. 6.10). 
  
 
 
Figure 6.10: Impact of siAGO2 on Expression of Involucrin During Differentiation. HPEKs nucleofected 
100 nM of siControl or siAGO2 and grown 0.07 mM or 1.5 mM Ca2+ for up to 5 days. Levels of IVL were analysed 
by RT-qPCR. Values were normalised to GAPDH and depicted relative to proliferating siControl. Data represents 
three independent experiments (+SEM). 
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Finally, given that AGO2 is vital to the function of the RISC, levels of miRNAs implicated 
with keratinocyte biology were analysed in HPEKs that had reduced levels of AGO2. Levels 
of both miR-21 and miR-205 were decreased by around 50% to 0.5-fold in differentiating 
HPEK nucleofected with siAGO2 when compared with those nucleofected with siControl. 
Interestingly, levels of miR-184 were reduced by 70% to 0.3-fold (Fig. 6.11).  
 
 
 
Figure 6.11: Effect of siAGO2 on Expression of miRNAs. HPEKs nucleofected 100 nM of siControl or siAGO2 
and grown 1.5 mM for 5 days. Levels of miR-21, miR-184 and miR-205 were analysed by RT-qPCR. Values 
were normalised to SNORD72 and depicted relative to proliferating siControl. Data represents three independent 
experiments (+SEM). 
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AGO2 accumulates in the nucleus of senescent fibroblasts were it regulates proliferation linked 
genes (Benhamed et al., 2012). Very recent work has reported AGO2 as predominately nuclear 
in both human skin and human primary keratinocyte monolayer and organotypic cultures 
(Sharma et al., 2016). Therefore, we anticipated that AGO2 may localise to the nucleus of 
differentiating HPEKs. Consequently, we analysed AGO2 subcellular location in proliferating 
HPEK and those stimulated with common differentiation reagents.  
 As shown in Figure 6.12, when HPEKs were maintained in low Ca2+ for 5 days, AGO2 
was perinuclear with almost none present within the nucleus. Following stimulation with 1.5 
mM Ca2+, AGO2 seemed relatively unchanged after 1 d, remaining predominately perinuclear 
although nuclei appear less defined which might suggest some nuclear AGO2. After 5 d of 1.5 
mM Ca2+, there appears to be a striking accumulation of AGO2 in the nucleus although some 
remains in the cytoplasm (Fig. 6.12). Following treatment with 100 nM PMA, AGO2 
localisation seemed relatively unchanged at both 1 d and 5 d time points (Fig. 6.13). When 
stimulated with 100 nM of 1,25(OH)D3 for 5 days the subcellular location of AGO2 appeared 
more dispersed throughout the whole cell suggesting some nuclear AGO2 though this could be 
due to DMSO (Fig. 6.14).  
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Figure 6.12: Impact of Ca2+ Induced Differentiation on AGO2 Subcellular Location. HPEKs were grown in 
0.07 mM or 1.5 mM Ca2+ for up to 5 days before AGO2 staining and nuclear counterstaining with DAPI. 
Fluorescent images were taken at 20x magnification from proliferating cells in addition to 1 d and 5 d 
differentiated HPEKs. 
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Figure 6.13: Effect of PMA Induced Differentiation on AGO2 Subcellular Location. HPEKs were grown in 
0.07 mM Ca2+ or 100 nM of PMA for up to 5 days before AGO2 staining and nuclear counterstaining with DAPI. 
Fluorescent images were taken at 20x magnification from proliferating cells in addition to 1 d and 5 d 
differentiated HPEKs. 
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Figure 6.14: Impact of 1,25(OH)D3 Induced Differentiation on AGO2 Subcellular Location. HPEKs were 
grown in 0.07 mM Ca2+ with DMSO or 100 nM of 1,25(OH)D3 for up to 5 days before AGO2 staining and nuclear 
counterstaining with DAPI. Fluorescent images were taken at 20x magnification from proliferating cells in 
addition to 1 d and 5 d differentiated HPEKs. 
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To quantify changes in subcellular location Manders overlap coefficient was used, which in its 
most simplistic form measures overlapping pixels with perfect overlap described as 1.0. Values 
were comparable between proliferating cells and those treated with 0.1% DMSO, 100 nM PMA 
and 100 nM 1,25(OH)D3 respectively suggesting weak to moderate co-localisation (Fig. 6.15). 
Changes in PMA was not significant but both DMSO and 1,25(OH)D3 reached significance 
although, DMSO is likely responsible for the changes exhibited by 1,25(OH)D3. In contrast, 
when treated with 1.5 mM Ca2+ there was a significant increase to around 0.85 when compared 
with proliferating control indicative of very strong co-localisation (Fig. 6.15). 
 
 
 
Figure 6.15: Manders Colocalisation Coeffecient Analysis. Colocalisation analysis between basal HPEKs, 
Vechicle (DMSO) and HPEKs differentiated for 5 days with PMA, 1.25(OH)D3 and Ca2+ using Fiji/ImageJ. 
Stained for AGO2 and counterstained for the nucleus using DAPI. Manders coefficients were calculated for each 
sample, the means from four fields of view from three independent experiments were pooled into a bar graph 
(+SEM). * represents p ≤ 0.05, **** represents p ≤ 0.0001. 
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To confirm these observations in living cells, HPEKs were nucleofected with a plasmid 
encoding enhanced yellow fluorescent protein (EYFP) tagged AGO2. Consistent with the 
immunofluorescent images, when maintained in low Ca2+, EYFP tagged AGO2 appeared 
perinuclear with little to no presence in the nucleus. Upon stimulation with 1.5 mM Ca2+ for 5 
days, EYFP-AGO2 appeared more disperse throughout the cell (Fig. 6.16).   
 Finally, to confirm AGO2 nuclear localisation during HPEK differentiation, fractional 
western blotting was performed. In proliferating cells, levels of cytoplasmic AGO2 were high 
representing 42% of the total cytoplasmic densitometric proportion. Following addition of 1.5 
mM Ca2+ levels of AGO2 present within the cytoplasm were almost halved after 5 days. β-
Actin was used as a cytoplasmic control with expression stable throughout (Fig. 6.17). In 
contrast, levels of nuclear AGO2 in proliferating HPEKs were very low representing 29% 
based on chemiluminescent density. When stimulated with 1.5 mM Ca2+ the amount of AGO2 
present in the nucleus increased, with a total nuclear densitometric proportion of 33% and 38% 
for 1 and 5 d respectively (Fig. 6.17). 
 
 
  
 
 
Figure 6.16: Impact of Ca2+ Induced Differentiation on YFP-AGO2 Subcellular Location. HPEKs 
nucleofected with 2 µg of EYFP-AGO2 were grown in 0.07 mM (A) or 1.5 mM Ca2+ (B) for 5 days. Fluorescent 
images were taken at 20x magnification. 
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Figure 6.17: Fractional Western Blotting for AGO2 Following Differentiation. HPEKs were grown in 0.07 
mM or 1.5 mM Ca2+ for 5 days. Cytoplasmic and nuclear fractions were separated and probed for AGO2 (A). 
Values were normalised to the respective loading control and densitometry was performed (B). Data represents 
two independent experiments (+SEM). 
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As a key part of the RISC complex, regulation of AGOs is likely a tightly controlled process 
that underpins cellular proliferation and differentiation. Work by Wang and colleagues 
identified that AGO2 is the most abundant AGO and binds to most miRNAs within the 
epidermis of mice (Wang et al., 2012). A study has identified that miR-184 targets AGO2 in 
HPEKs and HaCaTs, with recent work confirming this observation in pancreatic β cells 
(Roberts et al., 2013). In neuroblastoma cell lines, overexpression of either AGO1 or AGO2 
can induce differentiation independent of stimulation with differentiation reagents (Parisi et al., 
2011). We have previously shown that miR-184 is induced during Ca2+-dependent HPEK 
differentiation, suggesting that elevated levels of miR-184 may reduce AGO2 during 
differentiation (Fig. 3.6). However, little is known about the expression patterns and 
abundancies of AGO1-4 during human epidermal keratinocyte differentiation. Therefore, the 
first aim of this chapter was to evaluate expression of AGO1-4 during Ca2+-induced in vitro 
HPEK differentiation.  
 We have shown that expression of AGO transcripts do not change substantially during 
HPEK differentiation with AGO1 remaining relatively unchanged, AGO2 displaying a slight 
increase at 1 d, AGO3 exhibiting a modest increase at 4 d and AGO4 downregulated over the 
5 days, though this was not at a statistically significant level. Given that we have demonstrated 
induction of miR-184 during keratinocyte differentiation and that miR-184 targets AGO2 we 
anticipated a reduction in AGO2 during differentiation. Surprisingly, we observed no reduction 
in AGO2 expression after 5 days of differentiation suggesting that the induction of miR-184 is 
insufficient to cause noticeable inhibition of AGO2 or that AGO2 transcripts are not targeted 
for degradation and instead translationally repressed. To our knowledge this is the first time 
individual AGO expression has been assessed in differentiating monolayer HPEKs. To provide 
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contrast, expression of AGO2 is increased in human myeloblastic and monocytic cell lines 
during terminal differentiation into granulocytes (Iosue et al., 2013). Conversely, in mouse 
embryonic stem cells, expression of AGO2 protein is reduced following differentiation 
(Ngondo et al., 2018). Suggesting that changes in AGO during differentiation occurs in a 
tissue/cell type dependent fashion with substantial changes in AGO levels not required for 
HPEK differentiation or that the slight fluctuations in AGO transcripts observed may 
effectively perturb protein levels. Although we did not evaluate protein expression and may 
provide interesting further work.  
 When levels of AGO1-4 were compared in proliferating and differentiating HPEK, 
AGO4 was the most abundant transcript at every time point followed by AGO2 with both AGO1 
and AGO3 comparably low. Conversely, recent work evaluating AGO expression in human 
skin has demonstrated that AGO1 is the most abundant transcript followed by AGO2 and 
consistent with our data they show that AGO3 is the least abundant AGO transcript (Völler et 
al., 2016). We show that AGO4 is the most abundant transcript in HPEK monolayers suggesting 
that stratification has different AGO expression requirements than monolayer HPEK cultures, 
although protein levels were not assessed in either studies, work on organotypic cultures could 
provide a stratified in vitro model to bridge the gap between monolayer and skin. In contrast, 
work by Yi and colleagues on mouse epidermis, employing shotgun proteomics and AGO-
Immunoprecipitation methods, have demonstrated that Ago2 is most abundant at the protein 
level, followed by Ago1 with both Ago3 and Ago4 expressed at significantly low levels (Wang 
et al., 2012). We only assessed expression of AGO transcripts preventing a direct comparison. 
However, comparative analysis between human and mouse skin transcriptomes demonstrates 
that only ~30% of genes overlap of which AGOs were not included suggesting that their 
expression could be differential between mouse and human skin (Gerber Peter et al., 2014). 
  
191 
 
 
Upregulation of cutaneous AGO1 and AGO2 has been linked to squamous cell carcinoma, 
basal cell carcinoma and actinic keratosis (Sand et al., 2012). In contrast, overall expression of 
AGO1-4 is severely reduced in melanoma cell lines with AGO2 most effected (Völler et al., 
2016). Recent work has showed perturbed expression of miRNA biogenesis enzymes in 
psoriasis, demonstrating that levels of Dicer and Drosha transcripts are significantly higher in 
psoriatic lesions when compared with both non-lesional and healthy samples (Rostami 
Mogaddam et al., 2017). Moreover, a study by Roberts and colleagues found a significant 
reduction of AGO2 in psoriatic lesions (Roberts et al., 2013). Given the strong dysregulation 
of miRNAs and their biogenesis proteins observed in psoriasis, surprisingly little is known 
about the expression of AGO1-4.  
 Our analysis of a small set of 8 lesional and non-lesional psoriatic epidermis samples 
show that AGO1 and AGO4 transcripts were significantly downregulated in psoriatic lesions. 
Additionally, expression of both AGO2 and AGO3 seems patient specific with downregulation 
more commonly observed (Fig. 6.4-6.7). Surprisingly, to our knowledge this is the first time 
AGO1-4 expression in psoriasis has been reported together. Conversely, recent work reported 
a significant decrease of AGO2 in psoriasis although their sample size was small at five clinical 
samples (Roberts et al., 2013). However, in our data set expression of AGO2 from two out of 
eight PP samples was severely upregulated by 4 to 6-fold which may mask any significance. 
Nonetheless, reporting a slightly elevated number of samples suggests that expression of AGO2 
is more patient specific than previously considered although additional psoriatic samples would 
be required to confirm this suggestion. Conversely, a recent study demonstrated significantly 
upregulated AGO2 in PP samples when compared with PN (Zhou et al., 2016). However, 
consistent with our data, the same study shows a reduction of AGO1 in psoriatic lesions, though 
their findings represent gene expression data derived from RNA-sequencing without validation 
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by RT-qPCR. We have showed that AGO3 was expressed in very low levels in HPEK and 
others reported low levels of AGO3 present in human skin (Völler et al., 2016). Hence, 
unsurprisingly, AGO3 expression was relatively unchanged between PP and PN samples, 
suggesting that the other AGOs are favoured over AGO3 by epidermal keratinocytes. 
Interestingly, AGO4 the most abundant AGO transcript we found in HPEK was the most 
heavily downregulated in psoriatic lesions, suggesting that AGO4 may play an unidentified 
role in epidermal keratinocyte biology and providing an interesting area for further study. 
Conceivably, elevated levels of miRNAs produced by upregulated Dicer/Drosha put AGOs 
under functional strain or that mechanisms which may or may not be miRNA dependent 
directly affect AGO expression. 
 
 
The epidermis consists of a dynamic relationship between proliferating and differentiating 
keratinocytes with tight spatial and temporal control required to maintain normal skin 
homeostasis. AGOs are essential in maintaining tissue homeostasis by regulating expression 
of epidermal miRNAs. Given that double knockout of cutaneous Ago1 and Ago2 in mice can 
upset this homeostasis, resulting in hyper thickened epidermis likely down to a reduction of 
global miRNA levels, the effects of AGO2 perturbation on factors associated with 
differentiation of human keratinocytes is relatively unstudied (Wang et al., 2012).  Therefore, 
changes in the differentiation associated effectors, cyclin E and involucrin, were examined in 
proliferating and differentiating HPEK loaded with siAGO2.  
 In proliferating HPEK loaded with siAGO2 both CCNE1 and CCNE2 were elevated 
when compared with the controls (Fig. 6.9). Given that, miR-184 induces cyclin E protein (Fig. 
4.8) but has no effect on both CCNE1 and CCNE2 transcript levels (Fig. 4.6-4.7), this may 
suggest that AGO2 is not a target for miR-184 in the context of miR-184 induced 
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differentiation. To our knowledge this is the first time AGO2 has been linked to the regulation 
of cyclin E transcripts in HPEKs. Previous work in human fibroblasts, has shown that AGO2 
represses E2F target genes such as cyclin E whereby they show overexpression of AGO2 
reduces cyclin E promoter activity by 50% (Benhamed et al., 2012). Suggesting that elevated 
cyclin E in response to reduced AGO2 activity might be due to derepression of E2F genes. 
Both CCNE1 and CCNE2 transcripts consistently induced in differentiating HPEKs (Fig. 3.3). 
However, in cells loaded with siAGO2 this induction was severely diminished compared to 
cells loaded with control siRNA (Fig. 6.9). This could be a compensatory mechanism by the 
cell, whereby elevated levels of cyclin E transcript are present within proliferating HPEKs 
treated with siAGO2 and accumulation of more transcript is not required.  
In both proliferating and differentiating HPEKs loaded with siAGO2 we have shown 
that IVL levels are relatively unchanged when compared with the control, although an increase 
was observed over 5 days indicative of differentiation (fig. 6.10). Yi and colleagues have shown 
that knockout of both Ago1 and Ago2 has a severe effect on the skin of mice, resulting in a 
hyper thickened epidermis and more apoptotic basal keratinocytes (Wang et al., 2012). Taken 
together with the minimal effect of siAGO2 on the expression of the differentiation marker, 
IVL, this may suggest that cyclin E is responsible for the development defects observed in the 
skin of mice with ablated Ago1/Ago2 and would provide an interesting avenue of further 
investigation.  
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Consistent with the literature our data shows that levels of miRNAs associated with epidermal 
development and disease, including miR-205 (Wang et al., 2013) and miR-21 (Guinea-
Viniegra et al., 2014), are down regulated in HPEKs treated with siAGO2 (Fig. 6.11). Previous 
work has shown that global expression of mature miRNAs is reduced by 40% in embryonic 
fibroblasts derived from AGO2 knockout mice (Diederichs and Haber, 2007). A study on the 
skin of Ago2 knockout mice has shown that global miRNA expression is reduced on average 
by 30% (Wang et al., 2012). Interestingly, our data shows that levels of miR-184 are reduced 
more than the other miRNAs tested, suggesting that miR-184 is less stable than both miR-21 
and miR-205 when the pool of AGO2 molecules is limited. 
 
 
AGO2 is a central part of the RISC complex and through miRNA-dependent inhibition, acts as 
an influential regulator of mRNA translation in the cytoplasm of mammalian cells. However, 
emerging evidence suggests that AGO2 also has functional activity within the nucleus were it 
can regulate processes such as alternative splicing and TGS (Benhamed et al., 2012; Taliaferro 
et al., 2013). Work by Bischof and colleagues has shown that AGO2 accumulates in the nucleus 
of human lung fibroblasts undergoing an irreversible form of growth arrest called senescence 
(Benhamed et al., 2012). Moreover, later work demonstrates a substantial presence of nuclear 
AGO2 in several cell types including HeLa, A459 and human breast cancer cell lines (Gagnon 
et al., 2014). Recent work showed strong nuclear AGO2 in human skin and keratinocyte 
cultures (Sharma et al., 2016). Taken together, nuclear localisation of AGO2 does not seem to 
be dependent on cell type. Therefore, our final aim of this study was to evaluate subcellular 
localisation of AGO2 in basal and differentiated HPEKs using several common differentiation 
agents. 
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 In proliferating HPEKs our data indicates that little to no AGO2 was present within the 
nucleus with most distributed in a perinuclear fashion. In contrast, when differentiation was 
induced, AGO2 appeared to localise to the nucleus in a Ca2+ specific fashion (Fig. 6.12-6.14). 
Relevant work by Sharma and colleagues partially supports our work, describing AGO2 as 
predominantly nuclear in parabasal differentiating layers of human epidermis as well as 
suprabasal layers of organotypic cultures. Contradictory, the same study also reports nuclear 
AGO2 within monolayer cultures in addition to basal cells of skin and organotypic cultures 
(Sharma et al., 2016). However, the proliferative or differentiated state of these monolayer 
cultures were not well described. Previous work suggests that 2% fetal bovine serum (FBS) is 
enough to trigger terminal differentiation in keratinocytes (Borowiec et al., 2013). 
Consequently, the addition of 5% FBS to low Ca2+ media by this study most likely triggered 
differentiation of HPEK monolayers although they provided no information describing 
differentiation marker expression. Therefore, the nuclear AGO2 reported by Sharma et al., 
2016 in apparently proliferating keratinocytes may be due to FBS.  
Perinuclear distributions of AGO2 are a common feature in human cells whereby 
processing of miRNAs occurs just outside of the nucleus. We show perinuclear localisation of 
AGO2 in proliferating cells, to our knowledge this has not been previously described in 
keratinocytes (Fig. 6.12-6.16). Consistently, in a hepatocarcinoma cell line called Huh7, AGO2 
is distributed in a similar perinuclear fashion (Berezhna et al., 2011). Likewise, a very recent 
study has observed AGO2 in the perinuclear region of HeLa cells (Castanotto et al., 2018). 
This could suggest that in keratinocytes the majority of non-coding RNA maturation occurs 
within close proximity to the nucleus.  
For the first time to our knowledge, we have shown Ca2+-dependent AGO2 nuclear 
localisation during keratinocyte differentiation (Fig. 6.12, 6.15 and 6.16). In contrast, both 
PMA and 1,25(OH)D3 failed to trigger substantial nuclear AGO2 shifts (Fig. 6.13 and 6.14). 
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Given that AGO2 localises to the nucleus of senescent lung fibroblasts were it regulates 
proliferation-associated genes (Benhamed et al., 2012), a hallmark of keratinocyte 
differentiation is growth arrest therefore, AGO2 may have a nuclear role during Ca2+-
dependent keratinocyte differentiation.  
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MiRNAs are vitally important to epidermal homeostasis with a plethora of cutaneous diseases 
arising from dysregulated miRNA expression. With this in mind, a growing body of research 
has sought to elucidate the molecular mechanisms behind miRNA-dependent regulation of 
keratinocyte biology. A specific miRNA, miR-184, has been shown to modulate AGO2 activity 
in epidermal keratinocytes (Roberts et al., 2013). However, despite recent advances, the 
understanding of miR-184 in the context of human epidermal keratinocyte biology has 
remained poorly described. Thus, the aims of this thesis were: 
1. Investigate miR-184 expression during HPEK differentiation and elucidate the 
regulatory mechanisms. 
2. Examine the effects of ectopic miR-184 on HPEK proliferation and differentiation by 
utilising synthetic miR-184 mimics and miR-184 LNA inhibitors. 
3. Investigate miR-184 expression and function during HPEK migration. 
4. And finally, explore epidermal AGO dynamics and examine the miR-184:AGO2 axis 
during HPEK differentiation  
In chapter 3, the expression of miR-184 was examined in HPEKs differentiated with the 
common differentiation agents, Ca2+, PMA and Vitamin D. The results have shown that miR-
184 is induced during HPEK differentiation in a mechanism that is dependent on Ca2+ and the 
major keratinocyte Ca2+ entry pathway SOCE. Moreover, levels of miR-184 were upregulated 
in psoriatic lesions when compared to non-lesional skin. A very recent study reported elevated 
levels of miR-184 in differentiating epidermal keratinocytes (Nagosa et al., 2017). However, 
this is the first time to our knowledge that SOCE has been implicated in the regulation of 
miRNAs and may provide a basis for further work investigating other miRNAs regulated in 
this fashion. Limitations of this chapter are not evaluating the expression of miR-184 in a 
stratified system such as human epidermis or organotypic cultures as well as not using 
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additional techniques such as fluorescent in situ hybridization to explore expression and 
specificity of miR-184 in both proliferating and differentiating HPEK.
 To realise aim 2, chapter 4 investigated the effects of perturbed miR-184 levels on 
HPEK proliferation and differentiation. We report that following introduction of a synthetic 
miR-184 mimic, HPEKs accumulate in G1-phase of the cell cycle and promote expression of 
key effectors associated with growth arrest, cyclin E (Freije et al., 2012) and p21 (Santini et 
al., 2001) in addition to the differentiation marker, involucrin (Borowiec et al., 2013). 
Importantly, inhibition of physiological miR-184 during keratinocyte differentiation impaired 
the normal expression of involucrin, cyclin E and p21 typically observed during HPEK 
differentiation. A recent study has shown accumulation of cyclin E in differentiating 
keratinocytes causes DNA damage (Freije et al., 2012). However, this chapter shows for the 
first time to our knowledge that miR-184 causes sustained DNA damage, likely from cyclin E 
accumulation, which may explain induction of the DNA damage effector, p21. We propose 
that miR-184 leads to cyclin E induced DNA damage and induction of a p21 DDR consequently 
leading to growth arrest and commitment to differentiation through expression of involucrin. 
For the first time, chapter 5 shows the induction of miR-184 in scratched monolayers. 
Furthermore, we support the apparent role of SOCE in the regulation of miR-184 in epidermal 
keratinocytes. This chapter also shows the induction of the miR-184 sponge, UCA1, in 
wounded monolayers. One of the most exciting findings from this research was the modulation 
of keratinocyte migration by perturbation of miR-184 levels, whereby migration was 
stimulated in HPEKs loaded with miR-184 whilst inhibition of miR-184 reduced migration. 
However, by not identifying miR-184 targets in both differentiating and migrating HPEK, 
chapter 4 and 5 share a major limitation. We anticipated a role for AGO2, which has previously 
been shown to be a target for miR-184 (Roberts et al., 2013; Tattikota et al., 2014). Nonetheless, 
a putative link between AGO2 and miR-184 was not found in the context of miR-184 induced 
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differentiation. However, we have shown cause and effect with ectopic miR-184 modulating 
the differentiation and migration of HPEK. With science based fundamentally on observations 
these findings could lead to further work utilising genome wide expression profiling, as well 
as transcriptomic and proteomic analysis to expand our knowledge of miR-184 targets in 
keratinocyte differentiation and migration, facilitating the development of miRNA-based 
dermaceuticals for treatment of chronic wounds and cutaneous diseases such as psoriasis. 
In chapter 6, we report for the first time independent expression profiles for AGO1-4 in 
differentiating HPEK monolayers. Bosserhoff and colleagues show AGO1 as the most 
abundant AGO transcript in human skin (Völler et al., 2016). However, our data has shown 
that AGO4 was most abundant in HPEK monolayers. Moreover, evaluation of AGO2 in 
differentiating HPEKs revealed no reduction in response to enhanced physiological miR-184. 
Interestingly, both AGO1 and AGO4 were downregulated in psoriatic patients. Finally, it was 
established that in differentiating HPEK, AGO2 localises to the nucleus in a process that is 
reliant on Ca2+, pointing to a nuclear role for AGO2 during differentiation and representing an 
interesting area of further study to demystify the role of nuclear AGO2 in epidermal 
keratinocyte differentiation.  
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